Cell Cycle Regulation of Retinal Progenitors; a role for the Nance-Horan Syndrome Protein in Retinogenesis by Vorster, Paul J.
Virginia Commonwealth University
VCU Scholars Compass
Theses and Dissertations Graduate School
2015
Cell Cycle Regulation of Retinal Progenitors; a role




Follow this and additional works at: http://scholarscompass.vcu.edu/etd
Part of the Developmental Biology Commons
© The Author
This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in




Cell Cycle Regulation of Retinal Progenitors; a role for 







A thesis submitted in partial fulfillment of the requirements for the degree of Ph.D. in 
 








Paul J. Vorster 
 
 







Director: Gregory S. Walsh, Ph.D. 
 













Table of Contents 
 
Abstract...…………………….……...……………………………………………………....… pg 3 
Acknowledgements ...……………...………………………………………………….…...… pg 5 
List of Figures ………………………………………………………………………….……... pg 7 
List of abbreviations ………………………….………………………………………..…….. pg 9 
 
Chapter I: Introductory Literature Review 
 
Early eye development in vertebrates …………………..…………………………........... pg 12 
Retinogenesis ………………………………………………………………...…….….……. pg 13 
Nance-Horan syndrome ……………………………..………………………………..……. pg 13 
The NHS family of genes …………………………………………………………….….…. pg 14 
Retinal manifestations of NHS …………………………...……………………….……..... pg 15 
Structure and function of NHS …………………………………………………….………. pg 16 
Vertebrate model organisms as tools to study Nance-Horan syndrome ….…….……. pg 17 
A role for p53 in development ………………………….…………………………....…..... pg 18  
Defining a role for zebrafish p53 isoform, Δ113p53, during organogenesis …….…… pg 19 
Regulation of G1 phase of the cell cycle during neurogenesis ..……………….……… pg 20 
Figures and Legends ...……………………………………………………………….……. pg 22 
 
Chapter II: The Nance-Horan Syndrome Family of genes is conserved 
among vertebrates 
 
Abstract …………………………..…………………………………………………………. pg 24 
Introduction …………………………………………………………………………………. pg 25 
Materials and Methods ……………………………………………………………………. pg 27 
Results …………………………………...…………………………………………………. pg 31 
Discussion ……………………………….…………………………………………………. pg 37 
Figures and Legends …………………………………...…………………………………. pg 39 
 
Chapter III: Selective upregulation of Δ113p53 expression leads to cell 
cycle arrest of retinal progenitors in the absence Nance-Horan syndrome 
(NHS) 
 
Abstract …………………………..………………………………………………………..…. pg 54 
Introduction ………………………………………………………………………………..…. pg 55 
Materials and Methods ………………………………………………………………….….. pg 57 
Results …………………………………...…………………………………………….......... pg 62 
Discussion ……………………………….……………………………………………….….. pg 74 
Figures and Legends …………………………………...………………………………...... pg 78 
 




The retina develops when retinal progenitor cells (RPCs) exit cell cycle and differentiate 
into neurons. Many cells are added to the retina as equipotent RPCs go through a burst of 
proliferation. The overall size and volume of the retina is a result of the total number of 
cells that arise from these cell divisions prior to differentiation. The NHS family of genes 
are orthologs of the Drosophila gene, gukh. NHS, NHSL1 and NHSL2 are conserved 
among vertebrates, including human, mouse, Xenopus tropicalis and zebrafish. Humans, 
with mutation in the NHS gene, have Nance-Horan syndrome and display multiple defects 
in eye development, including, micropthalmia, cataracts and alternations in the layers of 
the retina. In this body of work we ask the questions, (1) is the function of NHS conserved 
in vertebrates, and (2) does NHS play a role in early cell divisions of RPCs?  
Multiple sequence alignment of amino acid sequences, from multiple species, revealed 
regions of high homology called Family Domains (FD) FD1 – FD9, NHS Domains (ND) 
ND1 – ND10, and NHS-like1 Domains (L1D) L1D1 – L1D4. We identified classical nuclear 
localization sequences (NLS) in FD 7 (found in both NHS and NHSL1), and ND2 (NHS 
only). Spatial and temporal expression of NHS genes was assessed by in situ 
hybridization in zebrafish and Xenopus tropicalis during early development. We show that 
NHS is expressed in the retinas of Danio rerio and Xenopus tropicalis during key stages 
of retinogenesis, and that knockdown of the gene resulted in a small eye phenotype in 
both species. Differentiation of neurons was delayed, while the total number of cells that 
makes up the volume of the retina was markedly reduced. Here we show that the small 
retina in nhsb knockdown embryos are due to p53-dependent cell cycle arrest with 
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specific induction of p53 target gene, Δ113p53 and p21. Δ113p53 protects nhsb-
knockdown cells from p53-mediated apoptosis. nhsb overcomes a proliferation restriction 
in retina progenitor cells during retinogenesis, while knockdown of nhsb increases 
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PSI-BLAST  position specific iterated BLAST 
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RMA   robust multi-array analysis 
RPE    retina pigment epithelial 
SAM   significance analysis of microarrays 
SLiMs   short linear motifs 
splMO   splice blocking morpholino oligonucleotide 
SRA 01/04  immortal human lens epithelial cell line 
WASP  Wiskott-Aldrich syndrome protein 
WAVE  WASP-family Verprolin-homology protein 
WHD   WAVE homology domain 
wt   wild-type 
Xcat   mouse model of NHS, X chromosome cataract 
xt   Xenopus tropicalis, or frog 
ZO-1   zona occludens protein 1  
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Early eye development in vertebrates 
The eye field, or eye primordium, is specified shortly after gastrulation at the anterior 
neural plate. It contains all the neural progenitors required to form the neural structures of 
the eye, as well as the retinal pigment epithelium (Li et al. 1997) (Wilson  Haourt, H 2004). 
The eye field is marked by overlap expression of a specific set of transcription factors, 
called eye field transcription factors (EFTFs), including Pax6, Rax, Six3 and Lhx2. 
Expression of EFTFs is highly conserved in vertebrates and cause the eye field to divide 
into the bi-lateral hemispheres that gives rise to the optic vesicles (OV) (Zuber et al. 2003) 
(Byerly and Blackshaw 2009). The distal OV folds into itself and creates concave 
structures called optic cups (OCs). During formation of the OCs, an ectoderm-derived 
structure called the lens placode is in close contact with the distal OV and forms the lens 
cup or lens pit. Although the lens placode is present during invagination of the OC, in vitro 
studies in mouse three-dimensional culture have shown that it is an autonomous 
morphogenetic process; the OC can form from the OV without the presence of the lens 
placode or other structures (Eiraku et al. 2011). The inverse, however, is not true since 
the lens placode requires interaction with the OV to invaginate (Streit 2007). The outer 
most layer of the OC forms the presumptive retina pigment epithelial (RPE) layer and the 
inner layer of the OC becomes the presumptive neural retina (NR) while remaining 




In vertebrates, most neurons cannot be replaced during the lifespan of the animal. During 
brain development the number of cells that arise from early cell divisions must therefore 
add up to the full complement of neurons in the central nervous system (CNS). Retinal 
neurogenesis, however, continues throughout the life of fish and amphibians, so that the 
overall volume of the eye remains proportional relative to body size which continues to 
increase throughout the life of the animal (Cerveny et al. 2010) (He et al. 2012). During 
the process of retinal neurogenesis, or retinogenesis, retina progenitor cells (RPCs) in the 
optic cup (OC) undergo a rapid transformation to form the functional retina. Precise 
coordination between cell proliferation and differentiation assures the correct volume and 
size of the retina, relative to body size (He et al. 2012). Initially, RPCs that make up the 
OC go through a burst of rapid cell proliferation. These multipotent RPCs then enter a 
phase of cell cycle exit and cell differentiation to acquire their postmitotic fates as neurons 
and glia in the retina. The six classes of cells found in the retina are retina ganglion cells, 
horizontal cells, bipolar cells, amacrine cells, rod photoreceptors, cone photoreceptors 
and Muller glia (Fig. 1). Axons from retinal ganglion cells located at the innermost layer of 
the neural retina, or ganglion cell layer, elongate and enter the optic stalk (OS) along with 
glial precursors. The OS elongates and eventually gives rise to the optic nerve, which 
innervates the optic tectum (Torres, Gómez-Pardo, and Gruss 1996). After neurogenesis 
in the central retina, a small population of proliferative progenitors remains at the 




In 1974, Walter E. Nance from the United States, reported a family of 7 males and 9 
females with severe congenital cataracts, dental anomalies and microcornea (Nance WE, 
Warburg M, Bixler D 1974). The female carriers were not affected as severely as the 
males. Corrective cataract surgery at infancy did not improved visual acuity of affected 
males. Simultaneously in 1974, Dr. Margaret B. Horan from Australia described a similar 
pedigree in an Australian family with hereditary cataracts. Although similar observations 
were made before then in 1937 by Walsh et al., in 1967 by Fraccaro et al. and in 1969 by 
Krill (Fraccaro M, Morone G, Manfredini U 1967) (Krill AE, Woodbury G 1969), the 
disease was accordingly termed Nance-Horan Syndrome (NHS). 
NHS is a rare X-linked developmental disorder characterized by severe congenital 
cataract, retinal cystoid degeneration, microopthalmia, numerous dental and craniofacial 
anomalies, and mental retardation. Facial dysmorphism in NHS patients is characterized 
by a long face, prognathism, a large nose, with a high nasal bridge, and large often 
protruding ears. The most prevalent dental abnormalities reported include diastema, 
supernumerary incisors or posterior teeth, which are often impacted, and shape 
abnormalities, the most typical being screwdriver-shaped teeth. Males with NHS are 
diagnosed early, often at birth by association of congenital cataracts. The true incidence 
of this disease has not been fully evaluated, but the disease is likely to be under 
diagnosed. 
 
The NHS family of genes 
Early in 1990, linkage analysis was performed on 36 members with Nance-Horan 
Syndrome. The NHS gene locus was mapped to the distal end of chromosome X, at 
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position Xp22.31 – Xp22.13 (Zhu D, Alcorn DM, Antonarakis SE, Levin LS, Huang PC, 
Mitchell TN, Warren AC 1990). To date, 33 different gene mutations have been identified 
in the NHS gene in patients and these typically result in a truncated protein (Li et al. 
2015). In fact, only one missense mutation in NHS has been reported to cause NHS 
(Chograni et al. 2011). The Nance-Horan family of genes are orthologs of the drosophila 
gene GUK-holder (gukh) (Katoh M 2004). gukh is a known adapter molecule that 
physically interacts with both Discs large (Dlg) and Scribble (Scrib). Because human 
homologs of Dlg and Scrib are known cancer-associated genes, NHS was also classified 
as a cancer associated gene (Katoh M 2004). The NHS gene family comprises the 
prototypical member, NHS, as well as NHS-like 1 (NHSL1) and NHS-like 2 (NHSL2) 
(Walsh et al. 2011). The NHS gene family is conserved in human and other vertebrates, 
including mice, frogs, and zebrafish. 
 
Retinal manifestations of NHS 
All males affected by Nance-Horan syndrome have severe bilateral cataracts at birth, 
often associated with microphthalmia, microcornea and glaucoma. After corrective 
cataract and glaucoma surgeries, vision remains poor and often results in postoperative 
complications (Huang et al. 2007) (Florijn et al. 2006) (Bixler D, Higgins M 1984). In 
heterozygous females, the phenotype is attenuated. Microcornea is rarely seen, while 
microphthalmia have not been reported in female carriers of the mutation (Huang et al. 
2007) (Florijn et al. 2006) (Bixler D, Higgins M 1984) (Lewis 1989). Recently, NHS-related 
retinal pathology was reported in two patients. In one case study, an electroretinogram 
(ERG) was used to measure electrical activity generated by neurons in the retina when 
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stimulated by light. A young boy with NHS from Belgium, had no response from rod 
photoreceptors as measured by scotopic ERG, and very limited response from cone 
receptors as measured by photopic ERG (Mathys et al. 2007). Another patient with NHS 
had severe retinoid cystic degeneration in the inner and outer plexiform layers, regions of 
the retina enriched with axons and dendrites. The inner and outer nuclear layers, where 
cell bodies of retinal neurons are located, were thinner than normal or absent (Ding X, 
Patel M, Herzlich AA, Sieving PC 2009). This suggests that in addition to the widely cited 
presence of congenital cataracts, NHS patients are likely to have an under-reported 
presence of retinal defects.   
 
Structure and function of NHS 
Position specific iterated BLAST (PSI-BLAST) analysis of the mouse NHS sequence 
(encoded by exon 1) revealed that the N-terminus of NHS is proline-rich, and that it is 
structurally similar to dynamin and synaptojanin (Huang et al. 2006). Both of these 
proteins are known to interact with the actin cytoskeleton. Another region within exons 1-4 
of NHS, similar to the Wiskott-Aldrich (WH1) domain of the WASP and WAVE proteins, 
was also identified by PSI-BLAST (Huang et al. 2006). Evidence from Brooks et al., has 
shown that the WHD domain in human NHS is functional in that it can bind to the same 
proteins as WAVE proteins (Brooks et al. 2010). WAVE proteins, members of the larger 
Wiskott-Aldrich syndrome protein (WASP) family, exist in an inhibitory heteropentameric 
WAVE complex that is activated by Rac to promote actin polymerization in protrusive 
membrane structures via interaction with the Arp2/3 complex (Takenawa and Suetsugu 
2007) (Insall and Machesky 2009) (Derivery and Gautreau 2010). Human NHS binds 
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components of the hetero-pentameric WAVE complex, but lacks the other domains 
required for interaction with actin and Arp2/3. For instance, the WHD of human NHS binds 
to Abi1, a member of the pentameric complex, which localizes to actin rich structures in 
cell culture (Brooks et al. 2010). Interestingly, a new function for the WHD domain of 
WAVE proteins in the nucleus was recently reported. It was shown that Xenopus WAVE1 
binds to active transcription components to transactivate genes during development in a 
manner that was dependent on the presence of the wave homology domain (WHD) 
(Miyamoto et al. 2013). In mouse, NHS localized to the cytoplasm and nucleus of 
epithelial cells in the lens, retina and brain. In the cytoplasm, it co-localized with tight 
junction protein ZO-1 (Sharma et al. 2006) (Sharma et al. 2009).  
 
Vertebrate model organisms as tools to study Nance-Horan Syndrome 
Nance-Horan syndrome is diagnosed after birth. During embryogenesis, the NHS gene 
has an important function in lens, eye and brain formation. Our ability to study the function 
of NHS in humans is limited to a window of development, which requires invasive 
procedures. Consequently, the literature on Nance-Horan Syndrome is mainly derived 
from case studies postpartum and family history (Ding X, Patel M, Herzlich AA, Sieving 
PC 2009). A few studies were done in cell culture with rat PC12, MDCK, human SRA 
01/04 or HEK 293A cells (Burdon et al. 2003) (Sharma et al. 2006) (Sharma et al. 2009). 
A better method of studying organogenesis is by use of model organisms like mice, frog 
and zebrafish, since it is important to study cell morphology and gene expression in 
context of surrounding tissues and external cues (Hashimoto, Morita, and Ueno 2014). A 
mouse model for NHS, called Xcat, was identified in a dominant cataract mutation screen. 
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NHS antibody stain of Xcat and wt mice showed localization of NHS in the lens and retina 
during development (Huang et al. 2006).  
Both Xenopus tropicalis and Danio rerio are excellent model organisms for studying early 
development. Eggs are laid externally in high numbers and development progresses 
rapidly after fertilization. Zebrafish is particularly well suited for studying neurogenesis due 
to a combination of genetic tools and state-of-the art imaging techniques that can be 
applied to transparent embryos (Schmidt, Strähle, and Scholpp 2013). To date, no one 
has used Xenopus or zebrafish to study the function of NHS during development.   
 
A role for p53 in development 
p53 plays an important role in cell cycle arrest and apoptosis. During conditions that 
cause DNA damage, p53 stops cell growth by transcriptional activation of its target gene 
Cdkn1a, which encodes the cyclin dependent kinase inhibitor, p21 (Kastan MB, 
Onyekwere O, Sidransky D, Vogelstein B 1991). During cell division, p21 blocks the 
Cdk4/cyclin D complex, and prohibits transition from G1 to S-phase (Ekholm and Reed 
2000) .p53 is also a transcriptional regulator of Bax, a pro-apoptotic protein, that regulates 
the mitochondrial apoptotic pathway by release of cytochrome c and activation of 
procaspase-3 (Marchenko, Zaika, and Moll 2000). Both cell cycle regulation and 
apoptosis occur during normal embryogenesis. Subcellular localization of p53 is seen in 
the nucleus at a critical point of differentiation in primary neurons, oligodendrocytes and 
PC12 cells (Eizenberg et al. 1996). Importantly, transgenic zebrafish with mutations in 
p53 develop normally, have a decreased apoptotic response to irradiation, fail to 
 19 
upregulate p21, and develop malignant peripheral nerve sheath tumors late in live 
(Berghmans et al. 2005). 
 
 
Defining a role for zebrafish p53 isoform, Δ113p53, during organogenesis 
p53 protein and p53 signaling pathways are evolutionarily conserved. In addition to full 
length p53 protein, it was discovered that p53 can actually be expressed as multiple 
isoforms through a combination of alternative splicing or the use of an additional 
alternative promoter contained within intron 4 (Chen et al. 2009). The promoter elements 
in intron 4 were also found to be evolutionarily conserved from humans to mice to 
zebrafish. In humans, the isoform produced from the alternative intron 4 promoter creates 
a p53 protein starting from amino acid 133, termed Δ133p53. In zebrafish, this isoform is 
conserved can called Δ113p53. These p53 isoforms lack the N-terminal transactivation 
domains and a portion of the DNA binding domain, but still encode the tetramerization 
domains in the C-terminus of the protein.  
A Loss-of-function mutation in the zebrafish def gene causes hypoplastic digestive 
organs. A group from Singapore discovered that the p53 isoform, Δ113p53, was highly 
upregulated in the absence of the def gene (Chen et al. 2005). Importantly, Chen et al. 
show the promoter contained within intron 4 is itself p53-responsive and that full-length 
p53 can bind to DNA sequences in this promoter. Their study demonstrated that the 
Δ113p53 isoform is directly transactivated by full-length p53. An important role for 
Δ113p53 was discovered during organogenesis where the isoform acts as a dominant 
negative by forming heterodimers with full-length p53. The smaller size of the organ was 
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caused by cell cycle arrest as elevated levels of Δ113p53 arrests cell proliferation in a 
p21-dependent manner, but did not cause apoptosis. Given that Δ113p53 lacks the 
activation domain but retains the oligmerization domain, it was not surprising that the 
Δ113p53 isoform would act as a naturally occurring dominant negative. However, Chen et 
al. went on to show that Δ113p53 had no effect, or even slightly enhanced the ability of 
p53 to upregulate p21, but inhibited p53’s transcriptional activation of the pro-apoptotic 
gene Bax. Therefore, Δ113p53 upregulation leads to the selective expression of 
downstream p53-target genes. Taken together, Δ113p53 upregulation can selectively 
antagonize p53-induced apoptosis and favors p53-mediated cell cycle arrest by 
upregulating p21 (Chen et al. 2009).  
 
 
Regulation of G1 phase of the cell cycle during neurogenesis 
During formation of the CNS, the number and ratio of neuronal subtypes that arise from 
neuronal progenitors, result from the temporary coordination of rapid cell division, cell 
cycle exit and neuronal differentiation. The G1 phase of the cell cycle is prolonged in 
differentiative divisions, while proliferative neuroepithelial cells, the progenitors of all 
neurons, take less time to process through G1 (Götz and Huttner 2005) (Calegari and 
Huttner 2003). The balance between differentiation and self-renewal is highly regulated by 
progression through G1 phase (Fluckiger et al. 2006), which in turn depends on 
expression of E and D-type cyclins, Cyclin-Dependent Kinases (CDKs) and CDK 
inhibitors p21 and p27 (Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB 1996). 
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Upon cell cycle exit, daughter neurons enter the post-mitotic G0-phase, terminally 
























We characterized the Nance-Horan syndrome family of genes in silico. Coding DNA of 
NHS, NHSL1 and NHSL2 orthologs are conserved among vertebrates, including human, 
mouse, Xenopus tropicalis and zebrafish. Multiple sequence alignment of amino acid 
sequences revealed regions of high homology called Family Domains (FD) FD1 – FD9, 
NHS Domains (ND) ND1 – ND10, and NHS-like1 Domains (L1D) L1D1 – L1D4. A 
proteomics screen identified short linear motifs (SLiMs) within FD, ND and L1D domains, 
which are conserved in vertebrates. Of note, we identified classical nuclear localization 
sequences in FD7 and ND2. Spacial and temporal expression of NHS genes was 
assessed by in situ hybridization in zebrafish and Xenopus tropicalis during early 









A bioinformatics screen for human homologs of the drosophila Guanylate-kinase holder 
(gukh), showed that GUKH1 was identical to the human Nance-Horan syndrome (NHS) 
gene (Katoh M 2004). gukh is a known adapter molecule that connects Discs large (Dlg) 
and Scribble (Scrib). Because human homologs of Dlg and Scrib are known cancer-
associated genes, NHS was also classified as a cancer associated gene. The Nance-
Horan syndrome family of genes are orthologs of drosophila gukh (Walsh et al. 2011). 
The NHS gene family comprises the prototypical member, NHS, as well as NHS-like 1 
(NHSL1) and NHS-like 2 (NHSL2). Most vertebrates, including mammals, mice and frogs, 
express 3 NHS paralogs. The exception is zebrafish, which due to a genome duplication 
event in the teleost lineage, have two copies of each paralog: nhsa, nhsb, nhsl1a, nhsl1b, 
nhsl2a, and nhsl2b (Walsh et al. 2011). The lack of widespread phenotypes in NHS 
patients could be due to redundancy of expression in the NHS gene family during 
development. The conserved, N-terminal WAVE homology domain (WHD) was identified 
in NHS, NHSL1 and NHSL2, and is known to associate with actin rich structures (Brooks 
et al. 2010). Our lab has shown that zebrafish nhsl1b plays a role in migration of facial 
brancial motor neurons, defining a role for nhsl1b as effector of planar cell polarity 
signaling (Walsh et al. 2011). Otherwise, very little is known about the structure and 
function of the NHS family of genes. We set out to characterize the NHS family by 
identification of conserved features in vertebrates. We also utilized in situ hybridization to 
assess spatial and temporal expression of the NHS family of genes. The outcome of 
these experiments can help assess the viability of Xenopus tropicalis and Danio rerio as 
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tools to further study the NHS family of genes during development. In addition, we hope to 







Materials and Methods 
 
Genes used and Cladogram 
Coding DNA sequences were gathered from, Ensembl (http://www.ensembl.org). Splice 
variants were checked by Mouse Genome Informatics (http://www.informatics.jax.org/), 
Zfin (http://zfin.org/), Xenbase (http://www.xenbase.org) and FlyBase (http://flybase.org/).  
Xenopus and zebrafish genes were manually curated using UCSC genome browser 
(https://genome.ucsc.edu/), Xenbase and Zfin. The following genes were used in our 
analysis: 
human: NHS (ENSG00000188158), NHSL1 (ENSG00000135540), NHSL2 
(ENSG00000204131). 
Mus musculus: NHS (ENSMUSG00000059493), NHSL1 (ENSMUSG00000039835), 
NHSL2 (ENSMUSG00000079481).   
Xenopus tropicalis: NHS (ENSXETG00000001112), NHSL1 (ENSXETG00000006237), 
NHSL2 (ENSXETG00000022580). 
Danio rerio: nhsa (ENSDARG00000070227), nhsb (ENSDARG00000079977), nhsl1a 
(ENSDARG00000054537), nhsl1b (ENSDARG00000042627), nhsl2a 
(ENSDARG00000089066), nhsl2b (ENSDARG00000090164). 
Drosophila melanogaster: gukh (FBgn0026239). 
Above genes were entered into ClustlW2 Phylogeny (http://www.ebi.ac.uk/) and aligned 
by multiple sequence alignment. A Newick output was generated using the Neighbour-




Percent Identity, Multiple sequence alignment 
The protein-protein basic local alignment search tool (BLASTP), was used to calculate 
total percent identity (%id) of proteins (http://blast.ncbi.nlm.nih.gov/).  
Multiple sequence alignments were performed in ClustalW 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). We used a gap distance of 5 and default 
settings for our analysis(Larkin et al. 2007). Family Domains (FD1 – FD9) were identified 
as extended stretches of >10 AAs present in both NHS and NHSL1, across all species. 
NHS domains (ND1 – ND10) were unique to NHS alignments only, but did not overlap 
Family Domains. Similarly, NHSL1 Domains (L1D1 – L1D4) were unique to NHSL1 
proteins. Domains were outlined and color-coded in Adobe Illustrator CS5.5 
(http://www.adobe.com/).  
 
Identification of Short Linear Motifs and the WHD domain 
The Eukaryotic Linear Motif (ELM) resource was used to identify short linear motifs 
(SLiMs) within conserved regions of NHS and NHSL1 (http://elm.eu.org/). Motifs are 
identified when short motifs of specific AAs are identified. For example, the ELM class 
DEG_SCF_TRCP1_1 describes the pattern D(S)G.{2,3}([ST]), whereby the first three 
amino acid positions (D,S,G) are fixed positions, followed by a flexible gap of either two or 
three amino acids of any type, followed by either an S or T residue. The round brackets 
around the second and last position indicate that these positions have to be 
phosphorylated to have a fully functional motif (Dinkel et al. 2014). ELM class 
DEG_SCF_TRCP1_1 is a SCF ubiquitin ligase binding Phosphodegrons. For purposes of 
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our analyses, AA sequences from all relevant species had to adhere to these rules for 
consideration. The exact AA sequence for each SLiM was duplicated and labeled on 
conserved domains (Fig 5, 6 & 7). The WAVE homology domain (WHD) was previously 
identified in human NHS, NHSL1 and NHSL2 (Brooks et al. 2010). Conservation of the 
WHD domain in mice, Xenopus and zebrafish was verified by HMM-HMM comparison 
(http://toolkit.tuebingen.mpg.de/hhpred). 
Reverse Transcriptase PCR 
RNA was isolated from whole embryos using an RNeasy kit (Qiagen) and genomic 
contamination was eliminated by on-column DNA digestion (Qiagen). First Strand cDNA 
was synthesized using the Protoscript M-MuLV First-Strand cDNA Synthesis Kit (New 
England Biolabs). Equal concentrations of RNA (1ug) from all developmental timepoints 
were used in the cDNA synthesis reaction. Concentration of cDNA across developmental 
timepoints was validated using primers specific to the ornithine decarboxylase (ODC) 
gene. cDNAs were amplified using primers designed to amplify a 3’ region of each gene 
with forward primers located in exon 7 and reverse primers located in exon 8, such that 
RT-PCR products spanned an intron-exon boundary. Primers were designed to be low in 
nucleotide similarity to ensure specificity. Primer sequences are listed in Supplemental 
Figure 1.A. 
 
in situ Hybridization 
We made 3’UTR probes for each of the NHS genes designing left PCR primers 
downstream of the stop codon and a right primer in the 3’UTR region of each gene. PCR 
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was performed on cDNA reverse-trasncribed from RNA isolated from 24 hpf embryos. 
PCR products were cloned into pCR4-Blunt, sequenced. Sense and antisense probes 










Characterization of the NHS family of genes in silico  
We screened the genomes of human, Mus musculus, Xenopus tropicalis and 
Danio rerio, in silico, for NHS, NHSL1 and NHSL2 genes. In human both NHS and NHSL2 
are located on the X chromosome, while NHSL1 is located on Chr 6. Mouse NHS and 
NHSL2 are also both located on the X chromosome, while NHSL1 is located on Chr 10. 
All human and mouse NHS genes were validated for non-redundancy by RefSeq 
(Fig.1.A). Xenopus tropicalis NHS is located on chromosome 2, while gene loci of NHSL1 
and NHLS2 remains undetermined. In zebrafish, nhsa is located on Chr 23, nhsb on Chr 
11, nhsl1a on Chr 17, nhsl1b also Chr 11 (Fig.1.A). Previously, it was not possible to 
identify orthologs of NHSL2 in zebrafish (Walsh et al. 2011). Due to alignment of up-to-
date cDNA and EST sequence data by Standard Ensembl genebuilds, we mapped gene 
loci of nhsl2a and nhsl2b genes. Zebrafish nhsl2a (ENSDARG00000089066) is located 
on chromosome 7: 52,927,886 - 53,001,466, and nhsl2b (ENSDARG00000090164) is 
located on Chromosome 21: 41,937,034-41,955,898. RefSeq did not validate any of the 
frog or fish NHS genes for non-redundancy (Fig.1.A). Some inconsistencies in EST data 
made manual curation of zebrafish nhsl2a, zebrafish nhsl2b and Xenopus NHSL2 difficult.  
In human and mice, NHS and NHSL1 are both located on the X chromosome (Fig.1.A). 
All NHS genes are located on separate chromosomes in Danio rerio and Xenopus 
tropicalis (Fig.1.A). 
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NHS basepair sequences from Homo sapiens, Mus musculus, Xenopus tropicalis 
and Danio rerio were entered into ClustlW2 Phylogeny (http://www.ebi.ac.uk/). A Newick 
output was generated for portions of similar coding DNA:  
(((xt_NHS:0.16254, (hs_NHS:0.06523, mm_NHS:0.06469): 0.08999):0.05165, 
(dr_NHSa:0.18500, dr_NHSb:0.18012): 0.03401): 0.16342, (dr_NHSL1a:0.24885, 
dr_NHSL1b:0.24107): 0.01194, (xt_NHSL1:0.24637, (hs_NHSL1: 0.09479,mm_NHSL1: 
0.09586): 0.13988):0.01292);. Cladistic analysis was performed to provide a graphical 
representation of the same genes. All of the above-mentioned vertebrate genes were 
subjected to pairwise alignment, along with Drosophila gukh gene (FBgn0026239) for 
comparison. Branches correspond to regions of similarity, which also indicate 
evolutionary conservation of genes (Fig.1.B). Proportions of similar DNA depicted by 
branches are comparable to the Newick output generated by ClustlW2 Phylogeny.  
Taken together, these data demonstrate that the NHS family of genes, are the 
vertebrate homologs of the Drosophila gene gukh. Moreover, NHS, NHSL1 and NHSL2 
genes are conserved in human and other vertebrates, including mice, frog, and zebrafish. 
 
Evolutionary conservation of NHS and NHSL1 protein domains 
NHS and NHSL1 proteins from all species were comparable in length, with mouse 
NHS being the longest at 1630 AA, and dr nhsb the shortest at 1431 AA in length 
(Fig.1.C). Due to inconsistencies in ESTs and amino acid (AA) sequences for NHSL2 
among vertebrates, we decided to exclude NHSL2 from the remainder of our in silico 
analysis. 
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Percent identity (%id) of NHS and NHSL1 proteins was determined using protein-
protein BLAST (http://blast.ncbi.nlm.nih.gov/). Human NHS and mm NHS had the highest 
%id of NHS orthologs with 87%, while Human NHS and dr nhsb had the lowest with 39%. 
When comparing NHSL1 orthologs, hs NHSL1 and mm NHSL1 had the highest %id of 
74%, while xt NHSL1 and dr NHSL1a had the lowest with 34% (Fig.1.D). Comparison of 
NHS to NHSL1 homologs revealed hs NHS and mm NHSL1 had the highest %id of 65%, 
while the majority of homologs had %id in the 50% - 30% range (Fig.1.D). NHS and 
NHSL1 proteins have a high percentage of total identity when compared across species.  
Next, we performed multiple sequence alignment between species by ClustlW to 
identify regions of similarity within proteins (Larkin et al. 2007). We identified 9 regions of 
high homology conserved in both NHS and NHSL1 and termed these Family Domains, 
FD1 – FD9 (Fig.2). We then identified regions specific only to NHS proteins that did not 
overlap with Family Domains. We called these NHS-specific domains - NHS homology 
domains, ND1 – ND10 (Fig.3). Finally, we identified 4 regions specific only to NHSL1 
proteins and termed them NHSL1 domains, L1D1 – L1D4 (Fig.4). In summary, Family 
domains (FD1 - FD9) are found in all NHSL1 and NHS proteins. NHS domains (ND1-
ND10) are unique to NHS only, and NHSL1 domains (L1D1 – L1D4) are unique to NHSL1 
proteins only. Regions were mapped and color-coded for easy identification and 
downstream analysis (Fig.2, Fig.3 & Fig.4). Taken together, NHS and NHSL1 proteins do 
not share a high percentage of total amino acid sequence identity, but do contain discrete 




Conserved domains contain multiple SLiMs 
 With only a few publications available on Nance-Horan syndrome, limited 
information is available on protein function of NHS and NHSL1. With hopes of learning 
more about the identity of NHS proteins, we queried various proteomic databases. 
Unfortunately, our analysis in InterProScan5, Pfam, Panther and BlastProDom identified 
no known globular domains in NHS or NHSL1 proteins. We turned our focus to short 
linear motifs (SLiMs) located within conserved NHS domains. SLiMs, also called 
MiniMotifs, are generally 3 - 11 AAs is length, and conduct diverse processes, including: 
cell cycle progression, protein degradation, sub-cellular localization, stabilization of 
scaffolding complexes, and serve as recognition sites of proteolytic cleavage 
(Dinkel_2013). We submitted AA sequences of family domains FD1 – FD9, NHS 
homology domains ND1 – ND10, and NHSL1 domains L1D1 – L1D4 to the Eukaryotic 
Linear Motif (ELM) resource. SLiMs were only recorded if they were identified in all 
species (Fig.5, Fig.6 & Fig.7). In some cases, no SLiMs were found (FD1), while the 
maximum number of 25 possible SLiMs were identified in ND7. Of note, Classic nuclear 
localization sequences (NLS) were identified in FD7 (Fig.5) and ND2 (Fig.6). While no 
globular domains were identified, NHS and NHSL1 proteins contained multiple SLiMs 
within conserved domains, including two NLSs. 
A N-terminal WAVE homology domain (WHD) was identified in NHS, NHSL1 and 
NHSL2, in human and mice, and is known to associate with actin rich structures(Brooks 
et al. 2010). Previously, our lab verified conservation of the WHD domain in human, mice, 
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Xenopus and zebrafish of NHS and NHSL1 proteins by HMM-HMM comparison 
(http://toolkit.tuebingen.mpg.de/hhpred). The WHD domain is conserved on the N-terminal 
portion of NHS and NHLS1 proteins in human, mouse, frog and fish and overlaps with 
FD1 (Fig.8.A).    
Recently, WHD-containing WAVE proteins were found in the nucleus and affect 
regulation of transcription. Interestingly, our SLiM analysis identified two NLS in NHS. 
Also, identified helix-turn-helix motif found in some DNA-binding proteins (results not 
shown). Taken together, our bioinformatics analysis suggests the intriguing possibility that 
NHS could have a nuclear function. Future studies will address whether this is the case. 
 
Spatial and temporal expression of the NHS family of genes during early 
development of Danio rerio and Xenopus tropicalis 
We used RT-PCR to determine the temporal expression pattern of zebrafish NHS 
family genes. We found that all NHS family genes (nhsa, nhsb, nhsl1a, nhsl1b, nhsl2a) 
except nhsl2b were expressed during key stages of early development. nhsl2b was 
detected after 48 hpf. The presence of transcripts at 0.5hpf, suggests that nhsa, nhsb, 
nhsl1a, nhsl1b and nhsl2a mRNA was maternally contributed to the embryo (Fig.8.B).  
Next, we compared spatial expression patterns of all NHS genes by performing in 
situ hybridization in Danio rerio and Xenopus tropicalis embryos. To reduce non-specific 
binding, we designed our anti-sense in situ probes to span the 3’UTR of genes. nhsa and 
nhsb are expressed at low levels, ubiquitously throughout zebrafish embryos. Upon 
further investigation, we noticed that nhsa and nhsb expression was augmented within 
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the brain, retina and otic vesicle at 24hpf to 72hpf (Fig.9.A & B). nhsl1a was highly 
upregulated in the lens, and lateral line sensory ganglia at 24hpf onwards, whereas 
nhsl1b was expressed in the brain, otic vesicle, lens and somite boundaries from 12hpf to 
72hpf (Fig.9.C & D). Expression of nhsl2a and nhsl2b was seen at the somite boundaries, 
brain and otic vesicle (Fig.9.E & F). 
In frog, NHS was expressed at low levels and accumulated within eye structures at  
stage 26 (Fig 9.G). NHSL1 was highly upregulated in structures of the brain, eye, brachial 
arches, otic vesicle and somite boundaries. NHSL2 was expressed in the eye, lens, 
brachial arches and within somites. (Fig.9.G). Taken together, all NHS genes are 
expressed in Danio rerio and Xenopus tropicalis. Transcripts are expressed in both model 
organisms at early development during formation of the brain, eye, lens, brachial arches, 









Nance-Horan syndrome is a sex-linked recessive disease. In humans and mouse, 
both NHS and NHSL1 are located on the X chromosome (Fig1.A). Proximity of these 
genes on the same chromosome across species, suggests a possible evolutionary 
conserved role for cis-regulation of NHS and NHSL1. In zebrafish, however, none of the 
NHS genes were identified on the same chromosomes. The chromosomal nature of 
genetic sex determination of zebrafish and frog remains unclear. Sex-associated loci are 
found on multiple chromosomes in these animals, and do not contain sex specific X or Y 
chromosomes (Wilson et al. 2014). It remains unclear if NHS genes are located on or 
close to sex-associated loci in these vertebrates. The evolutionary importance of why 
NHS and NHSL1 are located on the X chromosome of humans and mice, remains 
unclear. 
The NHS gene family is conserved in humans, mouse, frog and fish. While proteins 
share some percent identity, Clustal analysis identified regions of amino acids with high 
homology between species. We hypothesize that these homology domains contain 
information that are important for protein function, and is therefore evolutionary 
conserved. To gain a better understanding of protein function, we identified multiple 
SLiMs within these conserved protein domains. The presence of multiple nuclear 
localization sequences helped us reimagine a possible role for NHS proteins within the 
cell nucleus. As our research on the function of NHS proteins progress, we can use these 
evolutionary conserved protein motifs as guide to help us determine protein function 
during development.   
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RT-PCR analysis and in situ hybridization confirmed the presence of NHS genes 
during early development. Gene expression was augmented during organogenesis of the 
brain, and sensory organs, including the eye and otic vesicle. These regions contain 
neural progenitor cells that proliferate, differentiate and migrate to form the 























Selective up-regulation of Δ113p53 expression leads to cell 
cycle arrest of retinal progenitors in the absence of Nance-
Horan syndrome (NHS) 
 
 









The Nance-Horan syndrome gene (NHS) plays a role in lens, eye and brain development. 
To date, the function of NHS remains unclear. Recent evidence showed that p53 isoform, 
Δ113p53, inhibits abnormal cell growth during organogenesis. We show that NHS is 
expressed in the retinas of Danio rerio and Xenopus tropicalis during key stages of 
retinogenesis, and that knockdown of the gene resulted in a small eye phenotype in both 
species. Initially, knockdown of nhsb in zebrafish had no visible defects at 24hpf. But 
examination of the retina at 48hpf, we see a marked difference in size compared to 
control embryos. Cell proliferation is a major feature of the developing retina from 24 hpf 
to 48 hpf. Differentiation of neurons was delayed, while the total number of cells that 
makes up the volume of the retina was markedly reduced. Here we show that the small 
retina in nhsb knockdown embryos are due to p53-dependent cell cycle arrest with 
specific induction of p53 target gene, Δ113p53 and p21. Δ113p53 protects nhsb-
knockdown cells from p53-mediated apoptosis. We hypothesize that nhsb overcomes a 
proliferation restriction in retina progenitor cells during retinogenesis, while knockdown of 






The process of retinogenesis is highly conserved in vertebrates. It commences 
when a subset of retinal progenitor cells (RPCs) enter a period of rapid cell division. On 
average, RPCs progress through the entire cell cycle in only 4 hours, resulting in two 
daughter cells, which can continue to proliferate, or exit the cell cycle and differentiate into 
neurons. The number of cells that arise from these rapid progenitor cell divisions make up 
the volume and size of the retina (He et al. 2012). As RPCs differentiate into neurons, the 
pool of progenitors capable of proliferating and adding more cells to the structure, become 
less (Cerveny et al. 2010). Tight regulation of cell division and cell cycle exit are therefore 
major features of retinal development. 
The tumor suppressor protein p53 is well known for its function in cancer biology. 
Environmental stress conditions increase levels of p53 that regulates DNA repair, cell 
cycle arrest and apoptosis. p53 eliminates cancer causing cells and maintains genome 
stability. Until recently, the role of p53 during organogenesis was unclear. Zebrafish loss-
of-function mutants progress through development normally, but develop tumors early in 
adulthood. Overexpression of p53 in Drosophila caused a small eye phenotype due to cell 
death (Jin et al. 2000). In general, Mdm2, a E3 ubiquitin protein ligase, constantly 
promotes degradation of p53 and keeps protein levels low during normal development 
(Momand J, Zambetti GP, Olson DC, George D 1992). 
Zebrafish def gene is required for growth expansion of intestine and liver tissue 
during organogenesis. A loss-of-function mutation in the zebrafish def gene causes 
hypoplastic digestive organs, due to selective upregulation of p53 isoform, Δ113p53. 
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Importantly, p53 itself serves as a transcription factor of Δ113p53 and is therefore 
required, even at low level, for transcription of Δ113p53. It is thought that the Δ113p53 
isoform is able to form a tetramer with full-length p53 and, in some cases, functions as a 
dominant-negative regulator of p53 transcriptional activity. Hypoplastic digestive organs 
as seen in the def mutant, were caused by cell cycle arrest of progenitors and not 
apoptosis. In fact, Δ113p53 suppresses apoptotic activity and selectively promotes the 
expression of the p53-target gene, cyclin dependent kinase inhibitor, p21, which arrests 
cell at G1 phase of the cell cycle. 
Here, we show that expression of NHS is augmented in the retinas of zebrafish 
and frog during retinogenesis. Knockdown of nhsb in zebrafish does not have any 
obvious phenotype until 24hpf. At 48hpf, the retina is notably smaller when compared to 
wild-type embryos. Our results demonstrate that loss of nhsb leads to an increase in p53 
isoform Δ113p53, but not full-length p53 protein. Increased levels Δ113p53 lead to an 








Materials and Methods 
 
Zebrafish Husbandry 
Zebrafish (Danio rerio) were maintained according to standard procedures and staged as 
previously described (Kimmel et al., 1995). Unless otherwise stated, the majority of 
experiments were performed from embryos derived from crosses of *AB strain. The 
neurod:EGFP transgenic line, registered as TgBAC(neurod:EGFP)nl1Tg at The Zebrafish 
International Resource Center (ZIRC)(Obholzer et al., 2008) was maintained in the *AB 
background.  
 
Xenopus tropicalis Husbandry 
Water was maintained at 26C° (±0.2C°) for optimal egg quality necessary for 
microinjections. Ammonia levels were maintained at 0-1ppm or 1 mg/l, and the pH at 7.5. 
Hardness is critical for egg firmness for microinjection. We maintained hardness at 200 
ppm (KH), and conductivity at 1200μS (50μS). For in vivo fertilization, female and male 
adult frogs were induced to lay and fertilize eggs by injection of Human Chorionic 
Gonadotropin (HCG) into the dorsal lymph sac. Males were injected with 100 Units HCG 
and Females with 200 Units HCG. Four hours after injections, frogs mated naturally, and 
resulting embryos was harvested, dissected or microinjected at the blastula stage. 
Approximately 30 embryos were used per experiment. Unused embryos were euthanized 





Antisense morpholinos (MO) were injected at the 1-cell stage. Morpholinos were supplied 
by Gene Tools and were as follows:  
zebrafish nhsb:  
splMO1 E2I2 5’CCAGAAGACCCATCAGTACCTCTGT3’, 4 ng.  
splMO2 I2E3 5’ CTGCTGCTGGTCTGTGAAGCAAACA 3’, 3.5 ng.  
Xenopus tropicalis NHS:  
splMO E3I3 5’ GTGTGTAATATATCTTACCTCTCCG 3’, 8.5 ng or 17 ng.  
The p53 morpholino targets the translation start site of full-length p53 as described (Robu 
et al. 2007): 5’GCGCCATTGCTTTGCAAGAATTG 3’, 3 ng.  
A morpholino that targets the splice junction from exon ES to intron 4 of p53 and should 
disrupt splicing of Δ113p53 variant while leaving full-length p53 intact: 
splMO 5’ TGTCTTTTCAAATGTCTTACCCTCC 3’, 3 ng.  
Splice morpholinos were validated by RT-PCR. For gene expression in the retinaBriefly, 
total RNA was isolated from whole embryos using an RNeasy kit (Qiagen) and genomic 
contamination was eliminated by on-column DNA digestion (Qiagen). First Strand cDNA 
was synthesized using the Protoscript M-MuLV First-Strand cDNA Synthesis Kit (New 
England Biolabs). Equal concentrations of RNA (1ug) from all developmental timepoints 
were used in the cDNA synthesis reaction. Concentration of cDNA across developmental 




Affymetrix Array, Normalization and Functional Annotation 
We dissected 40 eyes from wildtype or nhsb splMO2-injected embryos at 48hpf. 
Dissections were done in ½ ringers solution on ice. Total RNA was extracted from pooled 
tissues using RNeasy kit (Qiagen) and treated with DNAse I. We used 200ng input total 
RNA for cRNA amplification using the Affymetrix One Cycle kit (PN 901228). Amplicons 
were fragmented, hybridized to GeneChip Zebrafish Genome Arrays and scanned on an 
Affymetrix Scanner 3000 7G scanner (Affymetrix). Quality control of total RNA, amplified 
RNA, and fragmented RNA was checked by size using Experion (Bio-Rad) (SFig 3). Data 
was analyzed by Affymetrix Expression Console software. Raw intensity data was 
exported and filtered with a lower cut off value of 2 to assure that probe intensities data 
were generated within the dynamic range of fluorescence. Data was normalized by 
Robust Multi-array Average (RMA) to account for a possible probe effect. We uploaded 
RMA data into TIGR multiexperiment viewer (http://www.tm4.org/mev.html), and 
assessed our samples using the Significance Analysis of Microarrays (SAM) method 
(Tibshirani_2005). A FDR of 0.21 and delta value of 0.41 was selected, which rendered 
a gene list of 1,212 significantly different genes (SFig 4 and SFig 5). Our gene list was 
entered into DAVID for Functional Annotation clustering (http://david.abcc.ncifcrf.gov/).  
 
Immunostaining and Imaging 
Embryos were fixed in 4% PFA overnight at 4C, imbedded in 30% sucrose and saturated 
in OCT, prior to storage at -20C. Coronal sections of 10uM were cut at -20C by 
cryosection and mounted to Colorfrost Plus, microscope slides (Fisher). Immunostaining 
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was performed on sections with the following antibodies: anti-phosphos histone 3 (1:1000 
http://www.cellsignal.com); anti-GFP (1:2000, Torrey Pines); cleaved caspase 3 (1:500) 
(http://www.cellsignal.com). After cryosectioning and immunostaining, sections were 
immunopreserved in 100% glycerol and mounted on coverslips. Confocal images of 
labeled cryostat sections or whole-mount embryos were obtained on a Carl Zeiss 
Spinning Disk Laser Confocal Observer Z1 (VCU) using either 20X or 63X objectives.  
 
 
CRISPR Design and injection 
We designed guide RNA (gRNA) sequence directed against exon1 of nhsb (5’ 
GGTCCGGGATAGAGCCACAT 3’). For making gRNA, the guide sequence template was 
generated by annealing and filling-in two oligonucleotides guide oligo (5’ 
aattaatacgactcactataGGTCCGGGATAGAGCCACATgttttagagctagaaatagc3’) and scaffold 
template (5’GATCCGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGAC 
TAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC3’). The resulting gRNA template 
that contains a T7 promoter, was purified using DNA clean columns (Zymo). gRNA was 
generated by in vitro transcription using T7 RNA polymerase (Megascript T7 Kit, 
Invitrogen). After transcription, gRNA was column purified (Illustra Probequant, GE 
Healthcare). 
 For making nls-zCas9-nls RNA, the template DNA (pT3TS-nls-zCas9-nls; 
Addgene) was linearized by XbaI, phenol-chloroform extracted followed by ethanol 
precipitation. Capped nls-zCas9-nls mRNA was synthesized using mMessage T3 kit 
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(Invitrogen) and purified using Illustra Probe-quant columns (GE Healthcare). The mix of 
gRNA and nls-zCas9-nls mRNA was injected into one-cell stage embryos. 
 
T7 Endonuclease I Assay 
Genomic DNA was prepared from whole embryos at 48 hpf. A short stretch of genomic 
region (~735 bp) flanking the target site was PCR amplified from genomic DNA (primer 
sequences are listed in Table S1). The PCR amplicons were run on an agarose gel and 
extracted using (Qiagen). A total of 200 ng of purified DNA was denatured and slowly 
allowed to re-anneal to encourage heteroduplex formation. The re-annealing procedure 
consisted of a 5 minute denaturation step, followed by cooling to 85 C at -2 C per second 
and further to 25 C at -0.1 C per second. The re-annealed amplicon was then digested 
with 20 units of T7 endonuclease I (New England Biolabs) at 37 C for 90 min. The 
reaction was stopped by adding 1 μL of 0.5M EDTA. The sample was run through a 2% 







NHS is expressed in the developing retina of Danio rerio and Xenopus tropicalis 
Humans with mutations in NHS are born with abnormalities of the lens and retina, 
however, the function of NHS during early development remains unclear. After comparing 




NHS is expressed in the developing retina of Danio rerio and Xenopus tropicalis 
Humans with mutations in NHS are born with abnormalities of the lens and retina, 
however, the function of NHS during early development remains unclear. After comparing 
gene expression patterns of all NHS family members in frog and fish by in situ 
hybridization, we noticed an increase of NHS expression in the forebrain and eye regions 
(Sec II. Fig.8).  
We expanded our study of NHS expression during zebrafish development by 
focusing on structures of the eye and nervous system. Antisense in situ probes were 
designed to span the 3’UTR of nhsa and nhsb to assure specific staining (Fig.1). 
Expression of nhsa and nhsb was augmented within the neural retina and lens from 24hpf 
– 72hpf (Fig.2.A, C). Plastic sections of zebrafish eyes at 24hpf, confirms the presence of 
nhsb within select retina progenitor cells (RPCs) at the onset of retinogenesis (Fig.2.B). At 
this stage of development, RPCs have not yet differentiated into specialized neurons of 
the retina, and go through a series of rapid cell divisions. Of note, RPCs immediately 
adjacent to the lens express nhsb. As development of the retina continues, nhsa and 
nhsb is enriched within different layers at 48hpf and 72hpf. Specifically, at 48 hpf nhsa is 
enriched in the outer plexiform layer, whereas nhsb is expressed higher levels in the inner 
plexiform layer (Fig.1.C). These time points correspond to layering of the retina as 
specific neurons differentiate and localize to the ganglion cell layer, inner nuclear layer or 
outer nuclear layer.  
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Retinogenesis is highly conserved in vertebrates. In Xenopus, retinogenesis 
occurs at embryonic stage 26 – stage 40, which is comparable to zebrafish development 
from 24hpf – 72hpf. In situ probes for xtNhs were designed to span the 5’UTR in to exon1 
(Fig.1). Similarly to zebrafish, NHS is expressed at low levels throughout Xenopus 
tropicalis embryos, with stronger expression in the brain, retina and lens (Fig.3.A). An 
increase in NHS expression was seen in RPCs adjacent to the lens. At later time points of 
retinogenesis, we noticed staining of concentric layers within the retina. At stage 37 - 
stage 39, dual staining with NHS in situ probes and DAPI, shows localization of mRNA 
within the inner and outer plexiform layers. These layers are enriched with axons and 
dendrites, and are clear of cell nuclei (Fig.3.B). 
Taken together, expression of NHS is enriched in the lens and retina of Xenopus 
tropicalis and Danio rerio during key stages of retinogenesis. Early on in retina 
development, NHS is expressed in RPCs adjacent to the lens. As cells differentiate into 
distinct layers of specialized neurons, NHS localizes to regions enriched with axons and 
dendrites.  
 
NHS is required for growth of the retina  
When we compare the genomic architecture of NHS orthologs between human, 
Danio rerio, and Xenopus tropicalis, we observe a similar arrangement of introns and 
exons (Fig.1). We sought to determine the biological role of NHS proteins during 
development. Due to a genome duplication event in the teleost lineage, zebrafish have 
two paralogs of nhs, called nhsa and nhsb. We first examined the role of zebrafish nhsa 
using a mutant line identified by TILLING. The nhsafh298 mutants carry a truncating 
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nonsense mutation at position Q217*. However, upon examination of embryos derived 
from an incross of nhsafh298/+  heterozygotes revealed no morphological differences 
between homozygous nhsafh298/298  embryos and their wild-type siblings (S.Fig.1.A). 
We next examined the role of nhsb in zebrafish embryo development. To do this, 
nhsb splice-blocking antisense morpholino oligonucleotides (splMO1) were injected at the 
one cell stage (Fig.1). nhsb knockdown embryos exhibit a small eye phenotype at 72 hpf 
(Fig. 4A). The choroid fissure often closed by 96 hpf, while the overall size of the retina 
remained small in comparison. We confirmed that injection of nhsb splMO1, which was 
targeted to the exon2 - intron2 boundary, caused a mis-splicing of the nhsb transcript 
leading to retention of intron2 (Fig. 4B). Additionally, we injected a second splice-blocking 
MO (nhsb splMO2), targeted to the intron2 - exon3 boundary that also caused retention of 
intron 2 in the nhsb transcript (data not shown). nhsb splMO2-mediated knockdown 
caused a similar defect in eye growth as seen with nhsb splMO1-injected embryos. We 
continued the rest of our experiments using nhsb splMO2. 
To ensure that this small eye phenotype was specific to disruptions in the nhsb 
gene, we used CRIPSR/Cas9 to generate insertion/deletion mutations at the nhsb locus. 
We designed two, single stranded guide RNAs (gRNA) composed of the targeting 
sequence followed by the CRISPR sequence that guides the Cas9 nuclease to the 
desired locus (Fig.1). As previously shown, injection of increasing amounts of gRNA can 
lead to bi-allelic disruptions in the targeted gene (Jao, Wente, and Chen 2013). We 
therefore co-injected nhsb gRNA (50-150 pg) and in vitro transcribed, capped, 
polyadenylated nls-Cas9-nls mRNA (150 pg) into one-cell stage embryos. We reasoned 
 65 
that a small proportion of nhsb gRNA/nls-Cas9-nls mRNA injected embryos would display 
a homozygous mutant nhsb phenotype, indicative of bi-allelic disruptions at the nhsb 
locus. 56% of injected embryos exhibited a growth defect in the eye, similar to that seen 
in nhsb morphants (S.Fig.1.B). We chose five injected embryos displaying the small eye 
phenotype and quantified the mutagenesis rate at the nhsb locus using the T7 
endonuclease I (T7E1) assay; all assayed embryos showed high mutagenesis rates 
(S.Fig.1.C). Taken together, our results demonstrate that loss-of-function of nhsb lead to 
defects in the growth of the retina. 
To determine whether the role of NHS in the growth of the retina is evolutionarily 
conserved among vertebrates, we designed splice-blocking MOs targeted against the 
exon3 - intron3 boundary of Xenopus tropicalis NHS. We co-injected NHS splMO along 
with rhodamine-dextran into two-cell stage embryos (S.Fig.2.A). We found that 96% of 
embryos injected with 17 ng of xtnhs splMO that also showed rhodamine-positive labeling 
in the eye had smaller retinas than the contralateral eyes that did not receive morpholino 
(Fig.4.C, S.Fig.2). This phenotype was dependent on the dose of injected splMO 
(S.Fig.2.B-C) and the efficacy of the morpholino was again validated by RT-PCR 
(Fig.4.D).  
These findings suggest that the role of NHS in retinal development is evolutionarily 
conserved since knockdown of NHS in frog and knockdown of nhsb in zebrafish show 
similar retinal defects.   
 
Decrease number of retina progenitors and differentiated neurons in nhsb 
morphant retina 
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We compared retinal morphology between wild-type and nhsb splMO2-injected 
zebrafish during earlier stages of development. At 24 hpf, nhsb knockdown embryos were 
indistinguishable from control embryos, suggesting that knockdown of nhsb does not 
affect eye field specification and/or separation. A striking difference in the size and shape 
of the retina was seen by 48 hpf when morphants exhibit a small retina located on top of 
the lens (Fig.8.A). The earliest manifestation of the nhsb mutant phenotype occurred 
between 24hpf - 48 hpf. This suggest that the expansion growth displayed by the retina 
normally between 24-48 hpf failed to occur in nhsn morphants. This observation 
complimented our in situ hybridization data, since nhsb expression increased in the retina 
after 24 hpf (Fig. 2.B-C).  
One possible explanation for the decreased size of the eye is an increase in cell 
death in retinal progenitor cells in nhsb morphants. We therefore analyzed apoptosis by 
determining the number of cleaved-caspase 3 positive cells in the retina. At 36 hpf, only 
0.187% (4/2137, n=6) of cells in control embryos, and 0.140% (2/1427, n=6) of cells in 
nhsb splMO2-injected zebrafish stained positive for cleaved-caspase 3. This suggests 
that there was no significant difference in cell death in nhsb morphant retinas as 
compared to controls (Fig.5.A).  
We next sought to determine whether differentiation of retinal progenitor cells into 
neurons was affected by loss of nhsb. To accomplish this, we made use of the 
TgBAC(neurod:EGFP) transgenic zebrafish that expresses GFP under control of the 
promoter for neuroD, that re-capitulates neuroD expression in the retina (Thomas et al., 
2012). This transgene is not expressed in proliferating retinal progenitors, but is 
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expressed in a subset of retinal neurons undergoing differentiation. Some of the first 
differentiating neurons identified with this transgenic line can be seen around 36 hpf. By 
48 hpf, many GFP-positive neurons are undergoing differentiation in the retina of wild-
type embryos (Fig.6). In contrast, by 36 hpf, no GFP-positive neurons are observed in 
nhsb splMO2-injected embryos. Even by 48 hpf, only a few GFP-expressing neurons 
could now be visualized in nhsb morphant retinas (Fig.6). These findings are consistent 
with the idea that in the absence of nhsb, we see an overall decrease in retina size due to 
the volume added by total number of cells, while neuronal differentiation of retinal 
progenitors is delayed. 
 
Expression of Δ113p53, but not wild-type p53 is upregulated in nhsb knockdown 
retinas 
Sequence analysis of short linear motifs (SLiMs) identified 2 conserved nuclear 
localization sequences (NLS) in NHS orthologs (Sec.II, Fig.7.A). To examine the cellular 
localization of NHS, immunostaining was performed using anti-human NHS antibody. 
Since there are two copies of NHS in zebrafish, we performed immunostaining on human 
MCF10A cells. We observed that NHS is localized in the cytoplasm in some cells 
whereas in a subset of cells we find distinct staining in the nucleus (Fig.7.A).  
A recent study showed that Xenopus WAVE1 binds to active transcription 
components through its wave homology domain (WHD) to activate genes during 
development (Miyamoto et al. 2013). Since NHS genes have a conserved WHD we 
considered the possibility that nhsb may similarly regulate transcription in RPCs. We set 
out to identify genes downstream of nhsb by using microarray analysis. Total RNA was 
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isolated from 40 zebrafish eyes dissected from wild-type and morphant embryos at 48 
hpf, and used for biotin labeling and amplification of mRNA. All amplicons were analyzed 
by size to ensure equal amplification and fragmentation prior to microarray hybridization. 
(S.Fig 3A). 
After filtering and RMA normalization of raw intensity values, we used SAM 
analysis to compare expression profiles of wild-type and nhsb splMO2-injected embryos. 
This resulted in 1,212 significantly different genes (S.Fig.4, S.Fig.5). Functional 
Annotation Clustering (DAVID) of our gene list (S.Fig.6), showed that a subset of genes 
were downregulated in the morphant compared to the wildtype controls including markers 
of differentiated neurons, such as neuroD, opsin, and rhodopsin. On the other hand, a 
subset of genes was upregulated including markers of retinal progenitor identity, such as 
mz98, ccnD1, and atoh1a. These findings suggest that cells in nhsb mutant retinas hold 
onto their identity as retina progenitors without differentiating into neurons (Fig.7.B). 
Surprisingly, Functional Annotation Clustering (DAVID) also identified a number of genes 
with known roles in the regulation of cell cycle progression including the tumor suppressor 
gene p53 and its response genes mdm2 and cyclin G1. 
To confirm the result obtained from our microarray study, we performed semi-
quantitative RT-PCR. We observed that the levels of p53 transcripts were unchanged in 
nhsb morphants compared to wildtype controls, a result that differs from our microarray 
expression analysis (Fig.7.C). The p53 gene is known to express multiple isoforms as a 
result of alternative splicing and promoter usage. A microarray detects differences in 
mRNA for a given gene by combining data from multiple probes, called a probe set. 
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Microarray chips used in our gene expression experiment are not designed to detect 
different splice variants (affymetrix.com). Recently, it was shown that a truncated variant 
of p53 is transcribed from an alternative promoter in intron 4 (Chen et al. 2009). This p53 
variant is translated from the 113 codon, termed Δ113p53, is a N-terminal truncated p53 
protein missing the transactivation domain, and a small portion of the DNA binding 
domain. This splice variant of p53 corresponds to the human splice form Δ133p53 (Chen 
et al. 2005).  Therefore, to distinguish between these p53 variants, we used primers to 
amplify specifically either full-length p53 transcripts or the truncated Δ113p53 
transcript(Chen et al. 2005). While full-length p53 RNA levels were not increased, the 
Δ113p53 isoform was highly upregulated in nhsb splMO2-injected eyes compared to wild-
type controls (Fig.7.C). Our data demonstrated that loss of function of nhsb selectively up-
regulated Δ113p53, but not p53. This suggests that nhsb may be, directly or indirectly, a 
negative regulator of Δ113p53 expression and might exert its function though regulation 
of the p53 pathway. 
Next, we investigated whether other p53 pathway genes are regulated by the loss 
of nhsb. Using semi-quantitative RT-PCR, we found that p53 responsive genes like mdm2 
and cyclinG1 were upregulated nhsb morphant embryos as compared to controls 
(Fig.7.C). Moreover, the cyclin dependent kinase inhibitor, p21, has highly upregulated in 
nhsb morphants (Fig.7.C). However, we saw no appreciable change in bax transcript 
levels in the absence of nhsb. This result is consistent with our observation that loss of 
nhs does not lead to an increase in apoptosis in the retina and suggests that loss of nhsb 
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leads to the selective upregulation of some p53-dependent target genes, involved in cell 
cycle regulation.  
 
Upregulation of Δ113p53 expression is correlated with a proliferation restriction on 
retinal progenitors  
A loss-of-function mutation in the zebrafish def gene caused hypoplastic digestive 
organs through selective upregulation of Δ113p53. An important role for Δ113p53 was 
discovered during organogenesis, when the isoform acts as a dominant negative by 
forming tetramers with full-length p53. The smaller size of the organ was caused by cell 
cycle arrest at elevated levels of Δ113p53, while inhibiting p53-mediated apoptosis(Chen 
et al. 2009). 
It is known that elevated levels of p21 inhibit G1/S-phase transition, leading to a 
lengthening or complete block in cell cycle progression. To test whether elevated levels of 
Δ113p53 played a role in cell cycle arrest, we analyzed cell cycle progression by 
calculating the proportion of RPCs at M-phase. For purposes of our analyses we used 
cryosections stained with phospho-histone 3 (PH3) antibody. At 24hpf the overall size of 
the retina was similar for both wt and nhsb mutant embryos. There was no significant 
different in the percentageof PH3-positive cells compared to total cells counted,(wt = 
0.4263%, and nhsb MO = 0.5135 (Fig.8.B). At 48 hpf, the overall size of the retina for 
control embryos were larger, when compared to nhsb mutant embryos (Fig.8.A). The 
photoreceptor layer, outer nuclear layer and inner nuclear cell layer was easily seen in 
control embryos, whereas we did not see any layering of neurons in nhsb knockdown 
embryos (Fig. 8A). At this later timepoint, a higher percentage of cells were detected in M-
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phase of control embryos (1.983%) when compared to nhsb morphant embryos (0.916%)  
(Fig.8.B). We did not observe that PH3-positive cells accumulated in our nhsb morphant 
embryos, suggesting that RPCs progress through M-phase normally. 
To determine whether the cell cycle was lengthened in nhsb morphant RPCs, a 
fluorescent marker of G1, S, and G2 phase, was injected into zebrafish embryos to 
analyze cell cycle progression. While progression of some cells was detected by live cell 
imaging, our results remain inconclusive from this experiment. 
Increased levels of Δ113p53 in RPCs coincided with high transcript levels of p21, a 
well-known cyclin dependent kinase inhibitor and regulator of G1/S-phase transition. 
While cell cycle progression was not stopped at M-phase, the total number of cells in 
retinas of mutant fish remained low, which is indicative of a proliferation restriction 
imposed on RPCs by p21.  
 
Knockdown of p53, reduces Δ113p53 and p21, and rescues the nhsb morphant 
phenotype to normal 
Our data suggest that NHS , directly or indirectly, is a negative regulator of 
Δ113p53 expression and that NHS might exert its function through the p53 pathway. To 
determine whether p53 regulation was responsible for the nhsb knockdown phenotype, 
we used two antisense morpholinos against p53. The first specifically targets the 
translation start site of full-length p53 protein (p53 MO) (Robu et al. 2007). We designed a 
second morpholino targeting the splicing site of the Δ113p53 transcript at the exon ES – 
intron 4 splice junction (Δ113p53 splMO). Importantly, it is designed to not affect splicing 
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of full-length p53 transcripts. Injection of p53 MO or Δ113p53 splMO alone had no 
discernable effect on retinal development (data not shown).  
Interestingly, co-injection of nhsb splMO2 together with p53 MO completely 
rescued the small eye phenotype (micropthalmia) seen in nhsb morphants (Fig. 9.A). This 
experiment was highly reproducible with 91% of embryos displaying the rescue 
phenotype (S.Fig.6.A). RT-PCR analysis confirmed knockdown of nhsb in our p53 MO-
rescued embryos (S.Fig.6.B). Using semi-quantitative RT-PCR, we observed that the 
rescue phenotype coincided with a reduction of Δ113p53 and p21 transcripts (Fig. 9.B), 
indicating that the proliferation restriction imposed on RPCs was released when p21 
decreased. This experiment suggests that the hypoplastic retina in nhsb morphants is 
Δ113p53- and p21-dependent. Since expression of Δ113p53 depends on the presence of 
full-length p53, we were able to decrease Δ113p53 by using p53 MO. 
When Δ113p53 splMO was co-injected with nhsb splMO2, we found that co-
injected embryos did not survive past 24 hpf due to cell death (S.Fig.6.C). These results 
demonstrate that the upregulation of Δ113p53 protect retinal progenitors from undergoing 
cell death in nhsb knockdown embryos, while imposing a proliferation restriction in a 
manner that likely involves p21. 
Taken together, our data suggest that nhsb may be, directly or indirectly, a 
negative regulator of Δ113p53 expression and might exert its function though regulation 
of the p53 pathway. Alternatively, since full-length p53 is required for expression of 
Δ113p53 transcripts, it is possible that nhsb functions, directly or indirectly, to keep the 
levels of full-length p53 protein low.  
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Other phenotypes in nhsb morphants 
One characteristic feature of NHS patients is the presence of craniofacial 
abnormalities (Burdon et al. 2003). To determine whether nhsb is required for craniofacial 
development, we injected wild-type embryos with nhsb splMO1 and visualized 
craniofacial cartilages with Alcian Blue staining at 96 hpf. We found that nhsb morphants 
exhibited craniofacial abnormalities including a mispatterned Mekel’s cartilage and 
ceratohyal cartilages. Co-injection of nhsb and p53 morpholinos rescued the eye (as 
above), but did not rescue the jaw phenotype (S.Fig.7.A, B). These results suggest that 
nhsb is involved in craniofacial development, but that it exerts its effect in a p53-
independent manner. This may indicate that NHS has multiple roles in development that 









We used a loss-of-function approach to study the function of nhs during early 
development. Examination of eye structures appeared normal at 24hpf, suggesting that 
nhs is not involved in, or play a role in eye field specification or eye field separation. The 
retina becomes hypoplastic after 24hpf and a marked difference is seen in the overall size 
of the retina at 48hpf compared to control embryos, whereas the lens and surrounding 
tissues appear normal in size. Retinogenesis occurs from 24hpf – 48hpf and includes 
stages of proliferation, cell cycle exit and cell differentiation. At 24hpf the entire retina is 
made up of actively dividing equipotent retina progenitor cells (RPCs). Lineage tracing 
experiments done in zebrafish embryos showed that RPCs could progress through the 
entire cell cycle in less than 4 hours. The numbers of cells that arise from these early cell 
divisions make up the overall size and volume of the retina. The smaller size of the retina 
at 48hpf, can therefore be the result of a lengthening of the cell cycle. As RPCs take a 
longer time to divide, the retina remains small in relation to the surrounding tissues. 
Unlike Drosophila, zebrafish RPCs do not have fixed lineage programs. Instead, the 
zebrafish retina is generated by a combination of stochastic decisions made by RPCs to 
divide and differentiate. Proliferation and cell fate assignment of equipotent RPCs appear 
to respond to the overall size of the retina (He et al. 2012) (Cerveny et al. 2010). In wild-
type embryos, it is not until 34hpf that we see the first terminally differentiated neurons 
within the retina. RPCs of nhs morphans did not differentiate into neurons until 48hpf, 
when the overall retina size was comparable to control embryos at 34hpf. When we 
compare gene expression of wild type embryos to nhsb MO injected embryos at 48hpf, 
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we see an upregulation of cell cycle genes in the smaller retinas of mutant fish. Similarly 
there is increased expression of differentiated neuronal markers like NeuroD in the control 
embryos, suggesting that cells in morphant fish, retain their progenitor identify and that 
differentiation is delayed. It appears that NHS is required in RPCs to progress rapidly 
through cell cycle. Expression pattern of nhs in the retina, as measured by in situ 
hybridization, nicely matched the phenotype displayed by the morphant. 
In this study we show that NHS proteins contain conserved nuclear localization 
sequences. Immunohistochemistry identified NHS in the nucleus of MCF10A cells. While 
subcellular localization of NHS to the nucleus was previously noted, a role for NHS as 
transcription regulator has not been reported. It is tempting to think of Nance-Horan 
syndrome pathogenesis as the cumulative result of altered gene expression and 
misregulation of gene networks during development. We hypothesized that NHS, similar 
to WAVE, has the potential to translocate into the nucleus and transactivate genes by 
binding to DNA through its WHD domain (Miyamoto et al. 2013). We conducted a 
microarray experiment to assess gene expression in control vs. nhs MO injected 
zebrafish. We found that a number of genes were significantly up or down regulated in the 
absence of nhs. Surprisingly, a massive increase in p53 isoform, Δ113p53, was found in 
mutant embryos. Chen et al., showed that Δ113p53 was regulated by an organ specific 
regulator def, during formation of the digestive organs. In control cells, def kept levels of 
Δ113p53 low, and allowed progenitor cells to proliferate and add to the total volume of the 
organ. We identified a similar role for nhsb in expansion growth of the retina. In the 
absence of nhs, Δ113p53 expression increased, which lead to a concomitant increase of 
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p21 and proliferation restriction on RPCs (Fig. 10.A). RT PCR showed that pro apoptotic 
gene bax was not increased in hypoplastic retinas. Immunohistochemistry confirmed that 
the small eye phenotype was not due to apoptosis. Our findings are in agreement with a 
previously reported role for Δ113p53 as regulator of p21, but not bax (Chen et al. 2009). 
These results suggest that (1) nhs is required in retina progenitors to keep levels of 
Δ113p53 low, and that (2) the absence of nhs causes a small retina due to cell cycle 
arrest, but not apoptosis. 
Cell cycle control plays an important role in early development. During 
organogenesis in particular, a massive number of cells are added to the embryo. 
Expression of Δ113p53 during development is an exciting new regulator of organ size. 
While Δ113p53 selectively halts proliferation of progenitors, cell death is avoided. Chen et 
al., showed that Δ113p53 forms tetramers with p53 and acts as an antagonist of 
apoptosis by serving as a dominant negative for bax expression. Importantly, the 
promoter region of Δ113p53 contains a binding site for p53, and p53 is required for 
expression of Δ113p53. Remarkably, the small eye phenotype was rescued by co-
injection of nhsb and p53 morpholinos. While knockdown of nhs alone increased levels 
Δ113p53, co-injection of nhsb and p53 morpholinos decrease Δ113p53 and p21. The 
proliferation restriction imposed on RPCs, which resulted in a small retina, appears to be 
Δ113p53 and p21 dependent (Fig. 10.B). The question remains whether nhs directly or 
indirectly regulates Δ113p53. 
The use of zebrafish and Xenopus is helping us understand early development. 
The process of organogenesis is best studied in context of surrounding tissues, where 
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external signals can contribute to the gene regulation and post-translational modifications 
which is imperative to development. I patients with Nance-Horan syndrome a small eye 
phenotype, or micropthalmia, is sometimes present. The overall reduction in size of the 
organ can be due to a proliferation restriction imposed on RPCs during development. 
Evidence from WAVE1 proteins in Xenopus, suggests that the WHD domain located on 
the N-terminal portion of NHS might play a role in transcription regulation. Our microarray 
data reciprocates the idea that NHS potentially regulates a small network of genes, 
specifically in the retina. We can therefore think of Nance-Horan syndrome as a small 
network of genes that are not regulated normally in the absence of NHS. To test this 
theory, the logical next step is to do ChIP seq and identify if NHS proteins bind to DNA, 
directly or indirectly, in RPCs. We have not ruled out the possibility that NHS can alter the 
structure of full-length p53 or Δ113p53. Many mechanisms are in place in regular cells to 
keep protein levels of p53 low (MDM2, E2F). Failure to keep endogenous levels of p53 
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Figure 1:   Genomic architecture of NHS is conserved among vertebrates. Comparison of 
human (hs), Xenopus tropicalis (xt), and Danio rerio (dr) NHS homologs. As noted by (Brooks 
2004), an unusaul distance is seen between exon1 and exon2 in all homologs. 
red bars exon/intron boundaries used in design of our splice blocking morpholinos.
blue bars labeled antisense probes used to for in situ hybridization
red star point mutation in mutant nhsa fish










Figure 10:   Working model of nhsb function during retinogenesis. 
(A) Upregulation of Δ113p53 antagonize p53 apoptotic activity and favors cell cycle arrest. (B) NHS 
loss of function leads to an increase in Δ113p53 and p21 which causes a increase in G1 phase of the 
cells cycle. Compared to Control, lengthening of the cell cycle result in less cells and a smaller retina. 























Supplemental figure 1: Mutant nhsa and nhsb zebrafish 
(A) Mutant nhsa fh298/298  fish do not express visible developmental defects during development. (B) 
mutant nhsb zebrafish generated by CRISPR. (C) PCR confirmation of insertion/deletions generated 
by non homologous end joining.
B
C Ctrl #1 #2 #3 #4 #5
fh298+/- nhsaX
Control nhsb CRISPR/Cas9 

Control vs. nhsb mo, Danio rerio 48 hpf, dissected eyes
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Supplemental Figure 3:   Microarray quality control and PCR primers 
(A) Size comparison of total RNA, amplified (amp) RNA, and fragmented (frag) RNA used in microar-
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Dr.13171.1.A1_at acidic1repeat1containing acrc Dr.17882.1.A1_at nidogen12a1(osteonidogen) nid2a
Dr.26324.1.A1_at acylJCoA1synthetase1shortJchain1family1
member11
acss1 Dr.16108.1.S1_at nuclear1import171homolog1(S.1cerevisiae) nip7
Dr.21047.1.S1_at activin1receptor1IIb acvr2b Dr.17452.1.S1_at nipsnap1homolog131(C.1elegans) nipsnap3






Dr.4408.1.S1_at adenosine1kinase1a adka Dr.7209.1.S1_at "nonJmetastatic1cells16,1protein1expressed1in1
(nucleosideJdiphosphate1kinase)"
nme6
Dr.13359.1.S1_at adenylosuccinate1lyase adsl Dr.4323.1.A1_at NJmyristoyltransferase11a nmt1a
Dr.18323.1.S1_at "adenylosuccinate1synthase,1like" adssl Dr.9728.1.A1_at NIN1/RPN121binding1protein111homolog1(S.1
cerevisiae)
nob1
Dr.19099.1.A1_at aspartylglucosaminidase aga Dr.1412.2.A1_at nucleolar1protein111 nol11
Dr.6924.1.S1_at SJadenosylhomocysteine1hydrolase ahcy Dr.24822.1.S1_at nucleolar1protein112 nol12
Dr.24918.1.A1_at A1kinase1(PRKA)1anchor1protein1(gravin)112b akap12b Dr.1726.1.A1_at nucleolar1protein1family161(RNAJassociated) nol6
Dr.26094.1.A1_at A1kinase1(PRKA)1anchor1protein117A akap17a Dr.12637.1.A1_at nucleolar1protein19 nol9
Dr.4274.1.A1_at "aldoJketo1reductase1family17,1member1A31
(aflatoxin1aldehyde1reductase)"
akr7a3 Dr.5522.1.S1_at nucleolar1and1coiledJbody1phosphoprotein11 nolc1
Dr.19785.1.A1_at "alkB,1alkylation1repair1homolog161(E.1coli)" alkbh6 Dr.18213.1.A1_at nodal1modulator nomo
Dr.1368.2.A1_at Aly/REF1export1factor alyref Dr.14960.1.S1_at NOP21nucleolar1protein1homolog1(yeast) nop2
Dr.25421.1.S1_at "anillin,1actin1binding1protein" anln Dr.20916.1.A1_at NOP581ribonucleoprotein1homolog1(yeast) nop58
Dr.25562.1.A1_at "acidic1(leucineJrich)1nuclear1phosphoprotein1
321family,1member1B"
anp32b Dr.282.1.S1_at NOP581ribonucleoprotein1homolog1(yeast) nop58
Dr.5499.1.S1_at "adaptorJrelated1protein1complex11,1sigma121
subunit"
ap1s2 Dr.25314.1.A1_at notch1homolog13 notch3
Dr.4447.1.S1_at anterior1pharynx1defective11B aph1b Dr.22.1.S1_at "nuclear1receptor1subfamily12,1group1F,1
member15"
nr2f5
Dr.5674.2.S1_at apolipoprotein1CJI1like apoc1l Dr.16181.1.A1_at "nuclear1receptor1subfamily12,1group1F,1
member16b"
nr2f6b








arhgef18a Dr.9746.9.A1_at nucleoporin1107 nup107
Dr.22964.1.S1_at rho/rac1guanine1nucleotide1exchange1factor1
(GEF)118b
arhgef18b Dr.5851.1.S1_at nucleoporin135 nup35
Dr.24199.1.A1_s_at cAMPJregulated1phosphoprotein119b arpp19b Dr.16553.1.A1_at nucleoporin137 nup37
Dr.4206.1.A1_at ASF11antiJsilencing1function111homolog1Bb asf1bb Dr.16507.1.A1_at nucleoporin143 nup43
Dr.4095.1.A1_at argininosuccinate1synthetase11 ass1 Dr.16507.2.S1_at nucleoporin143 nup43
Dr.25732.1.A1_at "ATPase1family,1AAA1domain1containing13B" atad3b Dr.20267.1.A1_at nucleoporin1621like nup62l
Dr.14282.1.S1_at activating1transcription1factor13 atf3 Dr.4121.1.A1_at nucleoporin188 nup88





atic Dr.14413.1.A1_at nucleoporin1like12 nupl2








atp2a1l Dr.4155.1.A1_at oligodendrocyte1transcription1factor13 olig3
Dr.2043.1.A1_at AU1RNA1binding1protein/enoylJCoenzyme1A1
hydratase
auh Dr.17944.1.S1_at "origin1recognition1complex,1subunit15" orc5
Dr.8332.1.A1_at aurora1kinase1B aurkb Dr.24945.1.S1_at "origin1recognition1complex,1subunit16" orc6
Dr.23942.1.S1_at "UDPJGlcNAc:betaGal1betaJ1,3JNJ
acetylglucosaminyltransferase15a"
b3gnt5a Dr.7063.1.A1_at OJsialoglycoprotein1endopeptidase osgep
Dr.16002.2.S1_at "bromodomain1adjacent1to1zinc1finger1
domain,11A"
baz1a Dr.26322.1.A1_at "proliferationJassociated12G4,1a" pa2g4a
Dr.19405.1.A1_at BJcell1receptorJassociated1protein131 bcap31 Dr.4846.1.S1_at "proliferationJassociated12G4,1a" pa2g4a
Dr.5925.1.A1_at brambleberry bmb Dr.5506.1.A1_at "proliferationJassociated12G4,1b" pa2g4b
Dr.25506.2.A1_at "bone1morphogenetic1protein1receptor,1type1
1aa"
bmpr1aa Dr.5701.1.S1_at PAK11interacting1protein11 pak1ip1
Dr.8289.1.S1_at "bone1morphogenetic1protein1receptor,1type1
1ba"






Dr.12295.2.A1_at block1of1proliferation11 bop1 Dr.17254.1.A1_at PARP11binding1protein parpbp
Dr.15442.1.A1_at BRCA11interacting1protein1CJterminal1helicase1
1
brip1 Dr.17401.1.A1_at prolylJtRNA1synthetase1(mitochondrial) pars2










bub1ba Dr.15074.1.A1_at polycomb1group1ring1finger16 pcgf6
Dr.11708.1.S1_at basic1leucine1zipper1and1W21domains12 bzw2 Dr.372.1.S1_at lJisoaspartyl1protein1carboxyl1
methyltransferase
pcmt
Dr.17482.1.S1_at c1orf1091homolog1(H.1sapiens) c1orf109 Dr.1348.1.S1_at proliferating1cell1nuclear1antigen pcna

































DrAffx.1.14.S1_at "coreJbinding1factor,1beta1subunit" cbfb Dr.191.1.S1_at pescadillo pes
Dr.20034.1.S1_at "chromobox1homolog18a1(Pc1class1homolog,1
Drosophila)"
cbx8a Dr.1058.1.S1_at prohibitin phb
Dr.8713.1.A1_at coiledJcoil1domain1containing193 ccdc93 Dr.5033.1.A1_at prohibitin12 phb2
Dr.25190.1.S1_at cyclin1A2 ccna2 Dr.7304.1.S1_at PHD1finger1protein16 phf6
Dr.24753.1.S1_at cyclin1D1 ccnd1 Dr.11242.1.A1_at "pleckstrin1homologyJlike1domain,1family1A,1
member13"
phlda3
Dr.24753.1.S2_at cyclin1D1 ccnd1 Dr.14395.1.A1_at PIH11domain1containing11 pih1d1
Dr.1212.1.S1_at cyclin1G1 ccng1 Dr.58.1.A1_at "phosphoinositideJ3Jkinase,1regulatory1
subunit13a1(gamma)"
pik3r3a





Dr.25673.2.S1_at cell1division1cycle1251homolog cdc25 Dr.18144.1.A1_a_at pleiomorphic1adenoma1gene1X plagx
Dr.8228.1.S1_at cell1division1cycle1251homolog cdc25 Dr.2929.1.A1_at pleiomorphic1adenoma1gene1X plagx
Dr.3850.1.A1_at cell1division1cycle161homolog1(S.1cerevisiae) cdc6 Dr.6805.1.A1_at "phospholipase1C,1gamma11" plcg1










cdon Dr.20131.4.S1_at poloJlike1kinase111(Drosophila) plk1
Dr.1019.1.A1_at chromatin1licensing1and1DNA1replication1
factor11
cdt1 Dr.2155.1.S1_at poloJlike1kinase131(Drosophila) plk3
Dr.6575.1.S1_at "CCAAT/enhancer1binding1protein1(C/EBP),1
beta"
cebpb Dr.5434.1.S1_at proteolipid1protein11a plp1a
Dr.18034.1.A1_at "CCAAT/enhancer1binding1protein1(C/EBP),1
zeta"






Dr.18241.1.A1_at centromere1protein1J cenpj Dr.21058.1.S1_at POC11centriolar1protein1homolog1A1
(Chlamydomonas)
poc1a
Dr.12523.1.A1_at centrosomal1protein1128 cep128 Dr.15162.2.S1_at protein1OJfucosyltransferase11 pofut1
Dr.20507.1.A1_at centrosomal1protein1551like cep55l Dr.519.1.A1_at "polymerase1(DNA1directed),1alpha11" pola1













chd1l Dr.2435.1.S1_at "polymerase1(DNA1directed),1epsilon12" pole2
Dr.15882.1.A1_at CHK11checkpoint1homolog1(S.1pombe) chek1 Dr.6031.1.A1_at "polymerase1(DNA1directed),1lambda" poll
Dr.26409.1.A1_at "checkpoint1with1forkhead1and1ring1finger1
domains,1E31ubiquitin1protein1ligase"
chfr Dr.770.1.A1_at polymerase1(RNA)1I1polypeptide1A polr1a











Dr.7926.1.A1_at "cirrhosis,1autosomal1recessive11A1(cirhin)" cirh1a Dr.4746.1.S1_at polymerase1(RNA)1III1(DNA1directed)1
polypeptide1E
polr3e








cnbpa Dr.6397.1.S1_at peptidylprolyl1isomerase1(cyclophilin)Jlike14 ppil4
Dr.116.1.S1_at cyclin1Pas1/PHO801domain1containing11 cnppd1 Dr.17119.1.A1_at "protein1phosphatase12,1regulatory1subunit1
B'',1beta"
ppp2r3b
Dr.4832.1.A1_at "collagen,1type1XV,1alpha11b" col15a1b Dr.25412.1.A1_a_at "protein1phosphatase14,1regulatory1subunit11" PPP4R11(21of1
2)
Dr.17635.1.A1_at "collagen,1type1XXVIII,1alpha11" col28a1 Dr.2790.1.A1_at "protein1phosphatase15,1catalytic1subunit" ppp5c
Dr.11526.1.S1_at COP91constitutive1photomorphogenic1
homolog1subunit13








Dr.3731.1.A1_at cleavage1and1polyadenylation1specific1factor13 cpsf3 Dr.14630.1.A1_at peptidylprolyl1isomerase1domain1and1WD1
repeat1containing11
ppwd1






Dr.18310.1.S1_at cryptochrome1DASH cryJdash Dr.5651.1.S1_at protein1arginine1methyltransferase15 prmt5
Dr.10332.1.S1_at cryptochrome15 cry5 Dr.3855.1.S1_at protein1arginine1NJmethyltransferase17 prmt7
Dr.13038.1.S1_at "crystallin,1lambda11" cryl1 Dr.3564.1.S1_at PRP19/PSO41homolog1(S.1cerevisiae) prp19












ctdspl2b Dr.2896.1.S1_at phosphoribosyl1pyrophosphate1synthetase11A prps1a
Dr.8148.1.S1_at "catenin1(cadherinJassociated1protein),1alpha1
1"
ctnna1 Dr.13586.1.A1_at proline1rich111 prr11
Dr.3048.1.A1_at "catenin,1beta1like11" ctnnbl1 Dr.20872.1.S1_at "proteasome1(prosome,1macropain)1subunit,1
alpha1type,16a"
psma6a
Dr.25770.1.S1_at CTP1synthase11a ctps1a Dr.15385.1.S1_at "proteasome1(prosome,1macropain)1subunit,1
beta1type,14"
psmb4
Dr.3485.1.S1_at cathepsin1A ctsa Dr.25360.1.A1_s_at "proteasome1(prosome,1macropain)126S1
subunit,1ATPase,11b"
psmc1b
Dr.3374.1.S1_at "cathepsin1B,1a" ctsba Dr.8135.1.S1_at proteasome1activator1subunit11 psme1
Dr.4782.1.S1_at cathepsin1C ctsc Dr.20803.1.S1_at polypyrimidine1tract1binding1protein11a ptbp1a
Dr.19238.1.S1_at cathepsin1D ctsd Dr.5460.1.A1_at polypyrimidine1tract1binding1protein11a ptbp1a
Dr.15507.2.A1_at cathepsin1L.1 ctsl.1 Dr.20073.1.A1_at polypyrimidine1tract1binding1protein11b ptbp1b




















































cyp46a2 Dr.20928.1.S1_at parvalbumin11 pvalb1
Dr.24486.1.A1_at cysteine1and1tyrosineJrich1protein11 cyyr1 Dr.18470.1.A1_at poliovirus1receptorJrelated131like pvrl3l
Dr.15604.1.A1_at dynein1assembly1factor1with1WDR1repeat1
domains11
daw1 Dr.16123.1.S1_at PWP11homolog1(S.1cerevisiae) pwp1
Dr.8661.1.A1_at deathJassociated1protein16 daxx Dr.7795.2.A1_at quinoid1dihydropteridine1reductase1b1 qdprb1
Dr.8070.1.S1_at developing1brain1homeobox11a dbx1a Dr.6000.1.A1_at glutamineJrich11 qrich1
Dr.245.1.A1_at DEAD/H1(AspJGluJAlaJAsp/His)1box1helicase111 ddx11 Dr.9747.1.A1_at queuine1tRNAJribosyltransferase11 qtrt1
Dr.24235.1.A1_at DEAD1(AspJGluJAlaJAsp)1box1polypeptide118 ddx18 Dr.15011.1.A1_at "RAB12,1member1RAS1oncogene1family" rab12
Dr.3281.1.A1_at DEAD1(AspJGluJAlaJAsp)1box1polypeptide131 ddx31 Dr.2730.1.S1_at RAB1interacting1factor rabif
Dr.13799.1.S1_x_at DEAD1(AspJGluJAlaJAsp)1box1polypeptide152 ddx52 Dr.15214.1.S1_at RAD181homolog1(S.1cerevisiae) rad18
Dr.16883.1.S1_at DEAD1(AspJGluJAlaJAsp)1box1polypeptide155 ddx55 Dr.1514.1.A1_at "RAD511homolog1(RecA1homolog,1E.1coli)1(S.1
cerevisiae)"
rad51
Dr.2066.1.A1_at DEK1oncogene dek Dr.1514.2.S1_at "RAD511homolog1(RecA1homolog,1E.1coli)1(S.1
cerevisiae)"
rad51
Dr.4024.1.S1_at DEAH1(AspJGluJAlaJHis)1box1polypeptide115 dhx15 Dr.12483.1.A1_at RAD511associated1protein11 rad51ap1
Dr.5257.1.S1_at digestive1organ1expansion1factor1homolog diexf Dr.321.1.S1_at rasJrelated1nuclear1protein ran
Dr.10492.1.S1_at deltaA dla Dr.12411.1.S1_at RAN1binding1protein11 ranbp1
Dr.574.1.S1_at deltaB dlb Dr.25678.2.A1_at Ran1GTPase1activating1protein11b rangap1b
Dr.574.2.S1_at deltaB dlb Dr.13285.1.A1_at "RasGEF1domain1family,1member11Bb" rasgef1bb
Dr.16183.1.S1_at deltaC dlc Dr.11735.1.A1_at "RASJlike,1family111,1member1A" rasl11a
Dr.8086.1.S1_s_at deltaC dlc Dr.21306.1.A1_at Ras1association1(RalGDS/AFJ6)1domain1family1
8b
rassf8b
Dr.20958.1.S1_at deltaD dld Dr.1119.1.S1_at "retinoblastoma1binding1protein14,1like" rbb4l
Dr.20429.2.S1_a_at "discs,1large1(Drosophila)1homologJassociated1
protein15"
dlgap5 Dr.3888.1.A1_at RNA1binding1motif1protein124a rbm24a






Dr.3526.1.S1_at denticleless1homolog1(Drosophila) dtl Dr.6949.1.A1_at RNA1terminal1phosphate1cyclaseJlike11 rcl1
Dr.5295.1.A1_at "dystrobrevin,1beta1a1|1dystrobrevin,1gammaJ
like"
dtnba1|1dtng Dr.15761.1.A1_at RecQ1proteinJlike1(DNA1helicase1Q1Jlike) recql
Dr.19959.1.S1_at "dihydrouridine1synthase12Jlike,1SMM11
homolog1(S.1cerevisiae)"
dus2l Dr.25449.1.A1_at RecQ1proteinJlike15 recql5
Dr.26415.1.A1_x_at "dihydrouridine1synthase12Jlike,1SMM11
homolog1(S.1cerevisiae)"
dus2l Dr.9525.1.A1_at RALBP11associated1Eps1domain1containing11 reps1
Dr.17122.1.A1_at dihydrouridine1synthase13Jlike1(S.1cerevisiae) dus3l Dr.17100.1.A1_at replication1factor1C1(activator11)11 rfc1
Dr.10567.1.A1_at dual1specificity1phosphatase116 dusp16 Dr.4387.3.S1_at replication1factor1C1(activator11)15 rfc5
Dr.24920.1.S1_at "dishevelled,1dsh1homolog121(Drosophila)" dvl2 Dr.23832.1.S1_at "regulatory1factor1X,11b1(influences1HLA1class1
II1expression)"
rfx1b
Dr.4922.1.A1_at E2F1transcription1factor14 e2f4 Dr.20543.1.S1_at "regulatory1factor1X,14" rfx4
Dr.21523.1.A1_at E2F1transcription1factor17 e2f7 Dr.17903.1.A1_at "rhomboid,1veinletJlike131(Drosophila)" rhbdl3
Dr.21415.1.A1_at E2F1transcription1factor18 e2f8 Dr.25770.2.A1_at "rhomboid,1veinletJlike131(Drosophila)" rhbdl3
Dr.14998.2.S1_at "enoyl1CoA1hydratase11,1peroxisomal" ech1 Dr.1709.1.S1_at "ras1homolog1gene1family,1member1Gc" rhogc
Dr.12679.1.S1_at epithelial1cell1transforming1sequence121
oncogene
ect2 Dr.2150.1.A1_at RAP11interacting1factor1homolog1(yeast) rif1
Dr.14507.1.A1_at embryonic1ectoderm1development eed Dr.2150.1.A1_x_at RAP11interacting1factor1homolog1(yeast) rif1
Dr.10127.1.A1_at ephrin1A5a efna5a Dr.14704.1.S1_at "ribonuclease1H2,1subunit1A" rnaseh2a
Dr.12617.1.A1_at ephrin1B3b efnb3b Dr.4468.1.S1_at "ribonuclease1H2,1subunit1B" rnaseh2b





ehhadh Dr.7625.1.S1_at replication1protein1A1 rpa1
Dr.15002.1.S1_a_at "eukaryotic1translation1initiation1factor11A,1XJ
linked,1a"
eif1axa Dr.4556.1.S1_at replication1protein1A2 rpa2
Dr.15002.1.S1_at "eukaryotic1translation1initiation1factor11A,1XJ
linked,1a"
eif1axa Dr.16936.1.S1_at RNA1polymerase1II1associated1protein13 rpap3











Dr.8.1.S1_at eukaryotic1translation1initiation1factor15A2 eif5a2 Dr.7888.1.S1_at RRS11ribosome1biogenesis1regulator1homolog1
(S.1cerevisiae)
rrs1
Dr.8.1.S2_at eukaryotic1translation1initiation1factor15A2 eif5a2 Dr.11481.1.A1_at RJspondin1homolog1(Xenopus1laevis) rspo1
Dr.5598.1.S1_at eukaryotic1translation1initiation1factor16 eif6 Dr.18135.1.A1_at rhotekin12 rtkn2
Dr.24196.1.S1_at "ELAV1(embryonic1lethal,1abnormal1vision,1
Drosophila)Jlike111(Hu1antigen1R)"














Dr.14980.1.S1_at "enkurin,1TRPC1channel1interacting1protein" enkur Dr.20191.1.S1_at SEH1Jlike1(S.1cerevisiae) seh1l
Dr.3945.1.A1_at erythrocyte1membrane1protein1band14.11like15 epb41l5 Dr.18416.1.A1_at selenium1binding1protein11 selenbp1
Dr.5765.1.S1_at eph1receptor1A2 epha2 Dr.1330.1.S1_at "selenoprotein1P,1plasma,11a" sepp1a

















Dr.13342.1.A1_at Ets21repressor1factor erf Dr.1632.1.A1_at si:ch211J156j22.4 si:ch211J
156j22.4
Dr.3337.1.S1_at establishment1of1cohesion111homolog12 esco2 Dr.15996.1.S1_at si:ch211J217k17.7 si:ch211J
217k17.7
Dr.4113.1.S1_at eukaryotic1translation1termination1factor11 etf1 Dr.4479.1.A1_at si:ch211J244o22.2 si:ch211J
244o22.2
Dr.7714.1.S1_at ets1variant15b etv5b Dr.133.1.A1_at si:ch211J255a21.1 si:ch211J
255a21.1
Dr.14893.1.A1_at "nuclease1EXOG,1mitochondrialJlike" exog Dr.12375.1.S1_at si:ch211J285f17.1 si:ch211J
285f17.1
Dr.9715.1.S1_a_at exosome1component14 exosc4 Dr.16494.1.A1_at si:dkeyJ11e23.4 si:dkeyJ
11e23.4
Dr.17708.1.S1_at exosome1component15 exosc5 Dr.22416.1.A1_at si:dkeyJ120m5.1 si:dkeyJ
120m5.1












fam53b Dr.4307.1.A1_s_at JJJ SI:DKEYJ
269O24.6
Dr.12682.1.A1_at "Fanconi1anemia,1complementation1group1G" fancg Dr.12485.1.A1_at si:dkeyJ27p23.3 si:dkeyJ
27p23.3
Dr.12462.1.A1_at FAST1kinase1domains12 fastkd2 Dr.16696.1.S1_at si:dkeyJ286j15.3 si:dkeyJ
286j15.3
Dr.21842.1.S1_at FAT1tumor1suppressor1homolog11 fat1 Dr.15473.1.A1_at si:dkeyJ97o5.1 si:dkeyJ97o5.1
Dr.5345.1.S1_at FJbox1protein15 fbxo5 Dr.3249.1.A1_at si:dkeypJ113d7.1 si:dkeypJ
113d7.1
Dr.18882.1.A1_at ferredoxin11Jlike fdx1l Dr.12668.1.A1_at si:dkeypJ26a9.2 si:dkeypJ
26a9.2
Dr.1294.1.S1_at flap1structureJspecific1endonuclease11 fen1 Dr.6786.1.A1_at si:dkeypJ35b8.5 si:dkeypJ
35b8.5
Dr.409.1.S1_at fibroblast1growth1factor1receptor14 fgfr4 Dr.12509.1.S1_at si:dkeypJ84a8.8 si:dkeypJ
84a8.8









fos Dr.25571.1.A1_at SJphase1kinaseJassociated1protein121(p45) skp2
Dr.17623.1.S1_at forkhead1box1M1 foxm1 Dr.24852.1.S1_at stemJloop1binding1protein slbp
Dr.13699.1.S1_at forkhead1box1N4 foxn4 Dr.4660.1.S1_at "solute1carrier1family1161(monocarboxylic1acid1
transporters),1member18"
slc16a8
Dr.18562.1.A1_a_at folylpolyglutamate1synthase fpgs Dr.24146.1.S1_at "solute1carrier1family1161(monocarboxylic1acid1
transporters),1member19b"
slc16a9b
Dr.18562.1.A1_at folylpolyglutamate1synthase fpgs Dr.25679.1.S1_at "solute1carrier1family111(glial1high1affinity1
glutamate1transporter),1member13a"
slc1a3a
Dr.18562.2.A1_x_at folylpolyglutamate1synthase fpgs Dr.5307.1.S1_at "solute1carrier1family120,1member11b" slc20a1b










Dr.23694.1.A1_at galactokinase12 galk2 Dr.10559.1.A1_at "solute1carrier1organic1anion1transporter1
family,1member12B1"
slco2b1
Dr.14883.1.S1_at GAR11ribonucleoprotein1homolog1(yeast) gar1 Dr.20402.1.A1_at structural1maintenance1of1chromosomes12 smc2








Dr.17767.1.S1_at gem1(nuclear1organelle)1associated1protein15 gemin5 Dr.13752.1.S1_at small1fragment1nuclease smfn
Dr.17767.2.A1_at gem1(nuclear1organelle)1associated1protein15 gemin5 Dr.24766.1.S1_at smoothened1homolog1(Drosophila) smo
Dr.4685.1.S1_at gem1(nuclear1organelle)1associated1protein18 gemin8 Dr.4416.2.A1_at smoothened1homolog1(Drosophila) smo
Dr.15045.1.S1_at GINS1complex1subunit12 gins2 Dr.14033.1.A1_at SPARC1related1modular1calcium1binding11 smoc1
Dr.13962.1.S1_at GINS1complex1subunit13 gins3 Dr.3569.1.S1_at sphingomyelin1phosphodiesterase14 smpd4
Dr.8091.1.S1_at GLIJKruppel1family1member1GLI2a gli2a Dr.12494.1.A1_at SET1and1MYND1domain1containing14 smyd4
Dr.2113.2.S1_a_at GM21ganglioside1activator gm2a Dr.7936.1.A1_at small1nuclear1ribonucleoprotein1polypeptides1
B1and1B1
snrpb
Dr.18605.1.A1_at "glia1maturation1factor,1gamma" gmfg Dr.3953.1.S1_at "small1nuclear1ribonucleoprotein1D31
polypeptide,1like"
snrpd3l
Dr.14739.1.S1_at "geminin,1DNA1replication1inhibitor" gmnn Dr.5299.1.S1_at sorting1nexin112 snx12











gnl3 Dr.6314.1.S1_at "superoxide1dismutase12,1mitochondrial" sod2
Dr.3178.1.A1_at guanine1nucleotide1binding1proteinJlike131
(nucleolar)Jlike
gnl3l Dr.5112.1.S3_at SRYJbox1containing1gene111b sox11b
Dr.10191.1.S1_at golgi1associated1PDZ1and1coiledJcoil1motif1
containing
gopc Dr.20910.1.S1_at SRYJbox1containing1gene119a sox19a
Dr.2793.1.A1_at glypican14 gpc4 Dr.8215.1.A1_at SRYJbox1containing1gene121a sox21a
Dr.17912.1.S1_at glycoprotein1M6Bb gpm6bb Dr.10460.1.S1_at SRYJbox1containing1gene19a sox9a
Dr.22965.1.S1_at GJrich1RNA1sequence1binding1factor11 grsf1 Dr.11850.1.S2_at SRYJbox1containing1gene19b sox9b
Dr.5624.1.S1_at gsk3b1interacting1protein gskip Dr.16885.1.A1_at "serine1palmitoyltransferase,1long1chain1base1
subunit12a"
sptlc2a
Dr.1388.1.S1_at "G11to1S1phase1transition11,1like" gspt1l Dr.923.1.A1_at sequestosome11 sqstm1
Dr.1754.1.S1_at glutathione1SJtransferase1M gstm Dr.9914.1.S1_at "signal1recognition1particle1receptor,1B1
subunit"
srprb
Dr.10042.1.A1_at histone1acetyltransferase11 hat1 Dr.9070.2.A1_at serine/arginineJrich1splicing1factor16a srsf6a
Dr.15779.1.S1_at "HAUS1augminJlike1complex,1subunit14" haus4 Dr.9070.3.A1_at serine/arginineJrich1splicing1factor16a srsf6a
Dr.15779.2.A1_at "HAUS1augminJlike1complex,1subunit14" haus4 Dr.3463.1.S1_at Sjogren1syndrome1antigen1B1(autoantigen1La) ssb
Dr.834.1.S1_at "HAUS1augminJlike1complex,1subunit16" haus6 Dr.395.1.A1_at "ST81alphaJNJacetylJneuraminide1alphaJ2,8J
sialyltransferase16"
st8sia6
DrAffx.2.19.S1_at hemoglobin1beta1embryonicJ3 hbbe3 Dr.2778.1.S1_at syntaxin14 stx4
Dr.1758.1.S1_at histone1deacetylase110 hdac10 Dr.6399.1.S1_at suppressor1of1fused1homolog1(Drosophila) sufu
Dr.5019.1.A1_at HD1domain1containing12 hddc2 Dr.9711.1.A1_at sulfatase11 sulf1
Dr.15003.1.A1_at haloacid1dehalogenaseJlike1hydrolase1domain1
containing12
hdhd2 Dr.6641.1.A1_at "suppressor1of1var1,13Jlike111(S.1cerevisiae)" supv3l1
Dr.1691.9.S1_at hatching1enzyme11b he1b Dr.17081.1.S1_at surfeit16 surf6























Dr.1460.1.S1_at hairyJrelated12 her2 Dr.3018.1.A1_at transcription1elongation1regulator11a1(CA150) tcerg1a
Dr.19467.1.A1_at hairy1and1enhancer1of1split161(Drosophila) hes6 Dr.25530.1.A1_s_at telomeric1repeat1binding1factor1(NIMAJ
interacting)11
terf1
Dr.3681.1.S1_at histone1H11like histh1l Dr.20000.1.S1_at "transcription1factor1A,1mitochondrial" tfam
Dr.15391.1.S1_at heterogeneous1nuclear1ribonucleoprotein1D hnrnpd Dr.7899.1.S1_at THO1complex12 thoc2
Dr.22828.1.A1_at hydroxysteroid1(17Jbeta)1dehydrogenase110 hsd17b10 Dr.3077.2.A1_at THO1complex161homolog1(Drosophila) thoc6
Dr.10742.2.S1_a_at "HSPA1(heat1shock170kDa)1binding1protein,1
cytoplasmic1cochaperone11"
hspbp1 Dr.13661.1.S1_at thymocyte1nuclear1protein11 thyn1
Dr.18265.1.S1_at id:ibd1172 id:ibd1172 Dr.16862.1.A1_at "TopBP1Jinteracting,1checkpoint,1and1
replication1regulator"
ticrr
Dr.7103.1.S1_at inhibitor1of1DNA1binding13 id3 Dr.8747.1.A1_at tubulointerstitial1nephritis1antigenJlike11 tinagl1
Dr.1636.1.A1_at interferonJrelated1developmental1regulator12 ifrd2 Dr.12950.2.S1_a_at timeless1interacting1protein tipin
Dr.15377.1.S1_at intraflagellar1transport11221homolog1
(Chlamydomonas)
ift122 Dr.5123.1.A1_at tight1junction1protein12b1(zona1occludens12) tjp2b
Dr.8145.1.S1_at insulinJlike1growth1factor12a igf2a Dr.21038.1.S1_at tight1junction1protein13 tjp3
Dr.8280.1.S1_at insulinJlike1growth1factor121mRNA1binding1
protein13
igf2bp3 Dr.7616.1.A1_s_at transketolase tkt
Dr.8280.1.S2_at insulinJlike1growth1factor121mRNA1binding1
protein13
igf2bp3 Dr.3811.1.A1_at tousledJlike1kinase11a tlk1a
Dr.8587.1.A1_at insulinJlike1growth1factor1binding1protein11a igfbp1a Dr.6670.1.A1_at transmembrane1protein1107 tmem107
Dr.8587.1.A2_at insulinJlike1growth1factor1binding1protein11a igfbp1a Dr.25489.1.S1_at transmembrane1protein1134 tmem134
Dr.3939.1.A1_at im:6903007 im:6903007 Dr.3402.1.A1_at transmembrane1protein12 tmem2















imp4 Dr.26411.1.S1_at "troponin1I,1skeletal,1fast12a.4" tnni2a.4
Dr.19345.2.S1_at "IMP4,1U31small1nucleolar1ribonucleoprotein,1
homolog1(yeast)"
imp4 Dr.2195.1.S1_at transportin13 tnpo3
Dr.7971.1.A1_at importin19 ipo9 Dr.2710.1.S1_at target1of1myb1Jlike tom1
Dr.12308.1.S1_at interferon1regulatory1factor19 irf9 Dr.12521.1.S1_at translocase1of1outer1mitochondrial1membrane1
201homolog1a1(yeast)
tomm20a
Dr.1482.1.A1_at ironJsulfur1cluster1scaffold1homolog1(E.1coli)1b iscub Dr.5418.1.S1_at topoisomerase1(DNA)1II1alpha top2a
Dr.7338.1.S1_at influenza1virus1NS1A1binding1protein1b ivns1abpb Dr.17989.1.A1_at topoisomerase1(DNA)1II1beta top2b
Dr.12589.1.S1_at jagged11b jag1b Dr.2052.1.S1_at tumor1protein1p53 tp53
Dr.26325.1.A1_at junctional1adhesion1molecule13b jam3b Dr.316.1.A1_at "tumor1protein1p531binding1protein,12" tp53bp2
Dr.10032.1.S1_at Jun1dimerization1protein12 jdp2 Dr.25206.1.S1_at trophoblast1glycoproteinJlike tpbgl
Dr.20639.1.S1_at KDEL1(LysJAspJGluJLeu)1containing11 kdelc1 Dr.20815.1.S1_at alphaJtropomyosin tpma
Dr.1557.1.S1_at kinesin1family1member111 kif11 Dr.23293.1.A1_at tubulin1polymerizationJpromoting1protein1
family1member13
tppp3
Dr.3076.1.A1_a_at kinesin1family1member115 kif15 Dr.7278.1.A1_at transmembrane1phosphatase1with1tensin1
homology
tpte
Dr.6662.1.S1_at kinesin1family1member118A kif18a Dr.10519.1.A1_at tripartite1motifJcontaining171 trim71
Dr.18075.1.S1_at kinesin1family1member120Bb kif20bb Dr.14411.1.S1_at tRNA1selenocysteine111associated1protein11a trnau1apa
Dr.8295.1.S1_at kinesin1family1member123 kif23 Dr.16529.1.S1_at "transient1receptor1potential1cation1channel,1
subfamily1V,1member11"
trpv1
Dr.25399.1.A1_at kinesin1family1member12C kif2c Dr.21722.1.A1_at tetraspanin117 tspan17










Dr.4616.1.A1_at lysineJrich1nucleolar1protein11 knop1 Dr.18499.1.A1_at "TSR3,120S1rRNA1accumulation,1homolog1(S.1
cerevisiae)"
tsr3
Dr.8763.1.A1_at karyopherin1(importin)1beta13 kpnb3 Dr.20010.2.A1_at "tubulin,1alpha181like" tuba8l
Dr.12091.1.A1_at "laminin,1alpha15" lama5 Dr.664.1.S1_at "tubulin,1alpha181like14" tuba8l4
Dr.4129.1.S1_at "laminin,1beta11a" lamb1a Dr.14735.1.A1_at taxilin1gamma txlng
Dr.17237.1.S1_at leucine1aminopeptidase13 lap3 Dr.18396.1.S1_at thioredoxin1interacting1protein1a txnipa
Dr.7573.1.A1_at "La1ribonucleoprotein1domain1family,1member1
1B"
larp1b Dr.4986.1.S1_at thioredoxin1reductase11 txnrd1
















Dr.16539.1.S1_at linJ521homolog1(C.1elegans) lin52 Dr.12611.1.S1_at uncJ1191homolog11 unc119.1
























































































































































































































Dr.18233.1.A1_at kinesin1family1member120A LOC325449 Dr.7226.1.S1_at wu:fj65h10 wu:fj65h10
Dr.15915.1.S1_at G1patch1domain1containing14Jlike LOC555692 Dr.7590.1.A1_at wu:fj68b05 wu:fj68b05
Dr.11818.1.A1_at e31ubiquitinJprotein1ligase1RNF19AJlike LOC557995 Dr.10282.1.A1_at wu:fk30a05 wu:fk30a05
Dr.26197.1.S1_at e31ubiquitinJprotein1ligase1RNF19AJlike LOC557995 Dr.10012.1.A1_at wu:fk83g11 wu:fk83g11
Dr.26197.2.A1_at e31ubiquitinJprotein1ligase1RNF19AJlike LOC557995 Dr.5569.2.A1_at wu:fl08f01 wu:fl08f01





LOC564200 Dr.2355.1.S1_at YesJassociated1protein11 yap1
Dr.9892.2.S1_at metalloJbetaJlactamase1domainJcontaining1
protein11Jlike





















Dr.17373.2.S1_at uncharacterized1LOC796453 LOC796453 Dr.17192.1.S1_at zgc:100870 zgc:100870
Dr.18151.1.S1_at uncharacterized1LOC798783 LOC798783 Dr.26532.1.A1_at zgc:101819 zgc:101819
Dr.9300.1.A1_at protein1FAM118BJlike LOC799102 Dr.20417.1.S1_at zgc:101858 zgc:101858
Dr.20533.1.A1_at leucine1rich1repeat1(in1FLII)1interacting1protein1
1a
lrrfip1a Dr.7250.1.A1_at zgc:110239 zgc:110239
Dr.24292.3.A1_a_at leucine1rich1repeat1neuronal11 lrrn1 Dr.24858.1.S1_at zgc:110540 zgc:110540
Dr.3707.1.A1_at large1subunit1GTPase111homolog1(S.1
cerevisiae)
lsg1 Dr.5959.1.A1_at zgc:112020 zgc:112020
Dr.15890.1.A1_at LSM121homolog1a1(S.1cerevisiae) lsm12a Dr.5167.1.A1_at zgc:114181 zgc:114181
DrAffx.1.53.S1_at Ly11antibody1reactive1homolog1(mouse) lyar Dr.7787.1.S1_at zgc:136826 zgc:136826
Dr.15000.1.S1_at lysophospholipase1I lypla1 Dr.11561.1.A1_at zgc:152651 zgc:152651
Dr.4833.2.S1_at MAD21mitotic1arrest1deficientJlike111(yeast) mad2l1 Dr.3512.1.A1_at zgc:152830 zgc:152830
Dr.4000.1.S1_at mitogenJactivated1protein1kinase1kinase1
kinase1kinase15
map4k5 Dr.12649.1.S1_at zgc:153041 zgc:153041
Dr.7930.1.S1_at mitogenJactivated1protein1kinase114a mapk14a Dr.20487.1.S1_at zgc:153115 zgc:153115
Dr.20395.1.A1_at mitogenJactivated1protein1kinaseJactivated1
protein1kinase12a
mapkapk2a Dr.13693.1.S1_at zgc:153377 zgc:153377
Dr.10840.1.S1_at "microtubuleJassociated1protein,1RP/EB1
family,1member11a"
mapre1a Dr.15964.1.A1_at zgc:158292 zgc:158292
Dr.26268.1.A1_at JJJ MARCO Dr.23447.1.A1_at zgc:158345 zgc:158345
Dr.3498.1.S1_at "methionine1adenosyltransferase1I,1alpha" mat1a Dr.5407.1.A1_at zgc:158363 zgc:158363
Dr.20010.6.A1_at methylcrotonoylJCoenzyme1A1carboxylase121
(beta)
mccc2 Dr.19956.1.S1_at zgc:158366 zgc:158366
Dr.784.1.S1_at MCM31minichromosome1maintenance1
deficient131(S.1cerevisiae)
mcm3 Dr.1992.1.S1_at zgc:158399 zgc:158399
Dr.5091.1.S1_at "MCM41minichromosome1maintenance1
deficient14,1mitotin1(S.1cerevisiae)"
mcm4 Dr.23944.1.S1_at zgc:162082 zgc:162082
Dr.1055.1.S1_at MCM71minichromosome1maintenance1
deficient171(S.1cerevisiae)
mcm7 Dr.8643.1.A1_x_at zgc:162193 zgc:162193
Dr.4989.1.S1_at minichromosome1maintenance1complex1
binding1protein
mcmbp Dr.4334.1.A1_at zgc:162967 zgc:162967
Dr.542.1.S1_at transformed13T31cell1double1minute121
homolog1(mouse)
mdm2 Dr.2039.1.A1_at zgc:165515 zgc:165515
Dr.18106.1.S1_at maternal1embryonic1leucine1zipper1kinase melk Dr.4868.1.A1_at zgc:174888 zgc:174888
Dr.18296.1.S1_at mind1bomb mib Dr.6620.1.A1_at zgc:174890 zgc:174890
Dr.8283.1.S1_at muscleJspecific1beta111integrin1binding1protein mibp Dr.2985.1.A1_at zgc:175096 zgc:175096
Dr.19450.1.S1_at micalJlike12b micall2b Dr.11429.1.A1_at zgc:175133 zgc:175133
Dr.6498.1.S1_at mesoderm1induction1early1response111
homolog1a1(Xenopus1laevis)
mier1a Dr.15851.1.A1_at zgc:193690 zgc:193690
Dr.26464.1.S1_at MYC1induced1nuclear1antigenJlike minal Dr.26453.1.S1_at zgc:64116 zgc:64116
Dr.13195.1.A1_at "mutL1homolog11,1colon1cancer,1nonpolyposis1
type121(E.1coli)"
mlh1 Dr.1863.1.A1_at zgc:77086 zgc:77086
Dr.1996.1.A1_at MAXJlike1protein1X mlx Dr.12453.1.A1_at zgc:86764 zgc:86764
Dr.2408.1.A1_at matrix1metalloproteinase12 mmp2 Dr.9464.1.A1_at zgc:92107 zgc:92107
Dr.5285.1.A1_at "MMS22Jlike,1DNA1repair1protein" mms22l Dr.14880.1.S1_at zinc1finger1protein1330 znf330
Dr.13950.1.S1_at mortality1factor141like11 morf4l1 Dr.11710.1.A1_at zinc1finger1protein1532 znf532
Dr.7116.1.S1_at MJphase1phosphoprotein1101(U31small1
nucleolar1ribonucleoprotein)
mphosph10 Dr.3201.1.S1_at zinc1fingerJlike1gene12a znfl2a
Dr.13254.1.A1_at "membrane1protein,1palmitoylated11" mpp1 Dr.4773.1.A1_at "Zwilch,1kinetochore1associated,1homolog1
(Drosophila)"
zwilch
Dr.1842.1.A1_at "membrane1protein,1palmitoylated11" mpp1 Dr.3891.1.A1_at septin16 5JSep
Dr.16031.1.S1_at mitochondrial1ribosomal1protein1L1 mrpl1 Dr.10904.3.A1_at JJJ JJJ
Dr.9805.1.S1_at mitochondrial1ribosomal1protein1L12 mrpl12 Dr.11610.1.S1_at JJJ JJJ
Dr.18076.1.A1_at mitochondrial1ribosomal1protein1L43 mrpl43 Dr.13336.1.S1_at JJJ JJJ
Dr.7183.1.S1_at mitochondrial1ribosomal1protein1L45 mrpl45 Dr.13336.2.S1_a_at JJJ JJJ
Dr.18075.3.A1_s_at mitochondrial1ribosomal1protein1S18B mrps18b Dr.13336.2.S1_at JJJ JJJ
Dr.15402.1.A1_a_at mitochondrial1ribosomal1protein1S5 mrps5 Dr.14236.1.A1_at JJJ JJJ
Dr.15068.1.S1_at mitochondrial1ribosome1recycling1factor mrrf Dr.15231.1.A1_at JJJ JJJ
Dr.4274.2.A1_at mRNA1turnover141homolog1(S.1cerevisiae) mrto4 Dr.15497.1.A1_at JJJ JJJ
Dr.4108.1.S1_at mutS1homolog161(E.1coli) msh6 Dr.16254.1.A1_at JJJ JJJ
Dr.20552.1.S1_at moesin1a msna Dr.17413.1.A1_at JJJ JJJ
Dr.24940.1.S1_at moesin1a msna Dr.17716.1.S1_at JJJ JJJ
Dr.7124.1.S1_at methylenetetrahydrofolate1dehydrogenase1
(NADP+1dependent)11b
mthfd1b Dr.17717.1.A1_at JJJ JJJ
Dr.14691.1.A1_at metaxin11b mtx1b Dr.18221.1.A1_at JJJ JJJ
Dr.977.2.A1_at MUS811endonuclease1homolog1(yeast) mus81 Dr.19431.1.A1_at JJJ JJJ
Dr.19951.1.S1_a_at MYB1binding1protein1(P160)11a mybbp1a Dr.19532.1.A1_at JJJ JJJ
Dr.25251.1.A1_at MYB1binding1protein1(P160)11a mybbp1a Dr.19743.1.A1_at JJJ JJJ
Dr.17421.1.A1_at myeloblastosis1oncogeneJlike12 mybl2 Dr.20010.14.S1_at JJJ JJJ
Dr.21800.1.A1_at "myosin1binding1protein1C,1fast1type1b" mybpc2b Dr.20521.1.A1_at JJJ JJJ
Dr.1.1.S1_at myelocytomatosis1oncogene1a myca Dr.21280.1.S1_at JJJ JJJ
Dr.9142.1.S1_at "myosin,1heavy1chain110,1nonJmuscle" myh10 Dr.21848.1.A1_at JJJ JJJ
Dr.2601.1.S1_at "N(alpha)Jacetyltransferase115,1NatA1auxiliary1
subunit1a"
naa15a Dr.22145.1.A1_at JJJ JJJ
Dr.21461.1.A1_at nuclear1assembly1factor111homolog1(S.1
cerevisiae)
naf1 Dr.23212.1.A1_at JJJ JJJ
Dr.23775.1.A1_at nucleosome1assembly1protein11Jlike14a nap1l4a Dr.23223.1.A1_at JJJ JJJ
Dr.20947.2.A1_a_at nuclear1autoantigenic1sperm1protein1(histoneJ
binding)
nasp Dr.25403.1.A1_at JJJ JJJ
Dr.17557.1.S1_at neurocalcin1delta1a ncalda Dr.25672.1.A1_at JJJ JJJ
Dr.25645.1.S1_at neurocalcin1delta1a ncalda Dr.25683.10.S1_at JJJ JJJ
Dr.9196.1.S1_at "nonJSMC1condensin1II1complex,1subunit1D3" ncapd3 Dr.25703.1.A1_at JJJ JJJ
Dr.15653.1.S1_at "nonJSMC1condensin1I1complex,1subunit1G" ncapg Dr.26056.1.A1_s_at JJJ JJJ
Dr.17297.1.A1_at "nonJSMC1condensin1II1complex,1subunit1G2" ncapg2 Dr.26490.2.A1_at JJJ JJJ
Dr.3958.1.A1_at "nonJSMC1condensin1I1complex,1subunit1H" ncaph Dr.3021.1.S1_at JJJ JJJ
Dr.25587.1.A1_at NDC11transmembrane1nucleoporin ndc1 Dr.337.1.A1_at JJJ JJJ
Dr.1175.1.A1_at "NADH1dehydrogenase1(ubiquinone)111alpha1
subcomplex,110"
ndufa10 Dr.3862.1.A1_at JJJ JJJ
Dr.20071.1.S1_at nei1endonuclease1VIIIJlike111(E.1coli) neil1 Dr.3862.2.S1_at JJJ JJJ
Dr.9529.1.A1_at nuclear1factor1(erythroidJderived12)Jlike13 nfe2l3 Dr.42.1.A1_a_at JJJ JJJ
Dr.26514.1.A1_at NFS11nitrogen1fixation111(S.1cerevisiae) nfs1 Dr.42.3.A1_x_at JJJ JJJ
Dr.20137.1.S1_at "neuroguidin,1EIF4E1binding1protein" ngdn Dr.7594.1.A1_at JJJ JJJ
Dr.20137.2.A1_at "neuroguidin,1EIF4E1binding1protein" ngdn DrAffx.2.105.S1_at JJJ JJJ
SAM$negative$genes
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abcc2 Dr.26323.1.A1_at RAP13GTPase3activating3protein rap1gap





acsl6 Dr.12216.1.A1_at RAS3guanyl3releasing3protein34 rasgrp4
Dr.6517.1.S1_at adenylosuccinate3synthase3like31 adssl1 Dr.15195.1.A1_at "RNA3binding3protein,3fox513homolog3(C.3
elegans)31"
rbfox1
Dr.17696.1.A1_at A3kinase3(PRKA)3anchor3protein311 akap11 Dr.16723.1.A1_at "RNA3binding3protein,3fox513homolog3(C.3
elegans)31"
rbfox1
Dr.12901.1.A1_at A3kinase3(PRKA)3anchor3protein36 akap6 Dr.5878.1.A1_at rabconnectin33 rc3
Dr.8180.1.S1_at "aminolevulinate,3delta5,3synthetase32" alas2 Dr.11063.1.A1_at 555 RCAN1B
Dr.4277.1.S1_at "ankylosis,3progressive3homolog3b" ankhb Dr.1817.1.A1_at regulator3of3calcineurin3family3member33 rcan3
Dr.7290.1.A1_at ankyrin3repeat3domain312 ankrd12 Dr.15089.1.S1_at rad3and3gem3related3GTP3binding3protein31 rem1
Dr.1190.1.S1_at annexin3A1b anxa1b Dr.12444.1.A1_at regulatory3factor3X5associated3protein rfxap
Dr.1442.2.S2_a_at amyloid3beta3(A4)3precursor3protein3a appa Dr.17500.1.A1_at RGP13retrograde3golgi3transport3homolog3(S.3
cerevisiae)
rgp1
Dr.2615.1.S1_at amyloid3beta3(A4)3precursor3protein3b appb Dr.14615.1.A1_at regulator3of3G5protein3signaling317 rgs17
Dr.5865.1.A1_at ADP5ribosylation3factor3interacting3protein32a arfip2a Dr.13030.1.A1_at regulator3of3G5protein3signaling35a rgs5a
Dr.12695.1.A1_at Rho3GTPase3activating3protein34b arhgap4b Dr.354.1.S1_at rhodopsin rho
Dr.9845.2.A1_at "ADP5ribosylation3factor5like33,3like32" arl3l2 Dr.11062.1.A1_at resistance3to3inhibitors3of3cholinesterase383
homolog3A
ric8a
Dr.18638.1.S1_at ADP5ribosylation3factor5like36 arl6 Dr.13795.1.A1_at relaxin33a rln3a
Dr.7450.1.A1_at ADP5ribosylation3factor5like38A arl8a Dr.12666.1.S1_at ring3finger3protein3146 rnf146
Dr.17322.1.A1_at 555 ASH1L Dr.19063.1.S1_at ring3finger3protein3175 rnf175
Dr.14729.1.S1_at astrotactin31 astn1 Dr.11667.1.S1_at ring3finger3protein341 rnf41
Dr.14729.3.S1_a_at astrotactin31 astn1 Dr.18132.1.A1_at ring3finger3protein344 rnf44
Dr.15962.1.A1_at ATG123autophagy3related3123homolog3(S.3
cerevisiae)
atg12 Dr.9906.1.S1_at retinal3outer3segment3membrane3protein31b rom1b
Dr.18987.1.S1_at ATG93autophagy3related393homolog3A3(S.3
cerevisiae)
atg9a Dr.17137.1.S1_at "RAR5related3orphan3receptor3A,3paralog3b" rorab
Dr.4686.1.S1_at "ATPase,3Na+/K+3transporting,3beta33b3
polypeptide"
atp1b3b Dr.26511.1.S1_at ribosomal3protein3L225like31 rpl22l1
Dr.15256.1.A1_at
"ATP3synthase,3H+3transporting,3mitochondrial3
F03complex,3subunit3b,3isoform31" atp5f1 Dr.25441.1.S1_at "ribosomal3protein,3large3P2" rplp2
Dr.10576.2.A1_at "ATPase,3H+3transporting,3lysosomal,3V03
subunit3c,3b"
atp6v0cb Dr.24633.1.S1_at "ribosomal3protein3S27,3isoform31" rps27.1
Dr.2032.1.A1_at "ATPase,3H+3transporting,3V03subunit3D3
isoform31"








atp6v1e1b Dr.540.1.S1_at retinal3homeobox3gene33 rx3
Dr.370.1.S1_at "ATPase,3H+3transporting,3V13subunit3G3
isoform31"






Dr.11059.1.S1_at "ATPase,3H+3transporting3V03subunit3e2" atpv0e2 Dr.6709.1.S1_at sb:cb252 sb:cb252









Dr.17142.1.A1_at beta5site3APP5cleaving3enzyme31 bace1 Dr.2720.1.A1_at "sarcoglycan,3epsilon" sgce
Dr.6278.1.A1_at BCL25associated3athanogene34 bag4 Dr.17453.1.A1_at SH23domain3containing33Cb sh2d3cb
Dr.20665.1.S1_at Bardet5Biedl3syndrome35 bbs5 Dr.7417.1.S1_at SH35domain3binding3protein35b3(BTK5
associated)
sh3bp5b
Dr.14345.1.A1_at Bardet5Biedl3syndrome37 bbs7 Dr.12559.1.S1_at si:ch211511c15.3 si:ch2115
11c15.3




bcat1 Dr.17180.1.A1_at si:ch2115181b18.1 si:ch2115
181b18.1




bloc1s4 Dr.16426.1.A1_at si:ch2115197g15.12 si:ch2115
197g15.12






















c1qa3|3c1qc Dr.14865.1.A1_at si:ch73552e5.2 si:ch73552e5.2
Dr.16848.1.A1_at C1q3and3tumor3necrosis3factor3related3protein3
4
c1qtnf4 Dr.15375.1.A1_at 555 SI:DKEY5
114C15.7
Dr.13585.1.A1_at carbonic3anhydrase3Xa ca10a Dr.22835.1.A1_at si:dkey512h9.11 si:dkey5
12h9.11
Dr.13585.2.S1_at carbonic3anhydrase3Xa ca10a Dr.21395.1.A1_at 555 SI:DKEY5
172J4.3




cacnb1 Dr.19960.1.A1_at si:dkey5229p15.1 si:dkey5
229p15.1
Dr.13791.1.A1_at cell3adhesion3molecule32a cadm2a Dr.24055.1.S1_at si:dkey525o1.6 si:dkey525o1.6
Dr.450.1.S1_at carbonic3anhydrase cahz Dr.24143.1.A1_at si:dkey56e12.4 si:dkey56e12.4
Dr.22781.1.A1_at calbindin31 calb1 Dr.5973.1.A1_at si:dkeyp5110c7.1 si:dkeyp5
110c7.1
Dr.7048.1.A1_at calbindin32a calb2a Dr.2124.1.A1_at si:dkeyp584f11.5 si:dkeyp5
84f11.5























































Dr.14824.1.S1_at CAS13domain3containing31 casd1 Dr.9900.1.A1_at "solute3carrier3family393(sodium/hydrogen3
exchanger),3member37"
slc9a7
Dr.22832.1.A1_at cerebellin313precursor cbln1 Dr.9918.1.S1_at sarcolemma3associated3protein3b slmapb
Dr.13908.2.S1_a_at chromobox3homolog31b3(HP13beta3homolog3
Drosophila)
cbx1b Dr.1867.1.S1_at spermine3synthase sms
Dr.12921.1.A1_at coiled5coil3domain3containing382 ccdc82 Dr.4117.1.A1_at SMAD3specific3E33ubiquitin3protein3ligase31 smurf1
Dr.10051.1.A1_at cyclin3G2 ccng2 Dr.7815.1.S1_at synaptosome5associated3protein325a snap25a
Dr.20083.1.A1_at cyclin3G2 ccng2 Dr.7598.1.S1_at synaptosome5associated3protein325b snap25b
Dr.10301.1.A1_at "CD823antigen,3b" cd82b Dr.14576.1.S1_at "synuclein,3gamma3b3(breast3cancer5specific3
protein31)"
sncgb
Dr.26344.3.S1_a_at cell3division3cycle342 cdc42 Dr.25550.1.A1_at "synuclein,3gamma3b3(breast3cancer5specific3
protein31)"
sncgb





cdc42ep3 Dr.16935.1.A1_a_at heme5binding3protein3soul4 soul4








Dr.13284.1.A1_at choline3kinase3alpha chka Dr.14335.1.A1_at shadow3of3prion3protein sprn
Dr.26446.1.S1_at "cholinergic3receptor,3nicotinic,3beta3
polypeptide33a"
chrnb3a Dr.26334.1.A1_at serine/arginine5rich3protein3specific3kinase31a srpk1a
Dr.771.1.S1_at "creatine3kinase,3mitochondrial31" ckmt1 Dr.13698.1.S1_at sperm3specific3antigen32 ssfa2
Dr.26433.1.S1_at CDC5like3kinase34a clk4a Dr.17292.1.A1_at slingshot3homolog32b3(Drosophila) ssh2b
Dr.11272.1.A1_at connector3enhancer3of3kinase3suppressor3of3
Ras32b
cnksr2b Dr.7560.1.S1_at "somatostatin31,3tandem3duplicate31" sst1.1
Dr.16729.1.A1_at contactin31b cntn1b Dr.12804.1.S1_at somatostatin33 sst3
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Dr.2038.1.S1_s_at COMM3domain3containing33 commd3 Dr.7026.1.A1_at SSU723RNA3polymerase3II3CTD3phosphatase3
homolog3(S.3cerevisiae)
ssu72





cox6b1 Dr.15262.1.S1_at serine/threonine3kinase3383like stk38l
Dr.5965.1.A1_at copine3II cpne2 Dr.1841.1.A1_at stathmin5like32a stmn2a
Dr.12552.1.S1_at cellular3retinoic3acid3binding3protein31a crabp1a Dr.613.1.S1_at stomatin stom
DrAffx.1.10.S1_at cysteine3rich3transmembrane3BMP3regulator313
(chordin3like)
crim1 Dr.25232.1.A1_at spermatid3perinuclear3RNA3binding3protein strbp
Dr.7400.1.A1_at "casein3kinase31,3epsilon" csnk1e Dr.12806.1.A1_at synapsin3IIb syn2b








Dr.4925.1.S1_x_at cytoglobin31 cygb1 Dr.25455.1.A1_at synaptophysin3b sypb
Dr.4925.1.S1_at cytoglobin31 cygb1 Dr.9125.1.S1_at synaptotagmin3XIa syt11a
Dr.3413.1.S1_at dachshund3c dachc Dr.13868.1.S1_at synaptotagmin3IV syt4






Dr.12983.1.A1_at dynactin35 dctn5 Dr.25330.1.A1_at tectonin3beta5propeller3repeat3containing32 tecpr2
Dr.16505.1.A1_at "DCN1,3defective3in3cullin3neddylation31,3
domain3containing343(S.3cerevisiae)"
dcun1d4 Dr.13696.1.S1_at testis3expressed32 tex2
Dr.7643.1.S1_at DENN/MADD3domain3containing36B dennd6b Dr.11698.1.S1_at transcription3factor3AP523gamma3(activating3
enhancer3binding3protein323gamma)
tfap2c
Dr.11107.1.A1_at desumoylating3isopeptidase31a desi1a Dr.16570.2.S1_at THAP3domain3containing34 thap4
Dr.16422.1.S1_at "DIRAS3family,3GTP5binding3RAS5like31a" diras1a Dr.18844.1.S1_at "T5cell3leukemia,3homeobox31" tlx1





dnajc27 Dr.17164.1.A1_at transmembrane3protein3178 tmem178
Dr.11133.1.A1_at dihydropyrimidinase5like35b dpysl5b Dr.9292.1.A1_at transmembrane3protein3237b tmem237b
Dr.12889.1.S1_at "dynein,3cytoplasmic31,3light3intermediate3
chain31"
dync1li1 Dr.6796.1.A1_at transmembrane3protein3595like tmem59l
Dr.16716.1.S1_at "dynein,3light3chain,3LC85type32a" dynll2a Dr.17560.1.S1_at transmembrane3protein39 tmem9
Dr.15116.1.S1_at "dynein,3light3chain,3LC85type32a" dynll2a Dr.17246.1.A1_at tenomodulin tnmd
Dr.25567.1.S1_at "eukaryotic3translation3initiation3factor33,3
subunit3M"
eif3m DrAffx.1.4.S1_at "tenascin3R3(restrictin,3janusin)" tnr
Dr.11824.1.S1_at "eukaryotic3translation3initiation3factor34A,3
isoform31B"
eif4a1b Dr.8875.1.S1_at toll3interacting3protein tollip
Dr.1909.1.S1_at "E745like3factor333(ets3domain3transcription3
factor,3epithelial5specific3)"
elf3 Dr.11206.1.S1_at triosephosphate3isomerase31a tpi1a
Dr.17507.1.S1_at ER3membrane3protein3complex3subunit33 emc3 Dr.4157.1.S1_at triosephosphate3isomerase31b tpi1b
Dr.3027.1.S1_at "erythrocyte3membrane3protein3band34.1b3
(elliptocytosis31,3RH5linked)"
epb41b Dr.9221.1.S1_at transformer323beta3homolog3(Drosophila) tra2b
Dr.14860.1.A1_at erythrocyte3membrane3protein3band34.15like3
3a
epb41l3a Dr.5637.1.S1_at tripartite3motif5containing38 trim8
Dr.26376.1.A1_at Enah/Vasp5like3b evlb Dr.12050.1.A1_at tripartite3motif5containing39 trim9
Dr.5648.1.A1_at Ewing3sarcoma3breakpoint3region31a ewsr1a Dr.18524.1.A1_at tetraspanin313b tspan13b
Dr.6814.1.S1_at "fatty3acid3binding3protein33,3muscle3and3
heart"
fabp3 Dr.13408.1.S1_at tweety3homolog33b3(Drosophila) ttyh3b
Dr.9450.1.A1_at "family3with3sequence3similarity384,3member3
A"
fam84a Dr.22554.1.A1_at tubby3homolog3(mouse) tub
Dr.15754.1.A1_at F5box3and3leucine5rich3repeat3protein32 fbxl2 Dr.12544.1.A1_at tumor3suppressor3candidate33 tusc3

















gabrd Dr.15856.1.A1_at uridine5cytidine3kinase32a uck2a
Dr.9917.1.S1_at glutamate3decarboxylase31b gad1b Dr.15745.1.S1_at urotensin3II5related3peptide urp2
Dr.4315.1.A1_at glycerophosphodiester3phosphodiesterase3
domain3containing31
gdpd1 Dr.16861.1.A1_at upstream3transcription3factor31 usf1
Dr.1118.1.A1_at glucose5fructose3oxidoreductase3domain3
containing32
gfod2 Dr.7095.1.A1_at vesicle5associated3membrane3protein31 vamp1










gnb5b Dr.8802.1.A1_at WD3repeat3domain311 wdr11
Dr.14190.1.A1_at "guanine3nucleotide3binding3protein3(G3
protein),3gamma313b"






gngt2a Dr.16768.1.A1_at tryptophan3rich3basic3protein wrb
Dr.6487.1.A1_at gephyrin3b gphnb Dr.4078.1.A1_at wu:fb06h03 wu:fb06h03
Dr.7873.1.S1_at G3protein5coupled3receptor385 gpr85 Dr.24899.1.A1_at wu:fb15e04 wu:fb15e04
Dr.3715.1.A1_at "gene3rich3cluster,3C103gene" grcc10 Dr.3497.1.A1_at wu:fb26f10 wu:fb26f10
Dr.18279.1.S1_at "glutamate3receptor,3ionotropic,3AMPA32a" gria2a Dr.2580.1.A1_at wu:fc07b10 wu:fc07b10
Dr.14327.1.A1_at G3protein5coupled3receptor3kinase313a grk1a Dr.24775.2.A1_at wu:fc21b07 wu:fc21b07
Dr.22673.1.A1_at "glutamate3receptor,3metabotropic31a" grm1a Dr.3233.1.A1_at wu:fc35d04 wu:fc35d04
Dr.8166.1.S1_at glycogen3synthase3kinase333beta gsk3b Dr.2701.1.A1_at wu:fc35e07 wu:fc35e07
Dr.4727.1.A1_at gelsolin3b gsnb Dr.21508.1.A1_at wu:fc38h03 wu:fc38h03
Dr.17943.1.A1_at gelsolin3b gsnb Dr.9916.1.A1_at wu:fc47e09 wu:fc47e09








Dr.8617.1.A1_at hyaluronan3and3proteoglycan3link3protein31b hapln1b Dr.2266.1.A1_at wu:fc63c11 wu:fc63c11
Dr.1450.1.S1_at hemoglobin3alpha3embryonic53 hbae3 Dr.21904.1.A1_at wu:fc79g11 wu:fc79g11
Dr.1450.1.S1_s_at hemoglobin3alpha3embryonic53 hbae3 Dr.6528.1.A1_at wu:fd60d11 wu:fd60d11
DrAffx.2.15.S1_at hemoglobin3beta3embryonic52 hbbe2 Dr.13571.1.A1_at wu:fi03b02 wu:fi03b02
Dr.14159.1.A1_at histone3deacetylase39b hdac9b Dr.6735.1.A1_at wu:fj37c02 wu:fj37c02
Dr.13839.1.A1_at "hepatoma5derived3growth3factor,3related3
protein33"











Dr.10615.1.A1_at homeodomain3interacting3protein3kinase33b hipk3b Dr.6457.1.S1_at wu:fj40g07 wu:fj40g07
Dr.24225.1.S1_at "heterogeneous3nuclear3ribonucleoprotein3K,3
like"
hnrpkl Dr.22764.1.A1_at wu:fj51e11 wu:fj51e11









Dr.19642.1.A1_at islet3cell3autoantigen31 ica1 Dr.13462.1.A1_at wu:fj55b04 wu:fj55b04
Dr.12836.1.S1_at "inhibitor3of3DNA3binding32,3dominant3
negative3helix5loop5helix3protein,3b"
id2b Dr.11830.1.A1_at wu:fj55b04 wu:fj55b04
Dr.12836.2.A1_at "inhibitor3of3DNA3binding32,3dominant3
negative3helix5loop5helix3protein,3b"
id2b Dr.23743.1.S1_at wu:fj58g06 wu:fj58g06
Dr.16287.1.A1_at "immunoglobin3superfamily,3member321b" igsf21b Dr.12924.1.A1_at wu:fj83e02 wu:fj83e02
Dr.17303.1.S1_at im:7142942 im:7142942 Dr.6450.1.A1_at wu:fj94a09 wu:fj94a09
Dr.5816.1.A1_at "inhibitor3of3growth3family,3member32" ing2 Dr.23250.1.A1_at wu:fk54e10 wu:fk54e10
Dr.13598.1.A1_at integrator3complex3subunit32 ints2 Dr.24492.1.A1_at wu:fl05f10 wu:fl05f10













Dr.6200.1.A1_at integral3membrane3protein32Ca itm2ca Dr.19352.1.A1_at zinc3finger3CCCH5type3containing310 zc3h10
Dr.11491.1.S1_at Josephin3domain3containing32 josd2 Dr.18465.1.A1_at "zinc3finger,3DHHC5type3containing33" zdhhc3
Dr.10326.1.S1_at jun3B3proto5oncogene3a junba Dr.175.1.A1_at zgc:103657 zgc:103657
Dr.8131.1.S1_at Kallmann3syndrome31a3sequence kal1a Dr.21291.1.A1_at zgc:109889 zgc:109889
Dr.17145.1.S1_at potassium3channel3tetramerisation3domain3
containing312.1
kctd12.1 Dr.15241.1.A1_at zgc:110063 zgc:110063
Dr.11022.1.A1_at lysine3(K)5specific3demethylase35Bb kdm5bb Dr.26355.1.A1_at zgc:111986 zgc:111986
Dr.9880.1.A1_at keratocan kera Dr.14654.1.S1_at zgc:114060 zgc:114060
Dr.18282.7.S1_at "KH3domain3containing,3RNA3binding,3signal3
transduction3associated31a"
khdrbs1a Dr.26124.1.A1_at zgc:114199 zgc:114199
Dr.15083.1.A1_at kinesin3family3member31A kif1a Dr.12242.1.S1_at zgc:123177 zgc:123177
Dr.12174.1.A1_at kinesin5associated3protein33a kifap3a Dr.14261.1.A1_at zgc:123178 zgc:123178
Dr.7499.1.A1_at kinesin3family3member3C3 kifc3 Dr.2204.1.A1_at zgc:136474 zgc:136474
Dr.9293.1.A1_at v5Ki5ras23Kirsten3rat3sarcoma3viral3oncogene3
homolog
kras Dr.24487.1.A1_at zgc:136930 zgc:136930
Dr.15888.1.A1_at KxDL3motif3containing31 kxd1 Dr.11452.1.A1_at zgc:153958 zgc:153958
Dr.9200.1.A1_at lysosomal3associated3protein3transmembrane3
43beta
laptm4b Dr.22840.1.S1_at zgc:158423 zgc:158423
Dr.6975.1.A1_at "La3ribonucleoprotein3domain3family,3member3
6"
larp6 Dr.14493.1.A1_at zgc:158624 zgc:158624
Dr.17515.1.A1_at lactate3dehydrogenase3Bb ldhbb Dr.4654.1.A1_at zgc:162126 zgc:162126
Dr.5853.1.A1_at "lectin,3galactoside5binding,3soluble,333binding3
protein3b"
lgals3bpb Dr.9069.1.A1_at zgc:162161 zgc:162161
Dr.277.1.S1_at LIM3homeobox31b lhx1b Dr.11110.1.A1_at zgc:162707 zgc:162707
Dr.1225.1.A1_at LIM3domain3kinase32 limk2 Dr.7022.1.A1_at zgc:165666 zgc:165666
Dr.11345.1.A1_at lin573homolog3A3(C.3elegans) lin7a Dr.15311.1.A1_at zgc:175128 zgc:175128




lingo1b Dr.26468.1.S1_at zgc:63972 zgc:63972
Dr.6295.1.S1_at LIM3domain3only34a lmo4a Dr.17194.1.A1_at zgc:65851 zgc:65851









































































































13|3LOC561668 Dr.13475.1.A1_at 555 555
Dr.14069.1.A1_at calsyntenin535like LOC555627 Dr.22720.1.A1_at 555 555
Dr.7441.1.A1_at glycerophosphodiester3phosphodiesterase3
domain5containing3protein355like
LOC560645 Dr.13933.1.A1_at 555 555
Dr.21875.1.A1_at "novel3protein3similar3to3H.sapiens3TTC9,3
tetratricopeptide3repeat3domain393(TTC9)"
LOC560706 Dr.14352.1.A1_at 555 555
Dr.23663.1.S1_at novel3protein3similar3to3vertebrate3atrophin313
(ATN1)
LOC561408 Dr.17958.1.S1_at 555 555
Dr.19528.1.A1_at uncharacterized3LOC562053 LOC562053 Dr.26299.1.A1_at 555 555







LOC568915 Dr.16794.2.A1_a_at 555 555
Dr.12472.1.A1_at syntaxin5125like LOC569124 Dr.16786.1.A1_at 555 555






LOC796404 Dr.8944.1.A1_at 555 555
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Dr.12598.1.S1_at neural3cell3adhesion3molecule32 ncam2 Dr.13222.1.A1_at 555 555
Dr.12107.1.A1_at N5myc3downstream3regulated3gene31a ndrg1a Dr.26519.2.A1_at 555 555
Dr.827.1.A1_at "NADH3dehydrogenase3(ubiquinone)313alpha3
subcomplex,34"
ndufa4 Dr.13465.1.A1_at 555 555
Dr.16132.1.A1_at "neurofilament,3medium3polypeptide3a" nefma Dr.26398.2.S1_at 555 555
Dr.22710.1.A1_at NEL5like32a nell2a Dr.936.1.A1_at 555 555
Dr.22741.1.A1_at NEL5like32b nell2b Dr.25884.1.A1_at 555 555
Dr.556.1.S1_at neurogenic3differentiation neurod Dr.14167.1.S1_at 555 555
Dr.5740.1.S1_at neurogenic3differentiation32 neurod2 Dr.12823.1.A1_at 555 555
Dr.8196.1.S1_at neurogenic3differentiation36a neurod6a Dr.17976.1.S1_at 555 555
Dr.8197.1.S1_at neurogenic3differentiation36b neurod6b Dr.16582.1.A1_at 555 555
Dr.4859.1.A1_at nexilin3(F3actin3binding3protein) nexn Dr.15208.1.A1_at 555 555
Dr.12913.1.A1_at neuroligin34a nlgn4a Dr.17141.1.A1_at 555 555
Dr.9836.1.S1_at NME/NM233nucleoside3diphosphate3kinase32a nme2a Dr.16506.1.A1_at 555 555
Dr.7457.1.A1_at nicotinamide3nucleotide3adenylyltransferase32 nmnat2 Dr.16373.1.S1_at 555 555
Dr.4949.1.A1_at nitric3oxide3synthase3interacting3protein nosip Dr.11232.1.A1_at 555 555
Dr.20524.1.A1_at neuronal3PAS3domain3protein34a npas4a Dr.17756.1.A1_at 555 555
Dr.23064.2.S1_at "neural3proliferation,3differentiation3and3
control,31"
npdc1 Dr.12943.1.A1_at 555 555
Dr.7065.2.A1_at natriuretic3peptide3precursor3C5like3protein nppcl Dr.20400.1.A1_at 555 555
Dr.10103.1.A1_at neuroplastin3a nptna Dr.14762.1.A1_at 555 555
Dr.14062.1.A1_at neuregulin33 NRG3 Dr.13441.1.A1_at 555 555
Dr.12859.1.S1_at "neurogranin3(protein3kinase3C3substrate,3
RC3)3a"
nrgna Dr.17920.1.A1_at 555 555
Dr.7206.1.A1_at neurensin31 nrsn1 Dr.16737.1.S1_at 555 555
Dr.10477.1.S1_at NSA23ribosome3biogenesis3homolog3(S.3
cerevisiae)
nsa2 Dr.12738.1.A1_at 555 555
Dr.3959.1.A1_at "5'5nucleotidase,3cytosolic3II,3like31" nt5c2l1 Dr.26429.1.A1_at 555 555
Dr.6259.1.S1_at nucleobindin32b nucb2b Dr.15403.1.A1_at 555 555
Dr.2992.1.A1_at optic3atrophy313(human) opa1 Dr.26085.1.A1_at 555 555
Dr.8194.1.S1_at "opsin313(cone3pigments),3short5wave5
sensitive31"
opn1sw1 Dr.12075.1.A1_at 555 555
Dr.19427.2.S1_at 555 OSBPL2A Dr.18656.1.S1_at 555 555
Dr.7597.1.S1_at oxytocin oxt Dr.17757.1.A1_at 555 555
Dr.11392.1.A1_at "poly3A3binding3protein,3cytoplasmic313b" pabpc1b Dr.11143.1.A1_at 555 555
Dr.26364.1.A1_at "platelet5activating3factor3acetylhydrolase,3
isoform3Ib,3alpha3subunit3b"
pafah1b1b Dr.15196.1.S1_at 555 555
Dr.15254.1.A1_at "platelet5activating3factor3acetylhydrolase31b,3
catalytic3subunit32"
pafah1b2 Dr.16081.1.S1_at 555 555
Dr.2836.1.A1_at paralemmin31b palm1b Dr.9998.1.A1_at 555 555
Dr.12635.1.A1_at progestin3and3adipoQ3receptor3family3
member3IIIa
paqr3a Dr.17577.1.A1_at 555 555
Dr.1697.1.A1_at "poly3(ADP5ribose)3polymerase3family,3
member312b"
parp12b Dr.11049.1.A1_at 555 555
Dr.22774.1.A1_at piccolo3(presynaptic3cytomatrix3protein)3b pclob Dr.11079.1.A1_at 555 555
Dr.17014.1.S1_at Purkinje3cell3protein343like31 pcp4l1 Dr.8650.1.S1_at 555 555
Dr.13800.1.A1_at peroxisomal3biogenesis3factor35 pex5 Dr.17398.1.A1_at 555 555
Dr.6819.1.A1_at phosphoglycerate3mutase31b pgam1b Dr.9417.1.A1_at 555 555
Dr.24191.1.S1_at "phosphoinositide535kinase,3regulatory3
subunit33b3(gamma)"
pik3r3b Dr.12871.1.A1_at 555 555
Dr.11329.1.A1_at "protein3kinase3(cAMP5dependent,3catalytic)3
inhibitor3beta"
pkib Dr.26254.1.A1_at 555 555
Dr.7101.1.S1_at pro5melanin3concentrating3hormone5like3
protein
pmchl Dr.23433.1.A1_at 555 555
Dr.11138.1.A1_at podocalyxin5like32 podxl2 Dr.20440.1.A1_at 555 555
Dr.13574.1.S1_at "POU3domain,3class34,3transcription3factor32" pou4f2 Dr.13616.1.A1_at 555 555
Dr.24898.1.S1_at pancreatic3progenitor3cell3differentiation3and3
proliferation3factor3a
ppdpfa Dr.241.1.A1_at 555 555
Dr.26034.1.A1_at
"protein3kinase,3cAMP5dependent,3regulatory,3
type3I,3alpha3(tissue3specific3extinguisher31)3a" prkar1aa Dr.12564.1.A1_at 555 555
Dr.8139.1.S1_at prospero5related3homeobox3gene31a prox1a Dr.16063.1.S1_at 555 555
Dr.22807.1.A1_at "pleckstrin3and3Sec73domain3containing33,3
like"
psd3l Dr.7363.1.A1_at 555 555
Dr.17113.1.A1_a_at phosphatase3and3tensin3homolog3A ptena Dr.10124.1.A1_at 555 555
Dr.12800.1.S1_at "protein3tyrosine3phosphatase5like3(proline3
instead3of3catalytic3arginine),3member3b"
ptplb Dr.14333.1.A1_at 555 555
Dr.13952.1.A1_at "protein3tyrosine3phosphatase,3non5receptor3
type311,3b"
ptpn11b Dr.22707.1.A1_at 555 555
Dr.14147.1.S1_at parvalbumin36 pvalb6 Dr.26174.1.A1_at 555 555
Dr.16940.1.S1_at "RAB11B,3member3RAS3oncogene3family,3b" rab11bb Dr.15471.1.A1_at 555 555
Dr.16940.2.A1_at "RAB11B,3member3RAS3oncogene3family,3b" rab11bb Dr.17957.1.A1_at 555 555
Dr.13273.1.S1_at "RAB15,3member3RAS3oncogene3family" rab15 Dr.19556.2.S1_at 555 555
Dr.25650.1.A1_at "RAB,3member3of3RAS3oncogene3family5like32" rabl2 Dr.13529.1.A1_at 555 555
Dr.6811.1.A1_at "ras5related3C33botulinum3toxin3substrate33a3
(rho3family,3small3GTP3binding3protein3Rac3)"
rac3a Dr.11376.1.A1_at 555 555
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Dr.14199.1.S1_at uncharacterized3LOC797202 LOC797202 Dr.13538.1.S1_at 555 555
Dr.10186.1.A1_at "phytanoyl5CoA3dioxygenase,3peroxisomal5
like"
LOC798210 Dr.16719.1.A1_at 555 555
Dr.22391.1.A1_at low3density3lipoprotein3receptor5related3
protein311
lrp11 Dr.16311.1.A1_at 555 555
Dr.10168.2.S1_at v5maf3musculoaponeurotic3fibrosarcoma3
(avian)3oncogene3homolog
maf Dr.14759.1.A1_at 555 555
Dr.4477.1.A1_at "membrane3associated3guanylate3kinase,3WW3
and3PDZ3domain3containing31b"
magi1b Dr.20489.2.S1_at 555 555






Dr.16118.1.A1_at microtubule5associated3protein3tau3b maptb Dr.11343.1.A1_at 555 555
Dr.20062.1.S1_at transformed33T33cell3double3minute343
homolog3(mouse)
mdm4 Dr.11355.1.A1_at 555 555
Dr.8060.1.S1_at mesoderm3specific3transcript mest Dr.17052.1.A1_at 555 555
Dr.25285.1.S1_at MID13interacting3protein31b mid1ip1b Dr.21822.2.A1_a_at 555 555
Dr.16892.1.A1_at "membrane3protein,3palmitoylated32b3
(MAGUK3p553subfamily3member32b)"
mpp2b Dr.24189.1.S1_at 555 555
Dr.17264.1.A1_at musashi3homolog32b3(Drosophila) msi2b Dr.18354.2.A1_at 555 555
Dr.17628.1.A1_at musashi3homolog32b3(Drosophila) msi2b Dr.14765.1.A1_at 555 555
Dr.5778.1.S1_at myostatin3b mstnb Dr.5685.2.S1_at 555 555
Dr.15836.1.A1_at metadherin3a mtdha Dr.26158.1.A1_at 555 555
Dr.18683.1.S1_at myocilin myoc Dr.14358.1.A1_at 555 555
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Supplemental Figure 5: List of SAM negative genes
Knockdown of nhsb causes changes in gene expression in the retina. SAM analysis 
identified significanly downregulated genes in nhsb MO injected embryos compared to control
Annotation'Cluster'1' Enrichment'Score:'5.49'
GO'Term Count' P_Value' Benjamini
DNA'replication' 15 1.30EF08 1.40EF06
DNA'replication' 16 3.10EF06 2.90EF04
dna'replication' 8 8.00EF04 1.80EF02
Annotation'Cluster'2' Enrichment'Score:'4.91'
GO'Term Count' P_Value' Benjamini
mitotic'cell'cycle' 19 3.40EF08 2.00EF05
M'phase'of'mitotic'cell'cycle' 17 9.30EF08 3.70EF05
cell'cycle'phase' 19 3.00EF07 8.80EF05
cell'cycle'process' 21 3.20EF07 7.60EF05
mitosis' 16 3.50EF07 7.00EF05
nuclear'division' 16 4.60EF07 6.80EF05
cell'cycle' 29 6.20EF07 8.20EF05
cell'division' 20 8.40EF07 1.00EF04
M'phase' 18 1.00EF06 1.10EF04
organelle'fission' 16 1.30EF06 1.20EF04
condensed'chromosome' 8 1.30EF05 1.60EF03
mitosis' 11 1.70EF05 1.40EF03
cell'cycle' 17 1.80EF05 1.10EF03
chromosome' 21 4.00EF05 3.20EF03
cell'division' 15 1.60EF04 6.30EF03
chromosomal'part' 16 4.60EF04 1.80EF02
kinetochore' 5 1.70EF03 3.40EF02
condensed'chromosome,'centromeric'region' 5 2.50EF03 5.20EF02
condensed'chromosome'kinetochore' 5 2.50EF03 5.20EF02
kinetochore' 5 3.60EF03 6.80EF02
chromosome,'centromeric'region' 6 5.60EF03 8.40EF02
Annotation'Cluster'3' Enrichment'Score:'4.74'
GO'Term Count' P_Value' Benjamini
DNA'replication' 15 1.30EF08 1.40EF06
Mismatch'repair' 9 3.20EF05 1.10EF03
Nucleotide'excision'repair' 8 1.40EF02 1.50EF01
Annotation'Cluster'4' Enrichment'Score:'4.09'
GO'Term Count' P_Value' Benjamini
intracellular'nonFmembraneFbounded'organelle' 73 1.70EF08 3.90EF06
nonFmembraneFbounded'organelle' 73 1.70EF08 3.90EF06
microtubule' 15 2.90EF05 1.40EF03
Kinesin,'motor'region,'conserved'site' 9 2.90EF05 3.60EF02
KISc' 9 9.50EF05 2.10EF02
Kinesin,'motor'region' 9 1.00EF04 4.20EF02
microtubule'motor'activity' 10 2.00EF04 9.10EF02
microtubule' 14 2.60EF04 1.50EF02
microtubule'cytoskeleton' 18 3.90EF04 1.80EF02
microtubuleFbased'process' 16 4.60EF04 2.20EF02
cytoskeletal'part' 26 4.60EF04 1.50EF02
cytoskeleton' 34 4.70EF04 1.40EF02
motor'activity' 12 1.50EF03 2.10EF01
microtubuleFbased'movement' 11 2.10EF03 7.50EF02
motor'protein' 10 2.90EF03 4.90EF02
Annotation'Cluster'5' Enrichment'Score:'3.65'
GO'Term Count' P_Value' Benjamini
cameraFtype'eye'development' 20 2.40EF05 1.90EF03
retina'development'in'cameraFtype'eye' 13 2.20EF04 1.20EF02
eye'development' 21 4.80EF04 2.20EF02
sensory'organ'development' 26 9.60EF04 4.10EF02
Annotation'Cluster'6' Enrichment'Score:'3.59'
GO'Term Count' P_Value' Benjamini
DNA'metabolic'process' 30 1.40EF05 1.20EF03
response'to'DNA'damage'stimulus' 19 1.20EF04 7.40EF03
cellular'response'to'stress' 20 1.30EF04 7.90EF03
DNA'repair' 13 2.00EF02 3.40EF01
Annotation'Cluster'7' Enrichment'Score:'3.04'
GO'Term Count' P_Value' Benjamini
ribosome'biogenesis' 15 4.30EF07 7.30EF05
ribonucleoprotein'complex'biogenesis' 16 4.60EF07 6.80EF05
rRNA'processing' 9 8.00EF04 3.60EF02
rRNA'metabolic'process' 9 9.90EF04 4.10EF02
nucleolus' 11 1.40EF03 3.20EF02
RNA'processing' 24 2.50EF03 8.50EF02
ncRNA'processing' 12 6.00EF03 1.60EF01
ribosome'biogenesis' 5 6.70EF03 8.30EF02
rrna'processing' 5 1.10EF02 1.20EF01
ncRNA'metabolic'process' 15 1.50EF02 3.00EF01
preribosome' 3 9.00EF02 5.70EF01
Annotation'Cluster'8' Enrichment'Score:'2.99'
GO'Term Count' P_Value' Benjamini
condensed'chromosome' 8 1.30EF05 1.60EF03
chromosome'segregation' 8 8.00EF05 5.30EF03
mitotic'sister'chromatid'segregation' 3 3.30EF02 4.40EF01
sister'chromatid'segregation' 3 3.30EF02 4.40EF01
Annotation'Cluster'9' Enrichment'Score:'2.58'
GO'Term Count' P_Value' Benjamini
WD40'repeat,'subgroup' 25 3.80EF05 2.40EF02
WD40' 25 1.90EF04 2.10EF02
WD40'repeat' 25 2.30EF04 7.00EF02
WD40'repeat,'region' 23 2.60EF04 6.40EF02
wd'repeat' 23 6.90EF04 1.70EF02
WD40'repeat'2' 21 8.50EF04 1.20EF01
WD40/YVTN'repeatFlike' 24 2.80EF03 3.00EF01
WD40'repeat,'conserved'site' 18 3.30EF03 3.20EF01
repeat:WD'3' 10 8.70EF03 3.60EF01
repeat:WD'5' 9 1.10EF02 4.00EF01
repeat:WD'1' 10 1.30EF02 4.20EF01
repeat:WD'2' 10 1.30EF02 4.20EF01
repeat:WD'6' 8 1.80EF02 4.90EF01
repeat:WD'4' 9 1.80EF02 4.70EF01
repeat:WD'7' 5 1.30EF01 9.50EF01
Annotation'Cluster'10' Enrichment'Score:'2.53'
GO'Term Count' P_Value' Benjamini
neurogenesis' 11 3.80EF04 1.10EF02
differentiation' 15 6.90EF04 1.90EF02
domain:EGFFlike'6' 5 1.40EF03 1.10EF01
developmental'protein' 26 2.20EF01 7.00EF01
Annotation'Cluster'11' Enrichment'Score:'2.38'
GO'Term Count' P_Value' Benjamini
chromosome'segregation' 8 8.00EF05 5.30EF03
establishment'of'organelle'localization' 7 6.00EF03 1.60EF01
organelle'localization' 7 8.50EF03 2.10EF01
metaphase'plate'congression' 3 1.10EF02 2.30EF01
chromosome'localization' 3 1.10EF02 2.30EF01
establishment'of'chromosome'localization' 3 1.10EF02 2.30EF01
Annotation'Cluster'12' Enrichment'Score:'2.29'
GO'Term Count' P_Value' Benjamini
DNA'damage'response,'signal'transduction' 7 5.90EF05 4.40EF03
cell'cycle'checkpoint' 6 1.50EF03 5.70EF02
DNA'integrity'checkpoint' 5 2.10EF03 7.40EF02
DNA'damage'checkpoint' 5 2.10EF03 7.40EF02
mitotic'cell'cycle'checkpoint' 3 3.30EF02 4.40EF01
regulation'of'cell'cycle' 7 7.00EF02 6.40EF01
regulation'of'mitotic'cell'cycle' 4 9.30EF02 7.30EF01
Annotation'Cluster'13' Enrichment'Score:'2.26'
GO'Term Count' P_Value' Benjamini
nucleotideFbinding' 85 1.90EF04 6.60EF03
nucleotide'binding' 126 1.20EF03 2.40EF01
purine'ribonucleotide'binding' 104 1.90EF03 2.00EF01
ribonucleotide'binding' 104 1.90EF03 2.00EF01
purine'nucleotide'binding' 107 2.10EF03 1.50EF01
atpFbinding' 58 9.60EF03 1.10EF01
adenyl'ribonucleotide'binding' 76 2.20EF02 5.50EF01
adenyl'nucleotide'binding' 79 2.30EF02 5.40EF01
purine'nucleoside'binding' 79 2.50EF02 5.40EF01
nucleoside'binding' 79 2.70EF02 5.30EF01
ATP'binding' 75 2.80EF02 5.10EF01
Annotation'Cluster'14' Enrichment'Score:'2.14'
GO'Term Count' P_Value' Benjamini
Notch'signaling'pathway' 14 1.60EF08 2.00EF05
notch'signaling'pathway' 10 3.40EF07 8.30EF05
domain:EGFFlike'3' 7 7.90EF05 3.90EF02
domain:DSL' 5 3.40EF04 8.20EF02
EGFFlike,'type'2' 7 4.20EF04 8.40EF02
domain:EGFFlike'1' 7 5.30EF04 6.50EF02
DSL' 5 5.40EF04 4.00EF02
Delta/Serrate/lagF2'(DSL)'protein' 5 5.60EF04 9.50EF02
Notch'ligand,'NFterminal' 5 5.60EF04 9.50EF02
domain:EGFFlike'2' 6 5.70EF04 5.60EF02
domain:EGFFlike'7;'calciumFbinding' 5 1.40EF03 1.10EF01
domain:EGFFlike'6' 5 1.40EF03 1.10EF01
Notch'signaling'pathway' 11 1.50EF03 2.60EF02
domain:EGFFlike'4;'calciumFbinding' 4 3.20EF03 2.10EF01
ubl'conjugation' 6 3.60EF03 5.30EF02
domain:EGFFlike'8' 4 6.10EF03 3.20EF01
disulfide'bond' 18 1.20EF02 1.20EF01
domain:EGFFlike'5' 4 1.50EF02 4.50EF01
PIRSF036324:deltaFlike'protein' 3 3.00EF02 1.00E+00
domain:EGFFlike'5;'calciumFbinding' 3 4.40EF02 7.40EF01
EGFFtype'aspartate/asparagine'hydroxylation'conserved'site' 8 7.80EF02 9.80EF01
disulfide'bond' 17 8.50EF02 8.80EF01
EGFFlike'calciumFbinding,'conserved'site' 8 9.90EF02 9.90EF01
EGF_CA' 8 1.10EF01 8.90EF01
EGFFlike'calciumFbinding' 8 1.20EF01 9.90EF01
domain:EGFFlike'4' 3 1.80EF01 9.80EF01
EGF'calciumFbinding' 5 2.30EF01 1.00E+00
EGF' 7 3.90EF01 1.00E+00
egfFlike'domain' 9 3.90EF01 8.40EF01
EGFFlike'region,'conserved'site' 13 4.10EF01 1.00E+00
EGFFlike,'type'3' 9 4.20EF01 1.00E+00
EGF' 9 4.90EF01 9.90EF01
EGFFlike' 9 5.00EF01 1.00E+00
EGF,'extracellular' 3 6.00EF01 1.00E+00
Annotation'Cluster'15' Enrichment'Score:'2.02'
GO'Term Count' P_Value' Benjamini
chromosome'organization' 23 6.10EF05 4.20EF03
chromatin'regulator' 7 3.40EF02 2.70EF01
chromatin'modification' 9 5.00EF02 5.40EF01
chromatin'organization' 13 7.90EF02 6.80EF01
Annotation'Cluster'16' Enrichment'Score:'1.86'
GO'Term Count' P_Value' Benjamini
DNAFdirected'DNA'polymerase'activity' 6 3.00EF03 1.60EF01
DNA'polymerase'activity' 6 4.90EF03 2.10EF01
nucleotidyltransferase'activity' 8 1.80EF01 9.00EF01
Annotation'Cluster'17' Enrichment'Score:'1.72'
GO'Term Count' P_Value' Benjamini
HLH' 15 5.80EF03 2.30EF01
Basic'helixFloopFhelix'dimerisation'region'bHLH' 15 6.30EF03 4.30EF01
HelixFloopFhelix'DNAFbinding' 10 5.60EF02 9.70EF01
domain:HelixFloopFhelix'motif' 6 6.50EF02 8.20EF01
Annotation'Cluster'18' Enrichment'Score:'1.59'
GO'Term Count' P_Value' Benjamini
Endonuclease' 7 3.00EF03 4.70EF02
nuclease' 5 4.50EF02 3.30EF01
nuclease'activity' 10 5.40EF02 5.80EF01
endonuclease'activity' 7 6.30EF02 6.30EF01
Annotation'Cluster'19' Enrichment'Score:'1.5'
GO'Term Count' P_Value' Benjamini
DNA'damage'response,'signal'transduction' 7 5.90EF05 4.40EF03
DNA'damage'response,'signal'transduction'resulting'in'induction'of'apoptosis'4 3.90EF03 1.20EF01
induction'of'apoptosis'by'intracellular'signals' 4 3.90EF03 1.20EF01
DNA'damage'response,'signal'transduction'by'p53'class'mediator' 3 1.10EF02 2.30EF01
DNA'damage'response,'signal'transduction'by'p53'class'mediator'resulting'in'induction'of'apoptosis'3 1.10EF02 2.30EF01
induction'of'programmed'cell'death' 4 4.10EF02 4.90EF01
induction'of'apoptosis' 4 4.10EF02 4.90EF01
positive'regulation'of'programmed'cell'death' 6 7.90EF02 6.70EF01
positive'regulation'of'apoptosis' 6 7.90EF02 6.70EF01
positive'regulation'of'cell'death' 6 7.90EF02 6.70EF01
regulation'of'apoptosis' 6 7.20EF01 1.00E+00
regulation'of'programmed'cell'death' 6 7.50EF01 1.00E+00
regulation'of'cell'death' 6 7.50EF01 1.00E+00
Annotation'Cluster'20' Enrichment'Score:'1.48'
GO'Term Count' P_Value' Benjamini
nucleobase,'nucleoside'and'nucleotide'biosynthetic'process' 23 2.20EF04 1.20EF02
nucleobase,'nucleoside,'nucleotide'and'nucleic'acid'biosynthetic'process'23 2.20EF04 1.20EF02
nitrogen'compound'biosynthetic'process' 29 3.30EF04 1.70EF02
protonFtransporting'VFtype'ATPase'complex' 6 1.10EF03 2.80EF02
purine'nucleotide'metabolic'process' 17 3.20EF03 9.90EF02
nucleotide'biosynthetic'process' 19 3.80EF03 1.10EF01
protonFtransporting'twoFsector'ATPase'complex' 9 5.90EF03 8.30EF02
purine'nucleotide'biosynthetic'process' 16 6.10EF03 1.60EF01
ribonucleotide'biosynthetic'process' 15 9.20EF03 2.20EF01
ribonucleotide'metabolic'process' 15 1.00EF02 2.30EF01
proton'transport' 9 1.00EF02 2.30EF01
hydrogen'transport' 9 1.00EF02 2.30EF01
purine'ribonucleotide'biosynthetic'process' 14 1.60EF02 3.00EF01
purine'ribonucleotide'metabolic'process' 14 1.70EF02 3.10EF01
monovalent'inorganic'cation'transmembrane'transporter'activity' 11 2.00EF02 5.50EF01
hydrogen'ion'transmembrane'transporter'activity' 10 2.50EF02 5.30EF01
ATP'synthesis'coupled'proton'transport' 8 2.50EF02 4.00EF01
energy'coupled'proton'transport,'down'electrochemical'gradient' 8 2.50EF02 4.00EF01
nucleoside'triphosphate'biosynthetic'process' 12 2.60EF02 4.00EF01
purine'nucleoside'triphosphate'biosynthetic'process' 12 2.60EF02 4.00EF01
purine'ribonucleoside'triphosphate'biosynthetic'process' 12 2.60EF02 4.00EF01
ribonucleoside'triphosphate'biosynthetic'process' 12 2.60EF02 4.00EF01
purine'nucleoside'triphosphate'metabolic'process' 12 2.70EF02 4.10EF01
purine'ribonucleoside'triphosphate'metabolic'process' 12 2.70EF02 4.10EF01
ribonucleoside'triphosphate'metabolic'process' 12 2.70EF02 4.10EF01
ATP'biosynthetic'process' 11 2.90EF02 4.20EF01
protonFtransporting'VFtype'ATPase,'V0'domain' 3 2.90EF02 2.80EF01
generation'of'precursor'metabolites'and'energy' 16 2.90EF02 4.20EF01
nucleoside'triphosphate'metabolic'process' 12 2.90EF02 4.10EF01
ion'transmembrane'transport' 8 3.10EF02 4.30EF01
ATP'metabolic'process' 11 3.10EF02 4.20EF01
oxidative'phosphorylation' 9 3.40EF02 4.40EF01
Oxidative'phosphorylation' 13 7.10EF02 4.00EF01
inorganic'cation'transmembrane'transporter'activity' 12 9.30EF02 7.50EF01
protonFtransporting'twoFsector'ATPase'complex,'protonFtransporting'domain'4 1.40EF01 7.00EF01
hydrolase'activity,'acting'on'acid'anhydrides,'catalyzing'transmembrane'movement'of'substances'8 1.60EF01 8.70EF01
protonFtransporting'twoFsector'ATPase'complex,'catalytic'domain' 4 1.70EF01 7.40EF01
ATPase'activity,'coupled'to'transmembrane'movement'of'ions' 6 1.70EF01 8.90EF01
cationFtransporting'ATPase'activity' 4 1.90EF01 9.00EF01
protonFtransporting'ATPase'activity,'rotational'mechanism' 3 2.20EF01 9.00EF01
PFPFbondFhydrolysisFdriven'transmembrane'transporter'activity' 7 2.60EF01 9.30EF01
primary'active'transmembrane'transporter'activity' 7 2.60EF01 9.30EF01
ATPase'activity,'coupled'to'movement'of'substances' 6 3.40EF01 9.60EF01
ATPase'activity,'coupled'to'transmembrane'movement'of'substances' 6 3.40EF01 9.60EF01
monovalent'inorganic'cation'transport' 13 5.60EF01 9.90EF01
ATPase'activity,'coupled'to'transmembrane'movement'of'ions,'phosphorylative'mechanism'3 6.30EF01 1.00E+00
transmembrane'transport' 20 8.50EF01 1.00E+00
ion'transport' 20 9.40EF01 1.00E+00
cation'transport' 14 9.50EF01 1.00E+00
Annotation'Cluster'21' Enrichment'Score:'1.43'
GO'Term Count' P_Value' Benjamini
nuclear'pore'complex' 4 5.50EF03 7.60EF02
nuclear'pore' 7 6.00EF03 8.10EF02
pore'complex' 7 6.00EF03 8.10EF02
nuclear'envelope' 8 2.00EF02 2.20EF01
mRNA'transport' 5 2.10EF02 1.80EF01
mRNA'transport' 5 3.60EF02 4.50EF01
RNA'transport' 5 4.20EF02 4.90EF01
nucleic'acid'transport' 5 4.20EF02 4.90EF01
nucleobase,'nucleoside,'nucleotide'and'nucleic'acid'transport' 5 4.20EF02 4.90EF01
establishment'of'RNA'localization' 5 4.20EF02 4.90EF01
RNA'localization' 5 4.80EF02 5.30EF01
organelle'envelope' 18 5.10EF02 4.30EF01
envelope' 18 5.50EF02 4.40EF01
translocation' 4 1.20EF01 5.50EF01
protein'transport' 8 2.30EF01 7.20EF01
endomembrane'system' 13 3.90EF01 9.20EF01
Annotation'Cluster'22' Enrichment'Score:'1.43'
GO'Term Count' P_Value' Benjamini
nucleolus' 11 1.40EF03 3.20EF02
membraneFenclosed'lumen' 24 4.80EF03 8.40EF02
intracellular'organelle'lumen' 23 5.20EF03 8.40EF02
organelle'lumen' 23 5.20EF03 8.40EF02
nuclear'lumen' 19 1.70EF02 2.00EF01
nuclear'body' 3 2.10EF01 8.00EF01
nucleoplasm' 9 5.10EF01 9.70EF01
nucleoplasm'part' 8 5.30EF01 9.70EF01
transcription'factor'complex' 4 7.50EF01 1.00E+00
Annotation'Cluster'23' Enrichment'Score:'1.29'
GO'Term Count' P_Value' Benjamini
Pept_C1' 6 2.40EF03 1.20EF01
Peptidase'C1A,'papain'CFterminal' 6 2.50EF03 2.90EF01
Peptidase'C1A,'papain' 6 4.10EF03 3.50EF01
Peptidase,'cysteine'peptidase'active'site' 7 3.10EF02 9.10EF01
PIRSF001182:papain' 4 3.30EF02 1.00E+00
Proteinase'inhibitor'I29,'cathepsin'propeptide' 4 4.70EF02 9.60EF01
thiol'protease' 7 1.40EF01 5.80EF01
cysteineFtype'endopeptidase'activity' 7 2.90EF01 9.40EF01
cysteineFtype'peptidase'activity' 8 4.60EF01 9.90EF01
endopeptidase'activity' 18 5.40EF01 9.90EF01
Protease' 13 6.60EF01 9.60EF01
Annotation'Cluster'24' Enrichment'Score:'1.26'
GO'Term Count' P_Value' Benjamini
dna'replication' 8 8.00EF04 1.80EF02
DNAFdependent'DNA'replication' 5 1.10EF02 2.30EF01
Nucleic'acidFbinding,'OBFfold' 7 4.50EF02 9.60EF01
DNAFdependent'ATPase'MCM,'conserved'site' 3 6.90EF02 9.80EF01
MCM' 3 8.50EF02 8.60EF01
DNAFdependent'ATPase'MCM' 3 8.60EF02 9.80EF01
DNA'replication'initiation' 3 1.00EF01 7.40EF01
AAA' 9 1.90EF01 9.40EF01
ATPase,'AAA+'type,'core' 9 1.90EF01 1.00E+00
ATPase,'AAAFtype,'core' 4 3.90EF01 1.00E+00
Annotation'Cluster'25' Enrichment'Score:'1.22'
GO'Term Count' P_Value' Benjamini
gut'morphogenesis' 6 1.00EF03 4.20EF02
digestive'tract'morphogenesis' 6 2.10EF03 7.60EF02
neural'plate'development' 6 2.80EF03 9.00EF02
digestive'system'development' 6 4.70EF03 1.30EF01
gut'development' 6 9.20EF03 2.20EF01
morphogenesis'of'embryonic'epithelium' 6 1.60EF02 3.00EF01
somatic'motor'neuron'differentiation' 3 2.10EF02 3.50EF01
neural'plate'formation' 4 2.60EF02 4.00EF01
floor'plate'formation' 4 2.60EF02 4.00EF01
diencephalon'development' 6 2.90EF02 4.20EF01
forebrain'development' 8 3.10EF02 4.30EF01
ventral'midline'development' 4 3.30EF02 4.30EF01
cell'differentiation'in'spinal'cord' 5 3.60EF02 4.50EF01
spinal'cord'development' 5 4.20EF02 4.90EF01
neural'plate'morphogenesis' 4 5.00EF02 5.40EF01
somitogenesis' 9 6.20EF02 6.10EF01
embryonic'cameraFtype'eye'development' 4 7.00EF02 6.40EF01
spinal'cord'motor'neuron'differentiation' 4 7.00EF02 6.40EF01
ventral'spinal'cord'development' 4 8.10EF02 6.80EF01
cell'fate'commitment' 7 9.50EF02 7.30EF01
segmentation' 9 9.60EF02 7.30EF01
anterior/posterior'pattern'formation' 12 1.00EF01 7.40EF01
chordate'embryonic'development' 13 1.10EF01 7.50EF01
embryonic'development'ending'in'birth'or'egg'hatching' 13 1.10EF01 7.50EF01
pancreas'development' 6 1.10EF01 7.50EF01
pattern'specification'process' 20 1.70EF01 8.50EF01
cell'fate'specification' 5 1.70EF01 8.60EF01
regionalization' 15 2.10EF01 9.10EF01
neuron'differentiation' 12 2.90EF01 9.50EF01
embryonic'morphogenesis' 17 3.00EF01 9.50EF01
determination'of'left/right'symmetry' 6 3.60EF01 9.70EF01
determination'of'bilateral'symmetry' 7 3.70EF01 9.70EF01
determination'of'symmetry' 7 3.70EF01 9.70EF01
morphogenesis'of'an'epithelium' 7 4.40EF01 9.80EF01
tissue'morphogenesis' 8 4.90EF01 9.90EF01
epithelium'development' 7 5.40EF01 9.90EF01
Annotation'Cluster'26' Enrichment'Score:'1.22'
GO'Term Count' P_Value' Benjamini
response'to'methylmercury' 4 2.00EF02 3.40EF01
response'to'cadmium'ion' 4 3.30EF02 4.30EF01
response'to'metal'ion' 6 3.80EF02 4.70EF01
response'to'inorganic'substance' 6 1.00EF01 7.40EF01
response'to'organic'substance' 5 3.40EF01 9.60EF01
Annotation'Cluster'27' Enrichment'Score:'1.12'
GO'Term Count' P_Value' Benjamini
gtpFbinding' 28 6.80EF03 8.00EF02
GTP'binding' 30 4.10EF02 5.50EF01
guanyl'ribonucleotide'binding' 30 4.70EF02 5.70EF01
guanyl'nucleotide'binding' 30 4.90EF02 5.80EF01
intracellular'signaling'cascade' 34 6.20EF02 6.00EF01
small'GTPase'mediated'signal'transduction' 18 1.10EF01 7.50EF01
Small'GTPFbinding'protein' 15 1.50EF01 1.00E+00
Ras' 11 2.50EF01 1.00E+00
Ras'GTPase' 10 4.80EF01 1.00E+00
Annotation'Cluster'28' Enrichment'Score:'0.97'
GO'Term Count' P_Value' Benjamini
exocrine'system'development' 4 1.10EF01 7.50EF01
exocrine'pancreas'development' 4 1.10EF01 7.50EF01
pancreas'development' 6 1.10EF01 7.50EF01
Annotation'Cluster'29' Enrichment'Score:'0.97'
GO'Term Count' P_Value' Benjamini
BRLZ' 8 6.20EF02 8.30EF01
BasicFleucine'zipper'(bZIP)'transcription'factor' 8 6.40EF02 9.80EF01
bZIP'transcription'factor,'bZIPF1' 5 6.70EF02 9.80EF01
Fos'transforming'protein' 3 6.90EF02 9.80EF01
domain:LeucineFzipper' 4 1.30EF01 9.50EF01
protein'dimerization'activity' 9 2.10EF01 9.10EF01
Basic'leucine'zipper' 3 3.30EF01 1.00E+00
Annotation'Cluster'30' Enrichment'Score:'0.92'
GO'Term Count' P_Value' Benjamini
establishment'of'organelle'localization' 7 6.00EF03 1.60EF01
organelle'localization' 7 8.50EF03 2.10EF01
Kupffer's'vesicle'development' 3 1.20EF01 7.80EF01
melanosome'localization' 3 1.60EF01 8.50EF01
establishment'of'melanosome'localization' 3 1.60EF01 8.50EF01
melanosome'transport' 3 1.60EF01 8.50EF01
pigment'granule'transport' 3 1.60EF01 8.50EF01
establishment'of'vesicle'localization' 3 2.30EF01 9.20EF01
establishment'of'pigment'granule'localization' 3 2.30EF01 9.20EF01
vesicle'localization' 3 2.60EF01 9.40EF01
pigment'granule'localization' 3 2.60EF01 9.40EF01
pigmentation' 5 2.70EF01 9.40EF01
cellular'pigmentation' 3 2.80EF01 9.40EF01
Annotation'Cluster'31' Enrichment'Score:'0.92'
GO'Term Count' P_Value' Benjamini
neural'plate'development' 6 2.80EF03 9.00EF02
morphogenesis'of'embryonic'epithelium' 6 1.60EF02 3.00EF01
regulation'of'vesicleFmediated'transport' 4 2.00EF02 3.40EF01
regulation'of'receptorFmediated'endocytosis' 3 2.10EF02 3.50EF01
regulation'of'endocytosis' 3 4.70EF02 5.30EF01
morphogenesis'of'an'epithelium' 7 4.40EF01 9.80EF01
tissue'morphogenesis' 8 4.90EF01 9.90EF01
epithelium'development' 7 5.40EF01 9.90EF01
ANK' 6 9.40EF01 1.00E+00
Ankyrin' 6 9.50EF01 1.00E+00
ank'repeat' 6 9.50EF01 1.00E+00
Annotation'Cluster'32' Enrichment'Score:'0.89'
GO'Term Count' P_Value' Benjamini
fin'development' 9 1.30EF02 2.60EF01
appendage'development' 9 1.40EF02 2.80EF01
pectoral'fin'development' 5 7.90EF02 6.70EF01
fin'morphogenesis' 6 1.50EF01 8.30EF01
appendage'morphogenesis' 6 1.60EF01 8.40EF01
pectoral'fin'morphogenesis' 3 4.10EF01 9.80EF01
forelimb'morphogenesis' 3 4.10EF01 9.80EF01
limb'morphogenesis' 3 4.40EF01 9.80EF01
limb'development' 3 4.40EF01 9.80EF01
Annotation'Cluster'33' Enrichment'Score:'0.87'
GO'Term Count' P_Value' Benjamini
diencephalon'development' 6 2.90EF02 4.20EF01
forebrain'development' 8 3.10EF02 4.30EF01
cell'fate'commitment' 7 9.50EF02 7.30EF01
pituitary'gland'development' 3 1.60EF01 8.50EF01
adenohypophysis'development' 3 1.60EF01 8.50EF01
gland'development' 4 2.80EF01 9.40EF01
embryonic'organ'morphogenesis' 7 4.00EF01 9.80EF01
endocrine'system'development' 4 4.10EF01 9.80EF01
Annotation'Cluster'34' Enrichment'Score:'0.84'
GO'Term Count' P_Value' Benjamini
protein'methyltransferase'activity' 6 2.80EF02 5.20EF01
histone'methyltransferase'activity' 5 3.60EF02 5.40EF01
proteinFlysine'NFmethyltransferase'activity' 4 9.50EF02 7.40EF01
lysine'NFmethyltransferase'activity' 4 9.50EF02 7.40EF01
histoneFlysine'NFmethyltransferase'activity' 4 9.50EF02 7.40EF01
NFmethyltransferase'activity' 5 1.20EF01 8.00EF01
methyltransferase' 9 1.80EF01 6.80EF01
SET' 6 1.90EF01 9.40EF01
SET' 6 1.90EF01 1.00E+00
PostSET' 3 2.40EF01 9.30EF01
PostFSET'zincFbinding'region' 3 2.40EF01 1.00E+00
Lysine'degradation' 4 4.90EF01 9.40EF01
sFadenosylFlFmethionine' 3 5.70EF01 9.40EF01
Annotation'Cluster'35' Enrichment'Score:'0.84'
GO'Term Count' P_Value' Benjamini
Globin,'subset' 4 4.70EF02 9.60EF01
oxygen'transport' 4 5.10EF02 3.50EF01
oxygen'binding' 4 5.30EF02 5.90EF01
oxygen'transporter'activity' 4 5.30EF02 5.90EF01
oxygen'transport' 4 5.90EF02 6.00EF01
gas'transport' 4 5.90EF02 6.00EF01
hemoglobin'complex' 3 1.10EF01 6.20EF01
cytosolic'part' 5 1.70EF01 7.30EF01
Globin' 3 1.80EF01 1.00E+00
heme'binding' 9 4.00EF01 9.80EF01
tetrapyrrole'binding' 9 4.50EF01 9.90EF01
iron' 12 4.80EF01 8.90EF01
iron'ion'binding' 16 5.00EF01 9.90EF01
heme' 7 5.30EF01 9.20EF01
Annotation'Cluster'36' Enrichment'Score:'0.83'
GO'Term Count' P_Value' Benjamini
ORANGE' 3 1.00EF01 8.90EF01
Orange'subgroup' 3 1.00EF01 9.90EF01
Orange' 3 3.10EF01 1.00E+00
Annotation'Cluster'37' Enrichment'Score:'0.8'
GO'Term Count' P_Value' Benjamini
L27,'CFterminal' 3 1.00EF01 9.90EF01
L27' 3 1.60EF01 9.40EF01
L27' 3 1.60EF01 1.00E+00
PDZ' 9 1.90EF01 9.30EF01
PDZ/DHR/GLGF' 9 2.00EF01 1.00E+00
Annotation'Cluster'38' Enrichment'Score:'0.79'
GO'Term Count' P_Value' Benjamini
SANT' 5 1.50EF01 9.30EF01
SANT,'DNAFbinding' 5 1.50EF01 1.00E+00
Myb,'DNAFbinding' 4 2.00EF01 1.00E+00
Annotation'Cluster'39' Enrichment'Score:'0.78'
GO'Term Count' P_Value' Benjamini
NucleotideFbinding,'alphaFbeta'plait' 15 1.60EF01 1.00E+00
RRM' 15 1.70EF01 9.30EF01
RNA'recognition'motif,'RNPF1' 15 1.70EF01 1.00E+00
Annotation'Cluster'40' Enrichment'Score:'0.75'
GO'Term Count' P_Value' Benjamini
FERM,'CFterminal'PHFlike'domain' 4 6.50EF02 9.80EF01
Band'4.1'subgroup' 4 8.60EF02 9.80EF01
FERM'conserved'site' 4 1.10EF01 9.90EF01
FERM,'NFterminal' 4 1.60EF01 1.00E+00
Ezrin/radixin/moesin'ERM' 3 1.60EF01 1.00E+00
FERM'central'domain' 4 2.50EF01 1.00E+00
FERM'domain' 4 2.90EF01 1.00E+00
FERM/acylFCoAFbinding'protein,'3Fhelical'bundle' 4 2.90EF01 1.00E+00
B41' 4 3.10EF01 9.50EF01
Band'4.1'domain' 4 3.10EF01 1.00E+00
Annotation'Cluster'41' Enrichment'Score:'0.71'
GO'Term Count' P_Value' Benjamini
DNA'helicase'activity' 4 3.60EF02 5.30EF01
domain:Helicase'CFterminal' 4 3.90EF02 7.10EF01
domain:Helicase'ATPFbinding' 4 4.90EF02 7.60EF01
ATPFdependent'DNA'helicase'activity' 3 9.20EF02 7.60EF01
helicase' 8 1.30EF01 5.70EF01
DEXDc' 7 2.10EF01 9.30EF01
ATPFdependent'helicase'activity' 7 2.10EF01 9.10EF01
purine'NTPFdependent'helicase'activity' 7 2.10EF01 9.10EF01
DEADFlike'helicase,'NFterminal' 7 2.10EF01 1.00E+00
helicase'activity' 9 2.20EF01 9.10EF01
RNA'helicase,'ATPFdependent,'DEADFbox,'conserved'site' 3 3.50EF01 1.00E+00
HELICc' 6 3.60EF01 9.70EF01
DNA/RNA'helicase,'CFterminal' 6 3.60EF01 1.00E+00
Helicase,'superfamily'1'and'2,'ATPFbinding' 5 5.80EF01 1.00E+00
RNA'helicase,'DEADFbox'type,'Q'motif' 3 5.90EF01 1.00E+00
DNA/RNA'helicase,'DEAD/DEAH'box'type,'NFterminal' 3 7.20EF01 1.00E+00
Annotation'Cluster'42' Enrichment'Score:'0.7'
GO'Term Count' P_Value' Benjamini
urogenital'system'development' 6 1.30EF01 7.90EF01
kidney'development' 6 1.30EF01 7.90EF01
pronephros'development' 3 5.00EF01 9.90EF01
Annotation'Cluster'43' Enrichment'Score:'0.68'
GO'Term Count' P_Value' Benjamini
disulfide'bond' 18 1.20EF02 1.20EF01
glycoprotein' 30 1.50EF02 1.40EF01
signal' 23 8.20EF02 4.80EF01
disulfide'bond' 17 8.50EF02 8.80EF01
topological'domain:Extracellular' 20 9.60EF02 9.00EF01
glycosylation'site:NFlinked'(GlcNAc...)' 29 1.60EF01 9.70EF01
topological'domain:Cytoplasmic' 25 2.00EF01 9.80EF01
signal'peptide' 23 3.40EF01 1.00E+00
transmembrane'region' 32 9.80EF01 1.00E+00
membrane' 71 9.90EF01 1.00E+00
transmembrane' 61 1.00E+00 1.00E+00
integral'to'membrane' 76 1.00E+00 1.00E+00
intrinsic'to'membrane' 77 1.00E+00 1.00E+00
Annotation'Cluster'44' Enrichment'Score:'0.67'
GO'Term Count' P_Value' Benjamini
Isomerase' 10 6.00EF03 7.80EF02
intramolecular'oxidoreductase'activity' 4 1.10EF01 7.70EF01
Fatty'acid'biosynthesis' 3 1.30EF01 5.80EF01
carboxylic'acid'biosynthetic'process' 6 2.90EF01 9.50EF01
organic'acid'biosynthetic'process' 6 2.90EF01 9.50EF01
cellular'amide'metabolic'process' 3 3.20EF01 9.60EF01
lipid'synthesis' 3 3.40EF01 8.20EF01
fatty'acid'biosynthetic'process' 3 5.00EF01 9.90EF01
fatty'acid'metabolic'process' 4 5.40EF01 9.90EF01
lipid'biosynthetic'process' 4 9.40EF01 1.00E+00
Annotation'Cluster'45' Enrichment'Score:'0.66'
GO'Term Count' P_Value' Benjamini
HATPase_c' 4 4.70EF02 7.80EF01
ATPFbinding'region,'ATPaseFlike' 4 4.70EF02 9.60EF01
positive'regulation'of'transcription,'DNAFdependent' 5 1.40EF01 8.20EF01
positive'regulation'of'RNA'metabolic'process' 5 1.50EF01 8.30EF01
positive'regulation'of'cellular'biosynthetic'process' 7 1.80EF01 8.80EF01
positive'regulation'of'biosynthetic'process' 7 1.80EF01 8.80EF01
positive'regulation'of'macromolecule'biosynthetic'process' 6 3.20EF01 9.60EF01
positive'regulation'of'nitrogen'compound'metabolic'process' 6 3.80EF01 9.70EF01
positive'regulation'of'macromolecule'metabolic'process' 6 4.40EF01 9.80EF01
positive'regulation'of'gene'expression' 5 4.80EF01 9.90EF01
positive'regulation'of'transcription' 5 4.80EF01 9.90EF01
positive'regulation'of'nucleobase,'nucleoside,'nucleotide'and'nucleic'acid'metabolic'process'5 5.70EF01 9.90EF01
Annotation'Cluster'46' Enrichment'Score:'0.63'
GO'Term Count' P_Value' Benjamini
ArmadilloFlike'helical' 9 7.60EF02 9.80EF01
ARM' 3 4.10EF01 9.80EF01
Armadillo' 3 4.10EF01 1.00E+00
Annotation'Cluster'47' Enrichment'Score:'0.62'
GO'Term Count' P_Value' Benjamini
Guanylate'kinase' 4 8.60EF02 9.80EF01
GuKc' 3 4.10EF01 9.80EF01
Guanylate'kinase/LFtype'calcium'channel'region' 3 4.10EF01 1.00E+00
Annotation'Cluster'48' Enrichment'Score:'0.61'
GO'Term Count' P_Value' Benjamini
nucleoside'metabolic'process' 6 1.70EF01 8.50EF01
purine'nucleoside'metabolic'process' 3 2.80EF01 9.40EF01
purine'ribonucleoside'metabolic'process' 3 2.80EF01 9.40EF01
ribonucleoside'metabolic'process' 4 2.90EF01 9.50EF01
Annotation'Cluster'49' Enrichment'Score:'0.61'
GO'Term Count' P_Value' Benjamini
TGFFbeta'receptor/activin'receptor,'type'I/II' 3 1.60EF01 1.00E+00
transforming'growth'factor'beta'receptor'activity' 3 1.90EF01 9.00EF01
transmembrane'receptor'protein'serine/threonine'kinase'activity' 3 2.20EF01 9.00EF01
transmembrane'receptor'protein'serine/threonine'kinase'signaling'pathway'4 2.60EF01 9.40EF01
TGFFbeta'signaling'pathway' 8 3.40EF01 8.60EF01
enzyme'linked'receptor'protein'signaling'pathway' 7 4.00EF01 9.80EF01
Annotation'Cluster'50' Enrichment'Score:'0.6'
GO'Term Count' P_Value' Benjamini
Intermediate'filament'protein,'conserved'site' 5 1.30EF01 9.90EF01
Filament' 5 2.40EF01 1.00E+00
Intermediate'filament'protein' 5 2.40EF01 1.00E+00
intermediate'filament' 5 2.50EF01 8.40EF01
intermediate'filament'cytoskeleton' 5 2.50EF01 8.40EF01
Intermediate'filament' 5 2.60EF01 7.50EF01
PIRSF002282:cytoskeletal'keratin' 3 5.40EF01 1.00E+00
Annotation'Cluster'51' Enrichment'Score:'0.59'
GO'Term Count' P_Value' Benjamini
sensory'perception'of'light'stimulus' 7 1.00EF01 7.40EF01
visual'perception' 7 1.00EF01 7.40EF01
neurological'system'process' 11 1.30EF01 8.00EF01
response'to'radiation' 7 1.30EF01 8.00EF01
response'to'light'stimulus' 6 1.60EF01 8.40EF01
vision' 3 2.10EF01 7.20EF01
cognition' 7 3.00EF01 9.50EF01
sensory'perception' 7 3.00EF01 9.50EF01
response'to'abiotic'stimulus' 8 3.30EF01 9.60EF01
sensory'transduction' 4 3.70EF01 8.40EF01
detection'of'light'stimulus' 3 4.10EF01 9.80EF01
detection'of'external'stimulus' 3 6.10EF01 1.00E+00
detection'of'abiotic'stimulus' 3 6.10EF01 1.00E+00
detection'of'stimulus' 3 6.20EF01 1.00E+00
Annotation'Cluster'52' Enrichment'Score:'0.58'
GO'Term Count' P_Value' Benjamini
ARF' 4 2.00EF01 9.30EF01
ADPFribosylation'factor' 4 2.00EF01 1.00E+00
PIRSF001711:ADPFribosylation'factor' 3 3.40EF01 1.00E+00
ARF/SAR'superfamily' 4 3.40EF01 1.00E+00
Annotation'Cluster'53' Enrichment'Score:'0.58'
GO'Term Count' P_Value' Benjamini
regulation'of'heart'contraction' 4 7.00EF02 6.40EF01
regulation'of'system'process' 4 1.50EF01 8.30EF01
hemopoiesis' 8 2.20EF01 9.20EF01
immune'system'development' 8 2.70EF01 9.40EF01
hemopoietic'or'lymphoid'organ'development' 8 2.70EF01 9.40EF01
erythrocyte'homeostasis' 3 4.10EF01 9.80EF01
homeostasis'of'number'of'cells' 3 4.10EF01 9.80EF01
erythrocyte'differentiation' 3 4.10EF01 9.80EF01
myeloid'cell'differentiation' 3 5.40EF01 9.90EF01
Annotation'Cluster'54' Enrichment'Score:'0.57'
GO'Term Count' P_Value' Benjamini
Cyclin,'NFterminal' 4 2.00EF01 1.00E+00
CYCLIN' 4 2.70EF01 9.40EF01
cyclin' 4 2.80EF01 7.60EF01
Cyclin' 4 2.80EF01 1.00E+00
CyclinFrelated' 4 3.40EF01 1.00E+00
Annotation'Cluster'55' Enrichment'Score:'0.56'
GO'Term Count' P_Value' Benjamini
Pyridoxal'phosphateFdependent'transferase,'major'region,'subdomain'1' 5 1.70EF01 1.00E+00
vitamin'binding' 9 2.30EF01 9.10EF01
pyridoxal'phosphate' 4 2.60EF01 7.50EF01
pyridoxal'phosphate'binding' 5 3.00EF01 9.50EF01
vitamin'B6'binding' 5 3.00EF01 9.50EF01
cofactor'binding' 13 4.70EF01 9.90EF01
Annotation'Cluster'56' Enrichment'Score:'0.54'
GO'Term Count' P_Value' Benjamini
DNA'binding' 91 2.30EF03 1.50EF01
dnaFbinding' 49 1.10EF01 5.40EF01
Transcription' 35 1.90EF01 6.80EF01
transcription'regulation' 35 2.10EF01 7.00EF01
transcription' 33 4.90EF01 9.90EF01
regulation'of'transcription' 67 5.70EF01 9.90EF01
transcription'regulator'activity' 51 5.90EF01 9.90EF01
transcription'factor'activity' 34 8.40EF01 1.00E+00
regulation'of'transcription,'DNAFdependent' 43 9.10EF01 1.00E+00
regulation'of'RNA'metabolic'process' 43 9.20EF01 1.00E+00
sequenceFspecific'DNA'binding' 24 9.40EF01 1.00E+00
Annotation'Cluster'57' Enrichment'Score:'0.53'
GO'Term Count' P_Value' Benjamini
aminoFacid'biosynthesis' 3 1.10EF01 5.40EF01
carboxylic'acid'biosynthetic'process' 6 2.90EF01 9.50EF01
organic'acid'biosynthetic'process' 6 2.90EF01 9.50EF01
amine'biosynthetic'process' 4 4.40EF01 9.80EF01
cellular'amino'acid'biosynthetic'process' 3 5.40EF01 9.90EF01
Annotation'Cluster'58' Enrichment'Score:'0.53'
GO'Term Count' P_Value' Benjamini
NFacyltransferase'activity' 5 9.30EF02 7.50EF01
AcylFCoA'NFacyltransferase' 4 3.10EF01 1.00E+00
NFacetyltransferase'activity' 3 4.30EF01 9.80EF01
acetyltransferase'activity' 3 6.30EF01 1.00E+00
Annotation'Cluster'59' Enrichment'Score:'0.52'
GO'Term Count' P_Value' Benjamini
protein'ubiquitination' 4 1.90EF01 8.80EF01
protein'modification'by'small'protein'conjugation' 4 2.40EF01 9.30EF01
ubiquitinFprotein'ligase'activity' 4 2.50EF01 9.30EF01
protein'modification'by'small'protein'conjugation'or'removal' 4 3.30EF01 9.60EF01
acidFamino'acid'ligase'activity' 8 3.40EF01 9.60EF01
small'conjugating'protein'ligase'activity' 5 5.40EF01 9.90EF01
Annotation'Cluster'60' Enrichment'Score:'0.52'
GO'Term Count' P_Value' Benjamini
vasculogenesis' 5 7.90EF02 6.70EF01
hemopoietic'stem'cell'differentiation' 3 1.20EF01 7.80EF01
stem'cell'differentiation' 3 1.60EF01 8.50EF01
hemopoiesis' 8 2.20EF01 9.20EF01
immune'system'development' 8 2.70EF01 9.40EF01
hemopoietic'or'lymphoid'organ'development' 8 2.70EF01 9.40EF01
blood'vessel'morphogenesis' 6 6.30EF01 1.00E+00
angiogenesis' 4 6.40EF01 1.00E+00
vasculature'development' 7 7.00EF01 1.00E+00
blood'vessel'development' 6 8.00EF01 1.00E+00
Annotation'Cluster'61' Enrichment'Score:'0.5'
GO'Term Count' P_Value' Benjamini
embryonic'retina'morphogenesis'in'cameraFtype'eye' 3 1.90EF01 8.80EF01
cameraFtype'eye'morphogenesis' 5 1.90EF01 8.80EF01
retina'morphogenesis'in'cameraFtype'eye' 3 4.80EF01 9.90EF01
eye'morphogenesis' 5 5.90EF01 1.00E+00
Annotation'Cluster'62' Enrichment'Score:'0.5'
GO'Term Count' P_Value' Benjamini
membraneFbounded'vesicle' 6 1.80EF01 7.50EF01
cytoplasmic'membraneFbounded'vesicle' 6 1.80EF01 7.50EF01
cytoplasmic'vesicle' 6 2.70EF01 8.40EF01
vesicle' 6 2.80EF01 8.50EF01
clathrinFcoated'vesicle' 4 3.10EF01 8.70EF01
synaptic'vesicle' 3 4.00EF01 9.30EF01
coated'vesicle' 4 4.30EF01 9.40EF01
synapse' 6 4.60EF01 9.50EF01
synapse'part' 5 5.70EF01 9.70EF01
Annotation'Cluster'63' Enrichment'Score:'0.46'
GO'Term Count' P_Value' Benjamini
fin'morphogenesis' 6 1.50EF01 8.30EF01
appendage'morphogenesis' 6 1.60EF01 8.40EF01
otic'vesicle'formation' 3 3.50EF01 9.70EF01
inner'ear'development' 6 3.80EF01 9.70EF01
ear'development' 6 3.90EF01 9.80EF01
embryonic'organ'morphogenesis' 7 4.00EF01 9.80EF01
inner'ear'morphogenesis' 4 4.30EF01 9.80EF01
ear'morphogenesis' 4 4.40EF01 9.80EF01
skeletal'system'development' 4 8.40EF01 1.00E+00
Annotation'Cluster'64' Enrichment'Score:'0.44'
GO'Term Count' P_Value' Benjamini
ligase'activity,'forming'carbonFnitrogen'bonds' 14 3.80EF02 5.40EF01
ligase' 11 1.10EF01 5.50EF01
acidFamino'acid'ligase'activity' 8 3.40EF01 9.60EF01
modificationFdependent'protein'catabolic'process' 12 4.40EF01 9.80EF01
modificationFdependent'macromolecule'catabolic'process' 12 4.40EF01 9.80EF01
proteolysis'involved'in'cellular'protein'catabolic'process' 13 4.50EF01 9.80EF01
cellular'protein'catabolic'process' 13 4.50EF01 9.80EF01
protein'catabolic'process' 14 4.60EF01 9.90EF01
ubl'conjugation'pathway' 9 5.10EF01 9.10EF01
small'conjugating'protein'ligase'activity' 5 5.40EF01 9.90EF01
cellular'macromolecule'catabolic'process' 13 6.10EF01 1.00E+00
macromolecule'catabolic'process' 14 7.00EF01 1.00E+00
proteolysis' 32 7.00EF01 1.00E+00
Annotation'Cluster'65' Enrichment'Score:'0.43'
GO'Term Count' P_Value' Benjamini
organelle'envelope' 18 5.10EF02 4.30EF01
envelope' 18 5.50EF02 4.40EF01
mitochondrion' 19 2.70EF01 8.50EF01
mitochondrial'lumen' 3 3.20EF01 8.80EF01
mitochondrial'matrix' 3 3.20EF01 8.80EF01
transit'peptide' 6 3.50EF01 8.20EF01
mitochondrial'part' 12 3.50EF01 9.00EF01
mitochondrial'envelope' 10 4.60EF01 9.50EF01
mitochondrial'membrane' 9 5.10EF01 9.70EF01
transit'peptide:Mitochondrion' 6 5.40EF01 1.00E+00
mitochondrial'inner'membrane' 6 7.20EF01 9.90EF01
organelle'inner'membrane' 6 7.40EF01 9.90EF01
organelle'membrane' 15 7.90EF01 1.00E+00
mitochondrion'inner'membrane' 3 8.70EF01 9.90EF01
mitochondrion' 7 8.80EF01 1.00E+00
Annotation'Cluster'66' Enrichment'Score:'0.43'
GO'Term Count' P_Value' Benjamini
translation'initiation'factor'activity' 6 2.10EF01 9.10EF01
Initiation'factor' 5 2.80EF01 7.60EF01
translation'factor'activity,'nucleic'acid'binding' 6 5.50EF01 9.90EF01
protein'biosynthesis' 4 5.90EF01 9.40EF01
Annotation'Cluster'67' Enrichment'Score:'0.43'
GO'Term Count' P_Value' Benjamini
nucleotide'phosphateFbinding'region:ATP' 11 2.20EF01 9.90EF01
active'site:Proton'acceptor' 8 3.90EF01 1.00E+00
domain:Protein'kinase' 5 4.20EF01 1.00E+00
binding'site:ATP' 5 5.50EF01 1.00E+00
Annotation'Cluster'68' Enrichment'Score:'0.42'
GO'Term Count' P_Value' Benjamini
guanylFnucleotide'exchange'factor'activity' 7 1.20EF01 8.00EF01
RasGEF' 3 1.60EF01 9.40EF01
GuanineFnucleotide'dissociation'stimulator'CDC25' 3 1.60EF01 1.00E+00
GTPase'regulator'activity' 9 6.50EF01 1.00E+00
nucleosideFtriphosphatase'regulator'activity' 9 6.70EF01 1.00E+00
small'GTPase'regulator'activity' 4 9.50EF01 1.00E+00
regulation'of'small'GTPase'mediated'signal'transduction' 4 9.50EF01 1.00E+00
Annotation'Cluster'69' Enrichment'Score:'0.41'
GO'Term Count' P_Value' Benjamini
cellFcell'signaling' 5 3.20EF01 9.60EF01
transmission'of'nerve'impulse' 4 3.60EF01 9.70EF01
synaptic'transmission' 3 5.00EF01 9.90EF01
Annotation'Cluster'70' Enrichment'Score:'0.39'
GO'Term Count' P_Value' Benjamini
positive'regulation'of'molecular'function' 5 2.70EF01 9.40EF01
positive'regulation'of'hydrolase'activity' 3 3.00EF01 9.50EF01
positive'regulation'of'catalytic'activity' 4 3.80EF01 9.70EF01
regulation'of'hydrolase'activity' 3 9.20EF01 1.00E+00
Annotation'Cluster'71' Enrichment'Score:'0.37'
GO'Term Count' P_Value' Benjamini
regulation'of'neurogenesis' 4 4.10EF01 9.80EF01
regulation'of'nervous'system'development' 4 4.10EF01 9.80EF01
regulation'of'cell'development' 4 4.40EF01 9.80EF01
Annotation'Cluster'72' Enrichment'Score:'0.37'
GO'Term Count' P_Value' Benjamini
DNA'packaging' 6 1.10EF01 7.50EF01
cellular'macromolecular'complex'subunit'organization' 10 2.20EF01 9.10EF01
cellular'macromolecular'complex'assembly' 9 2.60EF01 9.40EF01
chromatin'assembly'or'disassembly' 6 3.50EF01 9.70EF01
macromolecular'complex'subunit'organization' 11 3.80EF01 9.70EF01
nucleosome'organization' 4 4.00EF01 9.80EF01
nucleosome'assembly' 4 4.00EF01 9.80EF01
chromatin'assembly' 4 4.00EF01 9.80EF01
proteinFDNA'complex'assembly' 4 4.00EF01 9.80EF01
macromolecular'complex'assembly' 10 4.60EF01 9.90EF01
chromatin' 5 5.10EF01 9.60EF01
nucleosome' 3 5.50EF01 9.70EF01
proteinFDNA'complex' 3 5.90EF01 9.70EF01
cellular'protein'complex'assembly' 4 6.40EF01 1.00E+00
chromosomal'protein' 3 7.30EF01 9.70EF01
protein'complex'assembly' 5 8.10EF01 1.00E+00
protein'complex'biogenesis' 5 8.10EF01 1.00E+00
Annotation'Cluster'73' Enrichment'Score:'0.33'
GO'Term Count' P_Value' Benjamini
Pleckstrin'homologyFtype' 14 2.80EF01 1.00E+00
domain:PH' 3 3.20EF01 1.00E+00
PH' 8 7.10EF01 1.00E+00
Pleckstrin'homology' 8 7.20EF01 1.00E+00
Annotation'Cluster'74' Enrichment'Score:'0.3'
GO'Term Count' P_Value' Benjamini
Cytosolic'fattyFacid'binding' 3 4.10EF01 1.00E+00
LipocalinFrelated'protein'and'Bos/Can/Equ'allergen' 3 5.60EF01 1.00E+00
Calycin' 3 5.70EF01 1.00E+00
Annotation'Cluster'75' Enrichment'Score:'0.29'
GO'Term Count' P_Value' Benjamini
carboxylic'acid'binding' 6 3.70EF01 9.70EF01
amino'acid'binding' 3 4.90EF01 9.90EF01
amine'binding' 3 7.20EF01 1.00E+00
Annotation'Cluster'76' Enrichment'Score:'0.29'
GO'Term Count' P_Value' Benjamini
EFFHAND'1' 14 2.50EF01 1.00E+00
calciumFbinding'region:2' 3 4.00EF01 1.00E+00
calcium' 20 4.70EF01 8.90EF01
calciumFbinding'region:1' 3 5.00EF01 1.00E+00
EFh' 9 5.20EF01 9.90EF01
CalciumFbinding'EFFhand' 9 5.30EF01 1.00E+00
domain:EFFhand'2' 3 5.40EF01 1.00E+00
domain:EFFhand'1' 3 5.40EF01 1.00E+00
EF'hand' 8 5.80EF01 1.00E+00
EFFHAND'2' 11 6.30EF01 1.00E+00
EFFHand'type' 11 6.80EF01 1.00E+00
calcium'ion'binding' 25 7.50EF01 1.00E+00
Annotation'Cluster'77' Enrichment'Score:'0.28'
GO'Term Count' P_Value' Benjamini
K'Homology,'type'1' 3 4.50EF01 1.00E+00
K'Homology,'type'1,'subgroup' 3 5.00EF01 1.00E+00
KH' 3 5.70EF01 9.90EF01
K'Homology' 3 5.70EF01 1.00E+00
Annotation'Cluster'78' Enrichment'Score:'0.27'
GO'Term Count' P_Value' Benjamini
cisFtrans'isomerase'activity' 3 4.30EF01 9.80EF01
peptidylFprolyl'cisFtrans'isomerase'activity' 3 4.30EF01 9.80EF01
Rotamase' 3 4.60EF01 8.90EF01
protein'folding' 4 9.60EF01 1.00E+00
Annotation'Cluster'79' Enrichment'Score:'0.26'
GO'Term Count' P_Value' Benjamini
neural'crest'cell'differentiation' 4 4.00EF01 9.80EF01
mesenchyme'development' 4 5.10EF01 9.90EF01
mesenchymal'cell'differentiation' 4 5.10EF01 9.90EF01
neural'crest'cell'development' 3 6.20EF01 1.00E+00
mesenchymal'cell'development' 3 7.50EF01 1.00E+00
Annotation'Cluster'80' Enrichment'Score:'0.26'
GO'Term Count' P_Value' Benjamini
striated'muscle'cell'differentiation' 5 4.60EF01 9.90EF01
myofibril'assembly' 3 4.80EF01 9.90EF01
striated'muscle'cell'development' 4 4.90EF01 9.90EF01
cellular'component'assembly'involved'in'morphogenesis' 3 5.00EF01 9.90EF01
muscle'cell'differentiation' 5 5.00EF01 9.90EF01
cytoskeleton'organization' 8 5.20EF01 9.90EF01
muscle'cell'development' 4 5.20EF01 9.90EF01
actomyosin'structure'organization' 3 6.10EF01 1.00E+00
actin'cytoskeleton'organization' 4 7.90EF01 1.00E+00
actin'filamentFbased'process' 4 7.90EF01 1.00E+00
Annotation'Cluster'81' Enrichment'Score:'0.24'
GO'Term Count' P_Value' Benjamini
Apoptosis' 4 3.40EF01 8.20EF01
apoptosis' 5 6.40EF01 1.00E+00
programmed'cell'death' 5 6.40EF01 1.00E+00
death' 5 6.70EF01 1.00E+00
cell'death' 5 6.70EF01 1.00E+00
Annotation'Cluster'82' Enrichment'Score:'0.22'
GO'Term Count' P_Value' Benjamini
glycolysis' 4 2.60EF01 7.50EF01
glycolysis' 4 4.90EF01 9.90EF01
Glycolysis'/'Gluconeogenesis' 5 5.00EF01 9.40EF01
monosaccharide'catabolic'process' 4 6.10EF01 1.00E+00
glucose'catabolic'process' 4 6.10EF01 1.00E+00
hexose'catabolic'process' 4 6.10EF01 1.00E+00
cellular'carbohydrate'catabolic'process' 4 6.70EF01 1.00E+00
alcohol'catabolic'process' 4 6.70EF01 1.00E+00
hexose'metabolic'process' 5 7.40EF01 1.00E+00
glucose'metabolic'process' 4 7.60EF01 1.00E+00
monosaccharide'metabolic'process' 5 7.70EF01 1.00E+00
carbohydrate'catabolic'process' 4 8.10EF01 1.00E+00
Annotation'Cluster'83' Enrichment'Score:'0.21'
GO'Term Count' P_Value' Benjamini
translation' 20 2.40EF01 9.20EF01
ribosome' 10 6.40EF01 9.80EF01
structural'molecule'activity' 18 6.80EF01 1.00E+00
structural'constituent'of'ribosome' 8 7.30EF01 1.00E+00
ribosomal'protein' 7 7.80EF01 9.80EF01
Ribosome' 4 9.00EF01 9.90EF01
Annotation'Cluster'84' Enrichment'Score:'0.21'
GO'Term Count' P_Value' Benjamini
intracellular'transport' 14 3.80EF01 9.70EF01
protein'localization' 21 4.50EF01 9.80EF01
establishment'of'protein'localization' 18 6.30EF01 1.00E+00
protein'transport' 18 6.30EF01 1.00E+00
cellular'protein'localization' 9 6.50EF01 1.00E+00
cellular'macromolecule'localization' 9 6.60EF01 1.00E+00
protein'transporter'activity' 3 7.60EF01 1.00E+00
protein'targeting' 3 7.60EF01 1.00E+00
intracellular'protein'transport' 8 7.60EF01 1.00E+00
Annotation'Cluster'85' Enrichment'Score:'0.21'
GO'Term Count' P_Value' Benjamini
kinase'regulator'activity' 4 2.70EF01 9.30EF01
Apoptosis' 4 9.20EF01 1.00E+00
Insulin'signaling'pathway' 6 9.50EF01 1.00E+00
Annotation'Cluster'86' Enrichment'Score:'0.21'
GO'Term Count' P_Value' Benjamini
protein'amino'acid'dephosphorylation' 7 4.90EF01 9.90EF01
protein'tyrosine'phosphatase'activity' 6 5.00EF01 9.90EF01
ProteinFtyrosine'phosphatase,'active'site' 5 5.20EF01 1.00E+00
phosphoprotein'phosphatase'activity' 8 6.00EF01 9.90EF01
Dual'specificity'phosphatase,'catalytic'domain' 3 6.30EF01 1.00E+00
dephosphorylation' 7 6.60EF01 1.00E+00
protein'tyrosine/serine/threonine'phosphatase'activity' 3 6.70EF01 1.00E+00
DualFspecific/proteinFtyrosine'phosphatase,'conserved'region' 4 7.40EF01 1.00E+00
phosphatase'activity' 8 8.90EF01 1.00E+00
Annotation'Cluster'87' Enrichment'Score:'0.21'
GO'Term Count' P_Value' Benjamini
mRNA'processing' 7 4.40EF01 9.80EF01
mRNA'metabolic'process' 7 5.40EF01 9.90EF01
RNA'splicing' 4 6.50EF01 1.00E+00
mrna'splicing' 3 7.30EF01 9.70EF01
mrna'processing' 3 8.50EF01 9.90EF01
Annotation'Cluster'88' Enrichment'Score:'0.19'
GO'Term Count' P_Value' Benjamini
VEGF'signaling'pathway' 8 2.30EF01 7.50EF01
SH2' 6 5.20EF01 9.90EF01
SH2'motif' 6 5.30EF01 1.00E+00
ErbB'signaling'pathway' 6 7.40EF01 9.90EF01
Natural'killer'cell'mediated'cytotoxicity' 5 8.00EF01 9.90EF01
Phosphatidylinositol'signaling'system' 4 8.60EF01 9.90EF01
Insulin'signaling'pathway' 6 9.50EF01 1.00E+00
Regulation'of'actin'cytoskeleton' 9 9.70EF01 1.00E+00
Annotation'Cluster'89' Enrichment'Score:'0.19'
GO'Term Count' P_Value' Benjamini
homeostatic'process' 13 2.60EF01 9.40EF01
chemical'homeostasis' 5 6.00EF01 1.00E+00
cellular'homeostasis' 7 7.00EF01 1.00E+00
ion'homeostasis' 4 7.50EF01 1.00E+00
cellular'ion'homeostasis' 3 8.20EF01 1.00E+00
cation'homeostasis' 3 8.30EF01 1.00E+00
cellular'chemical'homeostasis' 3 8.40EF01 1.00E+00
Annotation'Cluster'90' Enrichment'Score:'0.19'
GO'Term Count' P_Value' Benjamini
metalloendopeptidase'activity' 4 5.90EF01 1.00E+00
metalloprotease' 3 6.50EF01 9.60EF01
metallopeptidase'activity' 7 7.30EF01 1.00E+00
Annotation'Cluster'91' Enrichment'Score:'0.18'
GO'Term Count' P_Value' Benjamini
endopeptidase'activity' 18 5.40EF01 9.90EF01
Protease' 13 6.60EF01 9.60EF01
peptidase'activity,'acting'on'LFamino'acid'peptides' 24 6.60EF01 1.00E+00
proteolysis' 32 7.00EF01 1.00E+00
peptidase'activity' 24 7.50EF01 1.00E+00
Annotation'Cluster'92' Enrichment'Score:'0.17'
GO'Term Count' P_Value' Benjamini
regulation'of'cellular'protein'metabolic'process' 5 4.30EF01 9.80EF01
regulation'of'translation' 3 7.20EF01 1.00E+00
posttranscriptional'regulation'of'gene'expression' 3 9.90EF01 1.00E+00
Annotation'Cluster'93' Enrichment'Score:'0.16'
GO'Term Count' P_Value' Benjamini
kinase' 29 4.50EF01 8.80EF01
Serine/threonine'protein'kinase,'active'site' 16 5.50EF01 1.00E+00
S_TKc' 12 5.80EF01 9.90EF01
Serine/threonine'protein'kinase' 12 5.90EF01 1.00E+00
serine/threonineFprotein'kinase' 15 5.90EF01 9.40EF01
Protein'kinase,'ATP'binding'site' 19 7.00EF01 1.00E+00
phosphorylation' 31 7.10EF01 1.00E+00
phosphorus'metabolic'process' 38 7.20EF01 1.00E+00
phosphate'metabolic'process' 38 7.20EF01 1.00E+00
protein'serine/threonine'kinase'activity' 17 7.40EF01 1.00E+00
Serine/threonine'protein'kinaseFrelated' 17 7.90EF01 1.00E+00
Protein'kinase,'core' 20 8.60EF01 1.00E+00
protein'kinase'activity' 20 9.60EF01 1.00E+00
protein'amino'acid'phosphorylation' 20 9.80EF01 1.00E+00
Annotation'Cluster'94' Enrichment'Score:'0.16'
GO'Term Count' P_Value' Benjamini
metalFbinding' 69 2.40EF01 7.20EF01
zincFfinger' 26 3.80EF01 8.40EF01
zinc' 46 6.70EF01 9.60EF01
metal'ion'binding' 122 9.80EF01 1.00E+00
cation'binding' 123 9.90EF01 1.00E+00
ion'binding' 123 9.90EF01 1.00E+00
transition'metal'ion'binding' 86 9.90EF01 1.00E+00
zinc'ion'binding' 67 9.90EF01 1.00E+00
Annotation'Cluster'95' Enrichment'Score:'0.15'
GO'Term Count' P_Value' Benjamini
UBQ' 3 6.80EF01 1.00E+00
Ubiquitin' 3 6.90EF01 1.00E+00
Ubiquitin'supergroup' 3 7.70EF01 1.00E+00
Annotation'Cluster'96' Enrichment'Score:'0.14'
GO'Term Count' P_Value' Benjamini
heme'binding' 9 4.00EF01 9.80EF01
tetrapyrrole'binding' 9 4.50EF01 9.90EF01
heme' 7 5.30EF01 9.20EF01
Monooxygenase' 4 8.60EF01 9.90EF01
Cytochrome'P450,'EFclass,'group'I' 3 8.80EF01 1.00E+00
Secondary'metabolites'biosynthesis,'transport,'and'catabolism' 3 8.80EF01 9.90EF01
Cytochrome'P450,'CFterminal'region' 3 8.90EF01 1.00E+00
Cytochrome'P450,'conserved'site' 3 8.90EF01 1.00E+00
electron'carrier'activity' 8 9.20EF01 1.00E+00
Cytochrome'P450' 3 9.20EF01 1.00E+00
Annotation'Cluster'97' Enrichment'Score:'0.14'
GO'Term Count' P_Value' Benjamini
FN3' 9 5.30EF01 9.90EF01
Fibronectin,'type'III' 9 5.40EF01 1.00E+00
Immunoglobulin' 8 5.70EF01 1.00E+00
Fibronectin,'type'IIIFlike'fold' 9 5.80EF01 1.00E+00
Immunoglobulin'domain' 6 6.30EF01 9.50EF01
IGc2' 9 6.70EF01 1.00E+00
Immunoglobulin'subtype'2' 9 6.80EF01 1.00E+00
Immunoglobulin'IFset' 7 7.00EF01 1.00E+00
Immunoglobulin'VFset' 7 9.20EF01 1.00E+00
IG' 8 9.90EF01 1.00E+00
Immunoglobulin'subtype' 8 9.90EF01 1.00E+00
ImmunoglobulinFlike'fold' 12 1.00E+00 1.00E+00
ImmunoglobulinFlike' 12 1.00E+00 1.00E+00
Annotation'Cluster'98' Enrichment'Score:'0.13'
GO'Term Count' P_Value' Benjamini
tRNA'metabolic'process' 6 5.90EF01 1.00E+00
tRNA'aminoacylation'for'protein'translation' 3 7.60EF01 1.00E+00
tRNA'aminoacylation' 3 7.70EF01 1.00E+00
amino'acid'activation' 3 7.70EF01 1.00E+00
aminoacylFtRNA'ligase'activity' 3 7.80EF01 1.00E+00
ligase'activity,'forming'aminoacylFtRNA'and'related'compounds' 3 7.90EF01 1.00E+00
ligase'activity,'forming'carbonFoxygen'bonds' 3 7.90EF01 1.00E+00
Annotation'Cluster'99' Enrichment'Score:'0.12'
GO'Term Count' P_Value' Benjamini
synapse' 6 4.60EF01 9.50EF01
synapse' 3 7.90EF01 9.80EF01
cell'junction' 6 9.50EF01 1.00E+00
cell'junction' 3 1.00E+00 1.00E+00
Annotation'Cluster'100' Enrichment'Score:'0.11'
GO'Term Count' P_Value' Benjamini
Variant'SH3' 4 3.90EF01 1.00E+00
SH3' 6 9.60EF01 1.00E+00
Src'homologyF3'domain' 6 9.60EF01 1.00E+00
sh3'domain' 3 9.90EF01 1.00E+00
Annotation'Cluster'101' Enrichment'Score:'0.11'
GO'Term Count' P_Value' Benjamini
Zinc'finger,'RINGFtype,'conserved'site' 9 7.60EF01 1.00E+00
RING' 13 7.80EF01 1.00E+00
Zinc'finger,'RINGFtype' 13 7.80EF01 1.00E+00
Zinc'finger,'C3HC4'RINGFtype' 10 7.80EF01 1.00E+00
Annotation'Cluster'102' Enrichment'Score:'0.11'
GO'Term Count' P_Value' Benjamini
PHD' 4 7.50EF01 1.00E+00
Zinc'finger,'PHDFtype' 4 7.60EF01 1.00E+00
Zinc'finger,'PHDFfinger' 4 7.60EF01 1.00E+00
Zinc'finger,'PHDFtype,'conserved'site' 3 8.50EF01 1.00E+00
Annotation'Cluster'103' Enrichment'Score:'0.11'
GO'Term Count' P_Value' Benjamini
tpr'repeat' 4 6.80EF01 9.60EF01
TPR' 5 6.80EF01 1.00E+00
Tetratricopeptide'repeat' 5 6.90EF01 1.00E+00
TetratricopeptideFlike'helical' 5 8.80EF01 1.00E+00
Tetratricopeptide'region' 4 8.80EF01 1.00E+00
Tetratricopeptide'TPRF1' 3 9.00EF01 1.00E+00
Annotation'Cluster'104' Enrichment'Score:'0.1'
GO'Term Count' P_Value' Benjamini
proteasome' 3 7.60EF01 9.80EF01
proteasome'complex' 3 7.80EF01 1.00E+00
Proteasome' 3 8.30EF01 9.90EF01
Annotation'Cluster'105' Enrichment'Score:'0.1'
GO'Term Count' P_Value' Benjamini
tube'development' 6 7.10EF01 1.00E+00
tube'morphogenesis' 4 7.30EF01 1.00E+00
heart'development' 5 9.70EF01 1.00E+00
Annotation'Cluster'106' Enrichment'Score:'0.1'
GO'Term Count' P_Value' Benjamini
Transcription'factor,'fork'head,'conserved'site' 3 7.80EF01 1.00E+00
FH' 3 8.10EF01 1.00E+00
Transcription'factor,'fork'head' 3 8.10EF01 1.00E+00
Annotation'Cluster'107' Enrichment'Score:'0.09'
GO'Term Count' P_Value' Benjamini
C2'membrane'targeting'protein' 4 7.60EF01 1.00E+00
C2' 4 8.50EF01 1.00E+00
C2'calciumFdependent'membrane'targeting' 4 8.50EF01 1.00E+00
Annotation'Cluster'108' Enrichment'Score:'0.08'
GO'Term Count' P_Value' Benjamini
PIRSF001710:RasFrelated'protein'Rab' 3 7.20EF01 1.00E+00
RAB' 3 8.80EF01 1.00E+00
Ras'small'GTPase,'Rab'type' 3 8.80EF01 1.00E+00
Annotation'Cluster'109' Enrichment'Score:'0.08'
GO'Term Count' P_Value' Benjamini
cellular'component'morphogenesis' 10 6.00EF01 1.00E+00
axon'guidance' 3 6.50EF01 1.00E+00
neuron'development' 6 7.40EF01 1.00E+00
cell'morphogenesis' 7 7.90EF01 1.00E+00
cell'projection'morphogenesis' 5 8.30EF01 1.00E+00
cell'part'morphogenesis' 5 8.50EF01 1.00E+00
cell'motion' 8 9.00EF01 1.00E+00
cell'morphogenesis'involved'in'neuron'differentiation' 3 9.20EF01 1.00E+00
axonogenesis' 3 9.20EF01 1.00E+00
neuron'projection'morphogenesis' 3 9.20EF01 1.00E+00
cell'projection'organization' 5 9.30EF01 1.00E+00
neuron'projection'development' 3 9.30EF01 1.00E+00
cell'morphogenesis'involved'in'differentiation' 3 9.60EF01 1.00E+00
Annotation'Cluster'110' Enrichment'Score:'0.07'
GO'Term Count' P_Value' Benjamini
negative'regulation'of'nitrogen'compound'metabolic'process' 3 7.80EF01 1.00E+00
negative'regulation'of'nucleobase,'nucleoside,'nucleotide'and'nucleic'acid'metabolic'process'3 7.80EF01 1.00E+00
negative'regulation'of'cellular'biosynthetic'process' 3 8.50EF01 1.00E+00
negative'regulation'of'macromolecule'biosynthetic'process' 3 8.50EF01 1.00E+00
negative'regulation'of'biosynthetic'process' 3 8.60EF01 1.00E+00
negative'regulation'of'macromolecule'metabolic'process' 4 9.80EF01 1.00E+00
Annotation'Cluster'111' Enrichment'Score:'0.07'
GO'Term Count' P_Value' Benjamini
integral'to'Golgi'membrane' 3 6.00EF01 9.80EF01
intrinsic'to'Golgi'membrane' 3 6.00EF01 9.80EF01
glycosyltransferase' 8 6.80EF01 9.60EF01
Golgi'membrane' 4 8.00EF01 1.00E+00
integral'to'organelle'membrane' 3 8.40EF01 1.00E+00
Golgi'apparatus'part' 4 9.00EF01 1.00E+00
intrinsic'to'organelle'membrane' 3 9.00EF01 1.00E+00
protein'amino'acid'glycosylation' 3 9.60EF01 1.00E+00
biopolymer'glycosylation' 3 9.60EF01 1.00E+00
glycosylation' 3 9.60EF01 1.00E+00
golgi'apparatus' 5 9.70EF01 1.00E+00
glycoprotein'biosynthetic'process' 3 9.80EF01 1.00E+00
glycoprotein'metabolic'process' 3 9.80EF01 1.00E+00
Golgi'apparatus' 7 9.90EF01 1.00E+00
Annotation'Cluster'112' Enrichment'Score:'0.05'
GO'Term Count' P_Value' Benjamini
apicolateral'plasma'membrane' 3 8.10EF01 1.00E+00
apical'junction'complex' 3 8.10EF01 1.00E+00
cell'junction' 6 9.50EF01 1.00E+00
cellFcell'junction' 3 9.70EF01 1.00E+00
Annotation'Cluster'113' Enrichment'Score:'0.05'
GO'Term Count' P_Value' Benjamini
ZnF_C4' 3 8.80EF01 1.00E+00
Nuclear'hormone'receptor,'ligandFbinding' 3 8.80EF01 1.00E+00
Zinc'finger,'nuclear'hormone'receptorFtype' 3 8.80EF01 1.00E+00
Zinc'finger,'NHR/GATAFtype' 3 8.80EF01 1.00E+00
Steroid'hormone'receptor' 3 8.80EF01 1.00E+00
HOLI' 3 8.90EF01 1.00E+00
Nuclear'hormone'receptor,'ligandFbinding,'core' 3 8.90EF01 1.00E+00
ligandFdependent'nuclear'receptor'activity' 3 9.20EF01 1.00E+00
steroid'hormone'receptor'activity' 3 9.20EF01 1.00E+00
Annotation'Cluster'114' Enrichment'Score:'0.03'
GO'Term Count' P_Value' Benjamini
proteinaceous'extracellular'matrix' 4 9.00EF01 1.00E+00
extracellular'matrix' 4 9.20EF01 1.00E+00
extracellular'region'part' 6 9.70EF01 1.00E+00
Annotation'Cluster'115' Enrichment'Score:'0.02'
GO'Term Count' P_Value' Benjamini
cell'motion' 8 9.00EF01 1.00E+00
cell'motility' 5 9.70EF01 1.00E+00
localization'of'cell' 5 9.70EF01 1.00E+00
ameboidal'cell'migration' 3 9.80EF01 1.00E+00
cell'migration' 4 9.80EF01 1.00E+00
Annotation'Cluster'116' Enrichment'Score:'0.02'
GO'Term Count' P_Value' Benjamini
LRRNT' 3 9.50EF01 1.00E+00
LeucineFrich'repeat,'cysteineFrich'flanking'region,'NFterminal' 3 9.50EF01 1.00E+00
leucineFrich'repeat' 5 9.60EF01 1.00E+00
LeucineFrich'repeat' 3 1.00E+00 1.00E+00
Annotation'Cluster'117' Enrichment'Score:'0.01'
GO'Term Count' P_Value' Benjamini
Zinc'finger,'C2H2Ftype/integrase,'DNAFbinding' 13 9.40EF01 1.00E+00
Zinc'finger,'C2H2Flike' 15 9.90EF01 1.00E+00
ZnF_C2H2' 15 9.90EF01 1.00E+00
Zinc'finger,'C2H2Ftype' 15 1.00E+00 1.00E+00
Annotation'Cluster'118' Enrichment'Score:'0.01'
GO'Term Count' P_Value' Benjamini
HomeodomainFrelated' 10 9.70EF01 1.00E+00
Homeobox' 10 9.80EF01 1.00E+00
Homeobox,'conserved'site' 7 9.90EF01 1.00E+00
HOX' 8 9.90EF01 1.00E+00
Homeobox' 8 9.90EF01 1.00E+00
Annotation'Cluster'119' Enrichment'Score:'0'
GO'Term Count' P_Value' Benjamini
ion'transport' 9 9.50EF01 1.00E+00
ionic'channel' 4 1.00E+00 1.00E+00
ion'channel'activity' 4 1.00E+00 1.00E+00
substrate'specific'channel'activity' 4 1.00E+00 1.00E+00
passive'transmembrane'transporter'activity' 4 1.00E+00 1.00E+00
channel'activity' 4 1.00E+00 1.00E+00
Annotation'Cluster'120' Enrichment'Score:'0'
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